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Abstract 
The mucosal linings of the airways are constantly exposed to an array of 
microbial pathogens. During the course of respiratory viral infection, Airway epithelial 
cells (AEC) actively participate in the innate antiviral immune response by limiting the 
spread of respiratory viruses and by fostering a proinflammatory environment that 
attracts and activates players of the immune system. A key step in the establishment of 
the antiviral and proinflammatory state is the activation of Transcription Factors (TFs), 
such as Nuclear Factor (NF)-κB and Interferon Regulatory Factor 3 (IRF-3), which 
regulate the expression of antiviral and proinflammatory cytokines. 
For the efficient functioning of these events, the signaling pathways involved 
underlie strict regulatory mechanisms. Recent data suggest that Reactive Oxygen 
Species (ROS), which are produced upon viral infection, are able to regulate these 
intracellular signaling pathways. One important source of ROS is the NADPH oxidase 
(NOX) family of enzymes, which is composed of NOX1-5 and Dual Oxidase (DUOX) 
1 and DUOX2. The aim of our study was to identify the NADPH oxidase(s) that 
regulate(s) antiviral and proinflammatory mechanisms following infection of AEC 
with Respiratory syncytial virus (RSV), which causes major human lower respiratory 
tract complications, and Sendai virus (SeV), a non pathogenic virus. 
During the course of our studies we identified that NOX2 is a key molecule in 
the early proinflammatory response to RSV and SeV infection. We demonstrate that 
NOX2 is necessary for the activation of NF-κB. Consequently, NOX2 impacts on the 
proinflammatory cytokine secretion upon AEC infection. Further, we observed that 
expression of the ROS-generating NADPH oxidase DUOX2 is strongly increased 
following infection of AEC with SeV. We identified that DUOX2 induction requires 
the synergistic stimulation by IFNβ and TNFα. Importantly, DUOX2 exhibited ROS-
dependent antiviral action. We identified that DUOX2 was necessary for sustaining the 
levels of late antiviral cytokines IFNβ and IFNλ. 
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When AEC were infected with RSV, DUOX2 expression was barely detectable. 
Our data reveal that RSV has developed an evasion mechanism to counteract DUOX2 
induction likely contributing to RSV pathogenicity.  
In conclusion, our work demonstrates for the first time the specific implication of 
NOX2 and DUOX2 in the antiviral and proinflammatory response to respiratory virus 
infection. 	  	  
Key words: 
Airways, virus, innate immunity, cytokines, interferons, Reactive Oxygen Species, 
NADPH oxidase. 
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Résumé 
Les voies respiratoires sont exposées à une panoplie de pathogènes. Lors d’une 
infection virale respiratoire les cellules qui recouvrent ces voies participent activement 
à la défense immunitaire contre ces derniers en limitant la propagation du virus et en 
engendrant une réponse proinflammatoire. Un évènement clef dans ces processus est 
l’activation des facteurs de transcription, notamment le « Nuclear Factor » (NF)-κB et 
l’« Interferon Regulatory Factor -3 » (IRF-3), qui régulent l’expression des cytokines 
antivirales et proinflammatoires.  
Des données récentes démontrent que les dérivés actifs de l’oxygène (ROS), 
produits suite à une infection virale, ont la capacité de réguler les voies de signalisation 
enclenchées par NF-κB et IRF-3. Une source importante de ROS est la famille de 
NADPH oxydases (NOX), qui contient les membres NOX1-5 et DUOX1 et 2. 
L’objectif de notre étude était d’identifier la NOX qui régule les mécanismes 
antiviraux et proinflammatoires suite à l’infection avec le virus respiratoire syncytial 
(RSV), qui cause des complications respiratoires majeures, et le virus Sendai (SeV), un 
modèle viral non-pathogène.  
Nos travaux ont permis d’identifier que NOX2 est une molécule clef dans la 
réponse proinflammatoire suite à l’infection virale. Plus spécifiquement, NOX2 est 
important pour l’activation de NF-κB et la sécrétion des cytokines régulées par ce 
dernier. De plus, nous avons observé une forte augmentation de la présence de DUOX2 
dans les cellules de voies respiratoires humaines infectées par SeV. Une étude plus 
approfondie nous a permis de caractériser qu’une synergie entre deux cytokines 
secrétées lors de l’infection, soit l’interféron (IFN) β et le TNFα, est responsable de 
l’induction de DUOX2. Nous avons aussi découvert que DUOX2 confère une activité 
antivirale et est nécessaire pour maintenir les taux des cytokines antivirales tardives 
IFNβ et IFNλ.  
 Lors d’une infection avec RSV, l’induction de DUOX2 n’est pas détectable. 
Nous avons  mis en évidence que RSV interfère avec l’expression de DUOX2 ce qui 
pourrait suggérer sa pathogénicité.  
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En conclusion, nos travaux démontrent pour la première fois une implication 
spécifique des NADPH oxydase NOX2 et DUOX suite aux infections virales 
respiratoires. 
 
Mots clefs : 
Voies aériennes, virus, immunité innée, cytokines, interférons, dérives actifs de 
l’oxygène, NADPH oxydase. 
 
 
 	  
	   v 
Table of Contents 
Abstract i 
Résumé iii 
Table of Contents v 
Table index ix 
Figure index xi 
Abbreviations xiii 
Acknowledgements xix 
1 INTRODUCTION 1 
1.1 The Paramyxoviridae – Respiratory viruses of etiologic importance 3 
1.1.1 The Paramyxoviridae family 3 
1.1.2 RSV and SeV virion structure 5 
1.1.3 RSV and SeV genome organization 6 
1.1.4 RSV and SeV replication cycle 7 
1.1.4.1 Virus attachment and entry 7 
1.1.4.2 Viral mRNA synthesis 8 
1.1.4.3 Genome replication 9 
1.1.4.4 Virion assembly and virion release 9 
1.2 The airway response to respiratory virus infection 12 
1.2.1 Airway physiology at the site of infection 12 
1.2.2 Airway defense mechanisms 14 
1.2.3 The AEC response to viral infection 19 
1.2.3.1 Viral recognition by Retinoic acid inducible gene-I (RIG-I)-like receptors 
(RLRs) 20 
1.2.3.2 IRF-3 and NF-kB activation in RLR signaling lead to antiviral and 
proinflammatory cytokines production 22 
1.2.3.3 Viral detection by Toll-like receptors (TLRs) 25 
	   vi 
1.2.3.4 The IFN-induced JAK-STAT pathway 26 
1.2.3.5 Establishment of the antiviral state by ISGs 27 
1.2.3.6 The TNF receptor 1 (TNFR1) signaling pathway 30 
1.2.4 Viral modification and evasion of antiviral immunity 33 
1.2.4.1 General viral evasion mechanisms 33 
1.2.4.2 Blocking IFN production 34 
1.2.4.3 Evasion of the IFN-mediated induction of the antiviral state 34 
1.2.4.4 Interference with innate and adaptive immune responses 35 
1.3 RSV-induced pathology – a multifaceted syndrome 37 
1.3.1 RSV-induced airway obstruction 39 
1.3.2 Inflammation and infiltration of innate immune players 39 
1.3.3 Adaptive immune responses 41 
1.4 ROS and their role in regulation of cellular signaling pathways 43 
1.4.1 The nature of ROS 44 
1.4.2 The origin of ROS 45 
1.4.3 The NADPH oxidase (NOX) family of enzymes 47 
1.4.3.1 NADPH oxidase composition 50 
1.4.4 The NOX2 NADPH Oxidase 51 
1.4.4.1 Mechanism of ROS generation by NOX2 51 
1.4.4.2 Regulation of NOX2 expression 53 
1.4.5 The DUOX2 NADPH oxidase 54 
1.4.5.1 Mechanism of ROS generation by DUOX2 54 
1.4.5.2 Regulation of DUOX2 and DUOXA2 expression 56 
1.4.6 Mechanisms of ROS action 57 
1.4.6.1 Oxidative Protein Modification 57 
1.4.7 Evidence of ROS production in virus-infected cells 59 
1.4.8 Regulation of antiviral signaling pathways by ROS 60 
1.4.8.1 Redox regulation of the NF-kB signaling pathway 61 
1.4.8.2 Redox regulation of the interferon response 64 
	   vii 
1.4.9 NADPH oxidase-dependent regulation of NF-kB 65 
1.5 NADPH oxidases in antimicrobial lung defenses 68 
1.5.1 The many roles of DUOXs in the airway epithelial immunity 68 
1.5.1.1 DUOXs contribute to airway antimicrobial defense 68 
1.5.1.2 DUOXs and airway inflammation 71 
1.5.1.3 NOX/DUOX enzymes as regulators of airway epithelial integrity 72 
1.5.2 The role of NOX2 in airway immunity 73 
1.5.2.1 NOX2 controls inflammation 74 
1.5.2.2 NOX2, a pleiotropic regulator of innate immunity 76 
1.5.2.3 Polyvalent functions of NOX2 in lung structural cells 77 
1.6 Study hypothesis and strategy 79 
2 RESULTS 81 
2.1 Dual role of NOX2 in Respiratory Syncytial virus- and Sendai virus-induced 
activation of NF-κB in airway epithelial cells 83 
2.1.1 Context and resume of results 83 
2.1.2 Author contributions 84 
2.1.3 Article 86 
2.2 IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent 
pathway triggering a novel DUOX2 NADPH Oxidase-mediated airway antiviral 
response 135 
2.2.1 Context 135 
2.2.2 Author contributions 136 
2.2.3 Article 137 
3 DISCUSSION 185 
4 CONCLUSION 207 
	   viii 
5 BIBLIOGRAPHY 211 
6 ANNEX I 	  
 
	   ix 
Table index 
 
Table I: Examples of members of the Paramyxoviridae family………………………..4 
Table II: NADPH oxidase expression pattern and dependency on regulatory 
subunits………………………………………………………………………………..49 
 
	   x 
	   xi 
Figure index 
 
Figure 1: RSV pleiomorphic forms……………………………………………………..5 
Figure 2: RSV virion structure………………………………………………………….6 
Figure 3: SeV and RSV genome………………………………………………………..7 
Figure 4: The Paramyxoviridae replication cycle……………………………………..11 
Figure 5: Summary of pulmonary physiology and defenses…………………………..16 
Figure 6: AEC defense mechanisms against respiratory viruses……………………...19 
Figure 7: The virus-induced IFN response…………………………………………….29 
Figure 8:  TNF-induced NF-κB activation…………………………………………….32 
Figure 9: Factors influencing the pathogenesis and clinical disease caused by RSV 
infection in infants and children……………………………………………………….38 
Figure 10: ROS-generating and ROS-involving reactions…………………………….47 
Figure 11: NOX2 structure and NADPH oxidase-dependent ROS production……….53  
Figure 12: Structural organization of the DUOX2 NADPH oxidase………………….56 
Figure 13: Redox modification of cysteine residues…………………………………..59 
Figure 14: NOX2 and DUOX2 in the antiviral airway defense……………………...208 
 
  
 
 
 
 
 
  
  
 
	   xii 
 
	   xiii 
Abbreviations 
ADAM17 A Disintegrin and Metalloproteinase 17 
AEC Airway epithelial cells 
AIR Autoinhibitory region 
ALI Air-liquid interface 
ARE Apical recycling endosome 
ASGM1 Asialo-GM1 
ASL Airway surface liquid  
ATP Adenosine triphosphate  
ATRA All-trans retinoic acid  
BALF Bronchoalveolar lavage fluid  
c-Flip Cellular FLICE-like inhibitory protein 
CARD Caspase recruitment domain 
CBP Creb binding protein  
cDC Conventional dendritic cell 
CF Cystic fibrosis 
CFTR Cystic fibrosis transmembrane conductance regulator 
CH Congenic hypothyroidism  
cIAP Cellular inhibitor of apoptosis 
COPD Chronic obstructive pulmonary disease 
COX Cyclooxygenase 
DBD DNA binding domain 
DC Dendritic cell 
DCFDA Dichlorofluorescin diacetate 
DD Death domain  
DI Defective interfering  
ds Double strand 
DUOX Dual oxidase 1 
DUOXA DUOX activator  
EGFR Epidermal growth factor receptor 
EGFα Epidermal growth factor α 
EMCV Encephalomyocarditis virus 
ENA-78 Epithelial neutrophil activating protein-78 
ER Endoplasmatic reticulum 
Erk Extracellular signal-regulated kinase 
ENaC Epithelial sodium channel 
F Fusion protein  
FAD Flavin adenine dinucleotide 
FADD FAS-associated death domain-containing protein  
FI-RSV Formalin-inactivated RSV vaccine  
G Glycoprotein  
GAS  γ-interferon activated sequence 
GCD Chronic granulomatous disease 
	   xiv 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
Gro-a Growth-regulated oncogene α 
HCV Hepatitis C virus  
HIV Human immunodeficiency virus 
HN Hemagglutinin neuraminidase  
HNE Human neutrophil elastase 
IAD IRF association domain 
ICAM Intercellular adhesion molecule 
IFIT1 Interferon-induced protein with tetratricopeptide repeats 1  
IFN Interferon 
IFN-lR1 IFNλ receptor 1  
IFNAR IFNα receptor  
IKK IκB kinase  
IL Interleukin 
IP-10 IFNγ-induced protein  
IP3  Inositol triphosphate 
IRF Interferon regulatory factor  
ISG Interferon stimulated gene 
ISGF3 Interferon stimulated gene factor 3 
ISRE Interferon stimulated response element  
JAK1 Janus kinase 1  
JUNK C-Jun-NH2-terminal kinase 
kb kilobases 
leRNA Leader RNA 
LGP2 Laboratory of genetics and physiology 2  
LOX Lipoxygenase 
LPO Lactoperoxidase 
LPS Lipopolysaccharide 
LUBAC Linear ubiquitin chain assembly complex 
M Matrix protein  
MDA5 Melanoma differentiation-associated gene 5  
MeV Measles virus  
MIP-1α Macrophage inflammatory protein-1a 
MMP9 Matrix Metalloprotease 9 
mRNA Messenger ribonucleic acid 
MSK-1 Mitogen and stress related kinase 1 
Muc Mucin 
MuV Mumps virus  
N Nucleocapsid protein  
NADPH Nicotinamide Adenine Dinucleotide Phosphate Hydrogen 
NAP1 NAK-associated protein 1 
NEBs Neuroepithelial bodies  
NEMO NF-κB modulator  
NK Natural Killer  
NLRX1 Nucleotide-binding oligomerization domain (NOD), leucine 
	   xv 
rich repeat containing X1  
NOD Nucleotide-binding oligomerization domain 
NOX NADPH oxidase 
NS Non structural protein  
OAS1 2’, 5’-oligoadenylate synthetase  
OSCN- Hypothiocyanate 
P Phosphoprotein  
PAMP Pathogen associated molecular pattern  
pDC Plasmacytoid dendritic cell 
PI3K Phosphoinosite 3 kinase 
PIV Human parainfluenza virus  
PKA Protein kinase A 
PKAc cAMP dependent protein kinase A  
PKC Protein kinase C 
PKR Protein kinase R  
PMA Phorbol-12-myristate-13-acetate 
PRR Pathogen recognition receptors 
PTP1B  Protein tyrosine phosphatase 1B 
RANTES Regulated and normal T cell expressed and secreted 
RD Repressor domain  
RHD Rel homology domain 
RNA Ribonucleic acid 
RIG-I Retinoic acid inducible gene-I 
RIP1 Receptor interacting protein 1  
RLR RIG-I-like receptor 
RNAi RNA interference 
RNS Reactive nitrogen species 
RSV Respiratory syncytial virus  
RV  Rhinovirus 
SCN- Thiocyanite 
SeV Sendai virus  
SH Short hydrophobic protein 
SH3  C-terminal Src homology 3  
SHP-2 Src-homology 2 containing protein phosphatase 2 
SOCS Suppressors of cytokine signaling   
SOD Superoxide dismutase 
SP Surfactant proteins  
ss Single-strand 
STAT Signal transducer and activator of transcription  
TAB TAK1-binding protein 
TACE TNFα-converting enzyme  
TAD Transactivation domain 
TAK1 Transforming growth factor β-activated kinase 1  
TANK TRAF family member associated NF-kB activator 
TBK1 TANK-binding kinase 1 
	   xvi 
TCR T cell receptor 
TF Transcription factor 
TGFα Tumor growth factor α 
Th T helper 
TJ Tight junction 
TLR Toll-like receptor 
TM Transmembrane domain 
TNFa Tumor necrosis factor α 
TNFR1 Tumor necrosis factor receptor 1 
TRADD Tumor necrosis factor receptor type 1-associated death 
domain protein  
TRAF TNF receptor associated factor 
trRNA Trailer RNA 
TSS Transcription star site 
Tyk2 Tyrosine kinase 2  
VEGF Vascular endothelial growth factor  
VEGF Vasoactive Endothelial Growth Factor 
vRNAP Viral RNA-dependent RNA polymerase 
WHO World health organization  
α Alpha 
β Beta 
γ Gamma 
ε Epsilon 
κ Kappa 
λ Lambda 
ω Omega 	  
	   xvii 
 
 
 
 
An meine zwei cocos, Mattias und Nathaniel 
 
 
Man sieht nur mit dem Herzen gut, 
das Wesentliche ist für die Augen unsichtbar. 
Antoine de Saint-Exupéry 
	   xviii 
	   xix 
Acknowledgements 	  
I am truly thankful to all the individuals that have contributed to and enriched my 
Ph.D. studies in so many different ways over the last years. Me sitting here and writing 
the following sentences would not be possible without you. Thank you! Merci! Danke! 
D’abord j’aimerais remercier ma directrice de recherche Nathalie Grandvaux. 
Merci pour la confiance que tu m’as attribuée en étant la première étudiante de ton 
laboratoire. Merci pour les heures que tu as passées à m’enseigner tout le savoir 
nécessaire afin d’avancer dans ma recherche et la complétion de mon doctorat.  
J’aimerais également remercier les membres du jury. Nikolaus Heveker, Guy 
Lemay et Albert van der Vliet, merci d’avoir accepté d’évaluer mes travaux de 
recherché de doctorat. 
À tous les membres du laboratoire, merci de m’avoir soutenue pendant ces 
années, merci d’avoir partagé des heures et des heures au laboratoire avec moi. Si 
j’avais été toute seule dans ces moments, le travail n’aurait pas été le même! Merci 
Anton, Alexis et Annick d’avoir été présents pour moi, de m’avoir appris comment 
parlent les Québécois, de m’avoir fait apprécier plus le hockey. Merci Annick de 
penser encore à moi quand tu fais des petites activités avec ton trésor. Merci 
Esperance, pour ton soutien au laboratoire, ton esprit calme et tranquille, pour ton 
oreille ouverte à mes soucis lors des heures de manips dans la salle de culture. Fabrice, 
merci de ne m’avoir jamais jugée parce que j’ai plus que 30 ans, je n’ai pas 200 
ami(e)s facebook et je ne sors pas à tous les jours de la semaine. Stéfany, ton arrivée au 
labo a donné beaucoup de plaisir à tout le monde, moi incluse. Merci ! Avec toi toutes 
les journées sont des bonnes journées, où le soleil brille et nos petits soucies 
deviennent insignifiants. Merci Julie, tu es sans comparaison la personne la plus 
agréable à travailler avec. Merci pour ton calme et tous les biscuits chinois bizarres que 
tu as partagés avec moi. Et il reste à remercier le triumvirat français, Lydie, Virginie et 
Nicolas. Merci de m’avoir réappris le français de la France. Merci Lydie pour ton élan 
contagieux au travail, pour toutes tes petites anecdotes sur la vie de la maman d’une 
	   xx 
princesse. Virginie, tu es la plus efficace des efficaces au téléphone, j’aimerais 
t’engager pour régler mes comptes au téléphone. Merci pour tes efforts et conseils. Et 
Nicolas, qui est extrêmement bon avec les ordinateurs, mais un peu moins bon en 
pâtisserie, merci pour les bonbons, la crème glacée, les chocolats. Grace à toi je n’ai 
jamais eu des problèmes à garder mon poids. 
Merci aux collègues des autres laboratoires. Il y a Nathalie, qui a été 
sympathique avec moi dès le début et qui n’a jamais cessé de l’être. Merci, ma 
meilleure amie de la Rive Sud. Merci aussi à toi, Sandy, co-habitante en diagonal du 
bureau d’étudiante. Merci pour tes petits 5-10 min que tu m’as consacrées à plusieurs 
reprises lorsque j’avais besoin de me changer les idées. Merci les filles pour des lunchs 
super agréables.  
Merci à Malek, qui a partagé le même chemin que moi depuis le début, qui m’a 
encouragée à des diverses moments avec des délicieux Baklavas. Merci aussi à Amal, 
tant des conseils tu m’a donnés par rapport à tout. Merci Mohammed, avec toi on était 
jamais seule au labo, parce que tu travailles trop fort. Loubna, depuis que tu es partie 
ce n’est pas la même chose. Merci pour tout le temps que tu as pris pour moi sur le 
Rotorgene. 
Merci aussi aux Manons (Bourcier et Livernois) pour toute votre aide 
organisationelle et vos histoires parfois hilarantes aux heures du lunch.  
I also would like to thank my dearest and best friend Anna, whom I know since 
my very first days in Montreal. Thank you so much for having shared so many 
different steps during the last years with me: immunology benchmate, party friend, 
roommate, work colleague, friend, self-proclaimed godmother of my babies, park 
hang-out friend. Hopefully you have enjoyed all this as much as I did.  
J’aimerais aussi remercier toutes les personnes qui se sont occupées de mon petit 
monstre Mattias. D’avoir la confiance de le laisser entre vos mains, de savoir qu’il est 
bien avec vous, a énormément aidé sur mon cheminement de travail. Merci Juliana! 
Merci aux éducatrices du CPE Viroulu!  
	   xxi 
Myriam et André, les beaux grands parents de mes enfants, merci également pour 
votre aide, votre soutien, votre écoute lors des dernières années de mes études. Merci 
pour toutes les journées où vous m’avez dépannée à garder Mattias s’il fallait aller au 
labo. Merci pour toutes les corrections que vous avez faites sur mes textes. 
Mama und Papa, ohne eure unendliche Zuversicht in meine Ideen und Pläne, 
eure Unterstuetzung in all meine Projekte hätte ich es wohl nie soweit geschafft. 
Danke, dass ihr mich immer auf meinen Wegen, wenn sie auch recht weit von euch 
entfernt waren, begleitet habt.  
Ian, merci pour tous tes encouragements, tes conseils, les discussions 
scientifiques et autres. Merci de toujours avoir compris ce que c’est faire un doctorat, 
faire de la recherche, avec ses hauts et ses bas. Ce travail n’aurait pas pu être fait sans 
toi. J’aimerais être un jour tellement importante pour toi comme tu l’étais pour moi lors 
des dernières années.  
Mattias und Nathaniel, auch wenn es euch vielleicht nicht immer leicht gefallen 
ist mich bei diesem Studium zu unterstuetzen, mich zu vielen Stunden mit Zellen, 
Mikroskop, Viren und der Schreiberei zu teilen, möchte ich dass ihr wisst wie sehr ich 
euch für eure unendliche Geduld dankbar bin. Letztendlich habt ihr mir die Kraft 
gegeben in den allerschwierigsten Momenten nicht einfach alles aufzugeben. Ihr seid 
meine Welt, vielen vielen Dank. 
 
 
 
 
 
 	  	  

 1 Introduction 
	   2 
	   3 
1.1 The Paramyxoviridae – Respiratory viruses of etiologic 
importance 
 
The Paramyxoviridae family contains some of the most severe respiratory viruses, 
whose infection might lead to respiratory tract disease. One of these is Respiratory 
Syncytial Virus (RSV). The first chapter of this doctoral thesis aims to introduce 
notions of the Paramyxoviridae family of viruses in terms of their family organization, 
virion structure, genomic organization and replication cycle. The focus will be on 
characteristics related to the two relevant viruses used in this study, RSV and Sendai 
virus (SeV). 
 
 
1.1.1 The Paramyxoviridae family  	  
Paramyxoviridae viruses are enveloped, negative-sense, single-stranded RNA viruses 
of the Mononegavirales order. The family is subdivided into two subfamilies, the 
Paramyxovirinae and the Pneumovirinae. The Paramyxovirinae subfamily divides 
itself into seven genera: Respirovirus, Rubulavirus, Morbillivirus, Avulavirus, 
Henipavirus, Acquaparamyxovirus and Ferlavirus (Knipe et al., 2001) (Table 1). Some 
important etiologic agents of this subfamily include different strains of Human 
Parainfluenza Virus (PIV; Respirovirus and Rubulavirus genera), Mumps virus (MuV; 
Rubulavirus genus), and Measles virus (MeV; Morbilivirus genus). Sendai virus (SeV), 
a member of the Respirovirus genus, is a murine parainfluenza virus type 1. It infects 
rodents and is believed to be the leading cause of pneumonia in mice (Faisca and 
Desmecht, 2007). In the laboratory, SeV is a prominent model in the study of the 
airway response to respiratory infections. The second subfamily, termed 
Pneumovirinae, is divided into two genera, Pneumovirus and Metapneumovirus, 
among which Respiratory Syncytial Virus (RSV; genus Pneumovirus) is an important 
etiologic agent (Table 1). RSV causes about 60% of all lower respiratory tract 
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infections in infants and is additionally a major cause for severe respiratory morbidity 
and mortality in elderly and immunocompromised individuals (Hall, 2001). It is also 
becoming increasingly acknowledged that RSV infection can lead to respiratory 
complications in healthy adults (Walsh, 2011). The World Health Organization (WHO) 
estimates that RSV is responsible for 64 million clinical infections and 160,000 deaths 
annually worldwide (Falsey et al., 2005). In the United States, RSV is the most 
frequent cause for hospitalization in infants (Leader and Kohlhase, 2002).  
 
 
Table I: Examples of members of the Paramyxoviridae family 
Family Paramyxoviridae  
Subfamily 
Paramyxovirinae 
 
Genus Rubulavirus Mumps virus (MuV) 
 Human parainfluenza virus type 2, type 4a and 4b 
Genus Avulavirus Newcastle disease virus (NDV) 
Genus Respirovirus Sendai Virus (SeV) 
 Human parainfluenza virus type 1 and type 3 
(hPIV1/3) 
Genus Henipavirus Hendra virus (HeV) 
 Nipah virus (NiV) 
Genus Morbillivirus Measles virus (MeV) 
Subfamily Pneumovirinae  
Genus Pneumovirus Human respiratory syncytial virus (hRSV) 
Genus Metapneumovirus Human metapneumovirus (hMPV) 
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1.1.2 RSV and SeV virion structure 
 
Paramyxoviridae are pleiomorphic in structure – both spherical and filamentous 
forms of the virus have been observed (Figure 1) (Bachi and Howe, 1973). 
Paramyxoviridae contain a lipid bilayer envelope, which is derived from the plasma 
membrane of the host cell during viral budding (Harrison et al., 2010). Inserted into 
this membrane envelope are two surface proteins:  Glycoprotein (G) and Fusion protein 
(F) for RSV; and Hemagglutinin Neuraminidase (HN) and F protein for SeV (Figure 
2). These membrane proteins serve two principal functions: first, viral attachment, and 
second, viral entry (Chang and Dutch, 2012). It is noteworthy to mention that RSV 
possesses a third membrane protein, the short hydrophobic protein (SH), which does 
not have a function in attachment or fusion. Inside the virion lies the nucleocapsid core, 
which contains the RNA genome surrounded by the Nucleocapsid protein (N), 
complexed to the Phosphoprotein (P) and the Large protein (L), the latter two forming 
the viral RNA-dependent RNA polymerase (vRNAP). Between the envelope and core, 
just below the inner membrane layer, lies the viral Matrix (M) protein, which is vital in 
determining virion architecture, and which is released from the core during virus entry. 
In addition, the viral M protein plays a central role in viral budding (Knipe et al., 
2001).  
Figure	  1: RSV pleiomorphic forms.  
Electron microscopy images of filamentous (A) and spherical (B) RSV virions budding 
from Vero cells.  From (Bachi and Howe, 1973), with permission from the American 
Society for Microbiology. 
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1.1.3 RSV and SeV genome organization 
 
The Paramyxoviridae genome is a negative-sense, single-strand genome of 15-19 
kb that encodes 6 and 10 viral genes for SeV and RSV, respectively (Figure 3). The 
genome generally possesses a 3’-extracistronic region of approximately 50 bp, called 
the “Leader” region, and a 5’-“Trailer” region of 50-161 bp. Between genes, intergenic 
sequences are found that serve as termination and initiation sequences in mRNA 
synthesis (Knipe et al., 2001). The SeV genome encodes for the following proteins in a 
3’-5’ order: 3’-N-P/C/V-M-F-HN-L-5’. P, C and V proteins are encoded from one P 
gene whose mRNA has several open reading frames. In contrast, the RSV genome 
encodes for 11 proteins in the following 3’-5’ order: 3’-NS1-NS2-N-P-M-SH-G-F-M2-
L-5’. The M2 gene is transcribed into an mRNA with two overlapping reading frames 
Figure 2: RSV virion structure.  
Schematic representation of the RSV virion structure. The viral envelope is made up of 
the plasma membrane into which viral proteins F, G and SH are inserted. Beneath the 
membrane layer lies the M protein. The nucleocapsid is made up of the viral genome 
that is tightly encapsidated by N.  N is complexed to P and L proteins that make up the 
vRNAP. Adapted from (Knipe et al., 2001). 
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resulting in the synthesis of two proteins, M2-1 and M2-2 (Knipe et al., 2001). RSV 
and SeV also code for accessory proteins that are not present in the infecting virion but 
have important roles as inhibitors of the host antiviral defense. Notably, NS1 and NS2 
proteins of RSV, and V and C proteins of SeV can foster evasion of the antiviral 
response (Gotoh et al., 2001). 
 
 
 
 
1.1.4 RSV and SeV replication cycle 
 
1.1.4.1 Virus attachment and entry 
Before infection of the host cell can occur, virus particles have to attach to their 
target cells, which brings the virion and host cell into close proximity. Then 
Paramyxoviridae entry into the host cell is mediated by fusion of the virus with the 
cellular membrane (Figure 4). These steps, attachment and entry, are assured by the 
viral attachment and fusion proteins G and F for RSV, and HN and F for SeV. In order 
for attachment to occur, certain viruses will attach to cell surface molecules found on 
the exterior of the host cell. This is the case for SeV, as SeV HN protein attaches to 
Figure 3: SeV and RSV genome.  
Schematic representation of the SeV and RSV genome. For explanation, see RSV and 
SeV genome organization. Adapted from (Knipe et al., 2001). 
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sialic acid containing cell surface glycoproteins and glycolipids (Villar and Barroso, 
2006). RSV, on the other hand, attaches to glycosaminoglycans containing the 
disaccharide heparan sulfate and chondroitin sulfate via the G protein (Feldman et al., 
1999; Krusat and Streckert, 1997). After attachment, the F protein initiates the fusion 
process, whereby the nucleocapsid is delivered into the cytoplasm. A recent 
publication has demonstrated that cholesterol-rich lipid raft domains are important for 
RSV entry into airway epithelial cells (AEC) (San-Juan-Vergara et al., 2012). Their 
viral entry can occur either through receptor-mediated endocytosis or direct penetration 
at the plasma membrane. Both processes have been described in the case of SeV and 
RSV infection (Kolokoltsov et al., 2007; Rasmusson et al., 1998; Srinivasakumar et al., 
1991). In the context of RSV fusion with the plasma membrane, the protein nucleolin 
has recently been decribed as a novel fusion receptor as it interacts with RSV-F at the 
cell surface and is essential for efficient RSV infection (Tayyari et al., 2011).  
 
1.1.4.2 Viral mRNA synthesis  
Once the virion is released into the cytoplasm, the next strategic step in the virus 
cell cycle is the generation of viral proteins that will provide building material for new 
virions. Some viral proteins also serve to interfere with the host metabolism in order to 
increase the potential for efficient viral replication. The Paramyxoviridae life cycle is 
entirely cytoplasmic (Figure 4). The virus brings its own vRNAP, which is a complex 
consisting of a tetramer of P proteins and one L protein. P proteins serve to recruit L 
proteins to the viral genome, which is strongly encapsidated by the N protein (Cowton 
et al., 2006). This polymerase transcribes the incoming negative sense genome into 5’-
capped, 2-O-methylated and 3’-polyadenylated mRNAs, an activity that is assured by 
the L protein (Liuzzi et al., 2005). All viral RNA synthesis begins at the 3’ end of the 
genome, where a cis-acting promoter sequence initiates the synthesis of short, non-
coding leader RNAs. At the beginning of the viral cycle, vRNAP is restricted to the 
production of these leader RNAs and thereafter mRNAs (Cowton et al., 2006). 
Scrolling down the viral genome, vRNAP terminates and reinitiates at each gene 
junction, thereby generating an mRNA transcript for each encoded gene. However, 
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vRNAP does not always reinitiate mRNA synthesis at the next gene junction, as it has 
a tendency to dissociate from its template at these sites. This in turn leads to a 
decreasing gradient of mRNA abundance from the genome’s 3’ end onward. This 
gradient of mRNA results in defined quantities of the viral N protein, which determine 
the balance between mRNA synthesis and genome replication. Once a sufficient 
amount of N protein is present in the cell, viral mRNA synthesis stops and vRNAP 
engages into the viral replication process (Knipe et al., 2001). It is noteworthy to 
mention that the RSV accessory M2-1 protein interacts with P and viral RNA. M2-1 
has been shown to be an essential transcription elongation factor, because in its 
absence RSV does not transcribe beyond the NS1 and NS2 genes (Fearns and Collins, 
1999). M2-2 is non-essential for viral growth but may be involved in the regulation of 
balancing viral transcription and viral replication (Bermingham and Collins, 1999). 
 
1.1.4.3 Genome replication  
The Paramyxoviridae negative-sense genome replicates via an intermediary full-
length complementary copy called the antigenome. For antigenome synthesis, vRNAP 
copies the negative sense genome but ignores all of the junctional signals and editing 
sites. It synthesizes an exact complementary positive-sense antigenome that becomes 
immediately bound by N proteins. This antigenome serves as a template for genome 
replication. The 3’ end of the antigenome contains a promoter that is recognized by 
vRNAP, which initiates synthesis of the genome in a manner similar to antigenome 
synthesis, i.e. ignoring all gene junctions (Cowton et al., 2006). Under conditions 
where sufficient unassembled N protein is present, encapsidation of the nascent 
genome prevents termination and leads to the synthesis of an encapsidated minus-
strand genome. 
 
1.1.4.4 Virion assembly and virion release  
Once the viral genome has replicated, sufficient building blocks for new virion 
assembly have been synthesized and nucleocapsid assembly is terminated. Virion 
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assembly can therefore begin and will culminate in the release of new virions. 
Nucleocapsids are assembled in two steps: first, free N subunits associate with the 
genome to form the helical ribonucleoprotein structure of viral genomic RNA and N; 
second, the RNA:N complex associates with the P and L protein complex. Virion 
assembly then takes place at the cell surface (Harrison et al., 2010). The viral integral 
membrane proteins are synthesized in the ER and undergo maturation or glycosylation 
in the Golgi complex before being transported through the secretory pathway and 
integrated into the cellular membrane. The viral M protein associates with these 
transmembrane glycoproteins at locations where budding occurs. The clear mechanism 
of assembly at the membrane is still unknown but the viral M protein is thought to play 
a major role in bringing the nucleocapsid to the plasma membrane to finalize the 
formation of the budding virion (Ghildyal et al., 2006). In this process, viral proteins 
also interact with host cellular factors and these interactions will drive viral budding. 
For instance, M protein, as well as SeV C protein, interacts with cellular molecules of 
the vacuolar sorting pathway to organize the assembly of the nascent virion (Irie et al., 
2007; Sakaguchi et al., 2005). For SeV and RSV it has been shown that viral budding 
preferentially takes place at apical side of AEC (Zhang et al., 2002). In this context, the 
cellular apical recycling endosome (ARE) plays an important role (Brock et al., 2003). 
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Figure 4: The Paramyxoviridae replication cycle. 
Following viral entry, the negative-sense viral genome serves as a template for viral 
mRNA synthesis by the vRNAP. Viral protein synthesis then occurs. When enough 
building blocks have been generated, viral genome replication begins. The negative-
sense viral genome is generated by the vRNAP via a positive-sense antigenome 
intermediate. Viral genomes are rapidly encapsidated and transported to virion assembly 
sites at the membrane. Following assembly, virions are released by budding from the 
plasma membrane. 
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1.2 The airway response to respiratory virus infection 
 
The airways are a complex barrier that separates the exterior environment with its 
hazardous components from our body. The following chapter will introduce airway 
physiology and airway defense strategies that serve to minimize or combat respiratory 
infections. These mechanisms range from general airway cell defense mechanisms to 
the specific detection of viral pathogens, leading to the initiation of a more global 
airway immune response. Lastly, Paramyxoviridae evasion of these mechanisms and 
resulting pathology will be discussed. 
 
 
1.2.1 Airway physiology at the site of infection 
 
The classical lung anatomy model consists of 24 generations of dichotomously 
branching airway tubes, where each tube divides into two smaller airways. At each 
division, the diameter of the airway decreases (Weibel, 1963). From the trachea to the 
bronchi (generation 0-10), the airways form a moderately tight pseudo-stratified 
ciliated columnar epithelium, exhibiting Transepithelial Electric Resistance (TEER) 
measurements of approximately 300 Ωcm2 (Wijkstrom-Frei et al., 2003). The main 
purpose of the epithelium in these proximal airways is to filter particles and kill 
invading microbes. The three main cell types present in this section of the airways are: 
ciliated cells, goblet cells, and basal cells. The main function of ciliated cells is to 
propel foreign particles and organisms out of this airway region via the mucociliary 
clearance mechanism. The goblet cell, which extends from the larger to the smaller 
bronchi, but is absent in the bronchioles, contains abundant granules for mucus 
secretion. Basal cells are the stem cell-like progenitor cells of the surface epithelium, 
and all ciliated and non-ciliated cells in the bronchial mucosa are derived from basal 
cells. Basal cells can survive mucosal injury, and consequently serve in the 
reconstruction of the bronchial mucosa (Fischer, 2009). The epithelium is covered with 
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a layer of airway surface liquid (ASL). The ASL is made up of two phases, the first of 
which is a periciliar layer of thin fluid film, into which the cilia beat at a rate of 12-16 
beats/second (Ng et al., 2004; Rutland et al., 1982; Tomashefski et al., 2008). Glands 
which are present in the submucosa of the trachea and bronchi, and which contain 
mucus and serous cells, contribute to the secretion of this mucus layer. The second 
phase is a high-viscosity upper mucus layer, which originates from submucosal glands, 
but also from goblet cells. The ASL contains a variety of molecules that serve in 
airway antimicrobial defense (Ganz, 2002) (Vareille et al., 2011).  
The membranous bronchioles are located in the descending airways. Here, the 
diameter of the airway decreases to about 1 mm (Tomashefski et al., 2008). 
Membranous bronchioles are lined by ciliated columnar epithelial cells and non-
ciliated Clara cells. Clara cells replace the disappearing goblet cells. The Clara cell also 
contains an abundance of secretory granules that primarily secrete antimicrobial and 
immunomodulatory surfactant proteins (SP). Due to its function as a reserve and 
reparatory cell, the Clara cell replaces the basal cell in the bronchioles. The terminal 
bronchiole leads into the acinus, the functional unit of the lung, which consists of the 
respiratory bronchiole, the alveolar ducts, the alveolar sac and the alveoli. The alveolar 
sac and the alveoli are the site of gas exchange. The alveoli are made up of large, thin 
type I cells, which only account for 40% of the alveolar lining cells, but cover 90% of 
the alveolar surface; and small cuboidal type II cells, which constitute 60% of the 
surface cells, but cover only 5% of the alveolar surface (Tomashefski et al., 2008). 
Besides secreting surfactant, type II cells also function as a reserve cell, as they can 
mature into type I cells. In the alveolar sac, the epithelium is very tight and has TEER 
measurements of more than 2,000 Ωcm2 (Fischer et al., 2007). The alveoli are lined 
with a very thin fluid film and, as a result, antimicrobial factors secreted in this zone 
are highly concentrated.  
For an efficient gas exchange of oxygen and carbon dioxide between air spaces 
and red blood cells, the alveolar arrangement is ideal. Alveolar interstitial cells are 
tightly surrounded by capillaries. The endothelial cell and epithelial alveolar type I cell 
cytoplasm is spread as thinly as possible, which leads to an air-blood distance of 
approximately 0.6 µm. At any given moment, about 200 mL of blood can be found 
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within the capillary network that spreads over 126 m2, which is equivalent to a 1.6 mL 
spread(Starosta et al., 2006) over 1 m2 (Tomashefski et al., 2008). The pulmonary 
endothelium of the alveolus, which occupies a surface area of more than 140 m2, is the 
largest and densest in the human body. Endothelial cells are connected to each other by 
loose junctions, which readily allow the passage of fluids, macromolecules and 
immune cells into the interstitial compartment (Tomashefski et al., 2008).  
Leukocytes are continuously present in the airways, and in normal, non-inflamed lungs 
the majority of them are macrophages. More specifically, in Bronchoalveolar Lavage 
Fluid (BALF) of healthy individuals, 94% of all leukocytes were found to be 
macrophages, followed by lymphocytes (4%), neutrophils (1%), and eosinophils 
(0.7%). Plasma cells, basophils and mast cells can also be found in these compartments 
at very low numbers 
 
 
1.2.2 Airway defense mechanisms 
 
The air we breathe carries many potentially harmful microbes. To protect us 
against them, the lung harbors an array of defense mechanisms. On the one hand, the 
composition and tightness of the airways provide anatomic defense mechanisms, due to 
the presence of tight junction barriers that make it difficult for pathogens to cross into 
the interstitial space (Bergelson, 2009). The continuous beating of ciliated AECs also 
contributes to such anatomical defense mechanisms. On the other hand, factors 
secreted from AECs into the ASL are known to have potent antimicrobial or 
immunomodulatory functions. These factors include antimicrobial proteins and 
peptides, which serve to eliminate the invading pathogen (Figure 5) (Tomashefski et 
al., 2008). Factors like mucins, surfactant proteins, lactoferrin and human β-defensins 
have been shown to play roles in AEC infection by respiratory viruses, such as RSV 
(Grover et al., 1997; Kota et al., 2008; LeVine et al., 1999; Vareille et al., 2011). 
Cytokines and chemokines that in turn attract innate and adaptive immune cells in the 
fight against an infection are also secreted from AECs. More specifically, via the 
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secretion of antiviral cytokines, such as type I and III interferons (IFNs), AECs are able 
to alarm the surrounding cells and signal the presence of a viral pathogen. Via the 
secretion of proinflammatory cytokines, such as Tumor Necrosis Factor α (TNFα), and 
chemokines, such as Regulated And Normal T cell Expressed and Secreted 
(RANTES)/CCL5, into the submucosa, AECs are able to call for “back-up” and recruit 
and activate players of the innate and adaptive immune response axes, which work 
together to eliminate infection (Figure 6)(Vareille et al., 2011). The following 
paragraphs will discuss the nature and function of these cytokines and chemokines in 
more detail, with an emphasis on their role in respiratory virus infection. 
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Figure 5: Summary of pulmonary physiology and defenses. 
Airway defenses in the trachea and bronchi include cough reflexes and mucociliary 
clearance. Further, soluble antimicrobial mediators, antibodies as well as innate and 
adaptive immune players are present. Alveolar defenses rely on antimicrobial 
properties of surfactant and initial clearance by alveolar macrophages; if needed, 
additional inflammatory cells are recruited by chemoattractants produced by 
macrophages and epithelial cells. From (Tomashefski et al., 2008). With permission 
from Springer Verlag-Gmbh. 
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Type I and III IFNs 
Following respiratory virus infection, AECs secrete considerable amounts of type 
I IFN, which is composed of 13 different IFNα species, IFNβ, IFNω, IFNκ, and IFNε 
(Ioannidis et al., 2012; Pestka et al., 2004). Additionally, AECs are considered to be a 
major source of the newly recognized type III IFNs, which include IFN-λ1/IL29, IFN-
λ2/IL-28A and IFN-λ3/IL-28B (Kotenko et al., 2003; Okabayashi et al., 2011; 
Sheppard et al., 2003). Type I and type III IFNs trigger similar intracellular signaling 
pathways and biological activities (Zhou et al., 2007). As will be discussed below in 
more detail, IFNs induce the Janus Kinase (JAK)-Signal Transducer and Activator of 
Transcription (STAT) signaling cascade, which culminates in the transcription of a vast 
quantity of Interferon Stimulated Genes (ISGs) that are responsible for establishing an 
antiviral state (Stark and Darnell, 2012). Whereas type I IFNs execute their antiviral 
functions on diverse subsets of cells due to the ubiquitous presence of IFNα receptor 
(IFNAR), the primary targets of type III IFNs are epithelial cells of airway mucosal 
sites since IFNλ recetor 1 (IFN-λR1) chain is primarily expressed on epithelial cells 
(de Weerd and Nguyen, 2012; Mordstein et al., 2008; Mordstein et al., 2010). 
. 
 
Proinflammatory cytokines and chemokines  
Aside from secreting IFNs, AECs respond to viral infection by releasing a vast 
number of different proinflammatory cytokines, which are crucial for the activation of 
the innate and adaptive immune responses.  
Neutrophils are the first responders recruited into the infected airways following 
viral infection and their recruitment is mediated by the secretion of interleukin (IL)-
8/CXCL8, Growth-regulated oncogene α (Gro-α)/CXCL11 and Epithelial Neutrophil 
Activating protein-78 (ENA-78)/CXCL5 from AECs (Message and Johnston, 2004; 
Vareille et al., 2011). The expression of these cytokines has been observed in RSV- 
and SeV-infected AECs (Oshansky et al., 2010; Villenave et al., 2010; Zhang et al., 
2001a). Neutrophil survival and activation is assured by AEC-secreted granulocyte 
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colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating 
factor (GM-CSF).  
RANTES/CCL5, together with IL-5, GM-CSF, eotaxin-1/CCL11, eotaxin-
2/CCL24 and eotaxin-3/CCL26, recruits eosinophils to the infected site (Gleich, 2000). 
As with IL-8, RANTES chemokine levels following RSV infection correlate with 
disease severity (Hornsleth et al., 2001).  
One further AEC-secreted cytokine that has been implicated in the recruitment of 
innate immune players to the lung is macrophage inflammatory protein-1α (MIP-
1a)/CCL3, which can recruit macrophages and Natural Killer (NK) cells (Biron et al., 
1999). Macrophages in turn find themselves activated by AEC-secreted IL-1β and 
TNFα (Message and Johnston, 2004). Conventional dendritic cells (cDCs) are 
recruited via MIP-3α/CCL20 secretion (Gill et al., 2005). Additionally, type I IFNs 
drive local DC differentiation and maturation. A second subset of DCs, plasmacytoid 
DCs (pDCs), is also recruited into the lung upon viral infection. The presence of pDCs 
is important for viral clearance as they are major IFNα producers (Smit et al., 2006). 
T and B lymphocytes constitute the cellular and humoral axes of the adaptive 
immune response, respectively. Respiratory virus infection generally induces an 
important cellular immune response of CD4+, CD8+ and γδ-T cells (Braciale et al., 
2012). CD8+ cytotoxic T cells play a crucial role in the clearance of viral infection. 
AECs can induce the migration of the CD4+ T helper 1 (Th1) subset of T cells to the 
mucosa via production of RANTES/CCL5 and IFNγ-induced protein (IP-10)/CXCL10, 
and that of CD4+ Th2 subset of T cells via production of IL-1β (Vareille et al., 2011). 
Th1 cells in turn produce IFNγ, IL-2, IL-12 and TNFα, which all contribute to efficient 
cellular virus clearance, whereas Th2 cells produce IL-4, IL-10 and IL-13, which play 
an important role in humoral immunity against viruses (Vareille et al., 2011).  
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1.2.3 The AEC response to viral infection 
 
The above paragraphs discussed the secretion of cytokines from the airway 
epithelium. This cytokine secretion is specifically induced upon detection of the 
invading pathogen by the AEC. The following sections will elaborate the essential 
events that culminate in this cytokine secretion from virus-infected airway epithelial 
Figure 6: AEC defense mechanisms against respiratory viruses. 
AEC act as a barrier against respiratory viruses. The mucociliary apparatus and tight 
junctions (TJs) add mechanical, biological, and chemical protection. The airway 
epithelium also regulates both innate and adaptive immune responses, through 
production of antiviral substances such as IFNs, lactoferrin, and β-defensins in the 
mucus layer and production of cytokines and chemokines, which recruit and activate 
immune cells in the submucosa. From (Vareille et al., 2011), with permission from the 
American Society for Microbiology. 
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cells. These events constitute the core mechanism that drives innate and adaptive 
immunity – viral detection, which via the activation of specific signal transduction 
pathways leads to the activation of transcription factors (TFs), such as Interferon 
Regulatory Factor-3 (IRF-3) and Nuclear Factor-κB (NF-κB). These in turn regulate 
the gene expression of essential antiviral and proinflammatory cytokines and 
chemokines. The downstream molecular changes induced by these secreted factors on 
the airway epithelium and innate immune players will also be discussed. In order to 
convey only the most relevant knowledge to the understanding of this thesis work, the 
following section will focus mainly on the events of viral recognition and the antiviral 
and proinflammatory responses to RSV and SeV infection, since viruses of other 
families are recognized and signal in quite distinct patterns to induce antiviral and 
proinflammatory responses that are tailored to defending against them.  
 
 
1.2.3.1 Viral recognition by Retinoic acid inducible gene-I (RIG-I)-like receptors 
(RLRs) 
Recognition of a virus by infected cells requires detection of the viral genome or 
of its proteins. The intracellular RLR family, comprised of RIG-I, Melanoma 
differentiation-associated gene 5 (MDA5) and Laboratory of genetics and physiology 2 
(LGP2) belongs to a series of intracellular Pathogen recognition receptors (PRRs) that 
detect viral genomes and initiate antiviral responses (Baum and Garcia-Sastre, 2010; 
Yoneyama et al., 2004). RIG-I has a central DExD/H-box RNA helicase domain, 
which serves in RNA binding and unwinding, and two N-terminal Caspase recruitment 
domains (CARDs), which are essential for the initiation of downstream signaling. 
Additionally, a C-terminal repressor domain (RD) can be found. The domain makeup 
of MDA5 is similar to that of RIG-I, with the exception that MDA5 does not contain a 
RD (Yoneyama et al., 2005). LGP2 also possesses helicase domains, but lacks the 
CARD domains present in RIG-I and MDA5. Several data have suggested that it is a 
regulator of RLR-signaling triggered by RIG-I or MDA5, although LGP2 has recently 
been implicated in the antiviral response following encephalomyocarditis virus 
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(EMCV) infection (Eisenacher and Krug, 2012; Venkataraman et al., 2007). RIG-I 
signaling activity, unlike that of MDA5, is autoregulated via intramolecular 
interactions between the CARDs and the RD (Saito et al., 2007). In the absence of an 
RNA ligand, RIG-I is inactive due to the interaction of these two domains, which free 
themselves following conformational changes only upon ligand binding. Once in an 
open confirmation, RIG-I becomes active and the CARDs are free to mediate the 
association with the downstream adaptor protein Mitochondrial antiviral signaling 
protein (MAVS) (also known as IFNβ promoter stimulator 1 (IPS-1), Cardif, or Virus-
induced signaling adapter (VISA)) (Meylan et al., 2005; Saito et al., 2007; Seth et al., 
2005; Xu et al., 2005). MAVS assembles into prion-like aggregates necessary for 
antiviral signaling (Hou et al., 2011). In this context, MDA5 has been demonstrated to 
form polar helical filaments on the bound RNA molecules, which nucleates the 
formation of these MAVS aggregates (Berke et al., 2012). 
Generally, RIG-I and MDA5 recognize distinct RNA structures, which leads to 
the detection of specific viruses (Kato et al., 2006; Loo et al., 2008). However, some 
viruses can be detected by several different PRRs (Kato et al., 2006; Loo et al., 2008). 
Recognition by RIG-I is selectively activated by double-stranded (ds)RNA molecules 
with an uncapped 5’-triphosphate, whereas MDA5 preferentially recognizes longer 
dsRNA molecules (Hornung et al., 2006; Kato et al., 2008; Pichlmair et al., 2006). 
Branched higher order dsRNA structures and the absence of 2’O-methylation at the 5’-
Cap are also recognized by MDA5 (Pichlmair et al., 2009; Zust et al., 2011). 
Moreover, sequence composition of the RNA molecule has been shown to be an 
important determinant in RNA recognition by these sensors. Indeed, PolyU/UC sites, 
which are polyuridine motifs that contain interspersed C nucleotides, are also important 
for the activation of RIG-I signaling (Hornung et al., 2006; Kato et al., 2008; Pichlmair 
et al., 2006). These overall sensing modalities are thought to restrict the detection of 
nucleid acids by these PRRs of foreign, non-self origin and prevent them from 
responding to host encoded genes (self). In terms of Paramyxoviridae infection, it is 
generally acknowledged that RIG-I and MDA5 play a role in detecting and initiating 
the AEC antiviral response to RSV and SeV infection (Gitlin et al., 2010; Kato et al., 
2005; Loo et al., 2008; Soucy-Faulkner et al., 2010; Yoboua et al., 2010). However, 
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which exact RNA motifs are responsible for RIG-I and MDA5 activation in their case 
remains a matter of debate. Although the study of Rehwinkel et al. suggests that SeV 
genomic RNA could be the RIG-I ligand leading to IFNβ activation, this event is rather 
unlikely in vivo considering the tight encapsidation of the Paramyxoviridae genome by 
the N protein (Gerlier and Lyles, 2011; Rehwinkel et al., 2010). Baum et al. have 
suggested that Defective interfering (DI) genomes, which result during genome 
replication due to vRNAP jumping from one template to another and thereby generate 
short genomes with deletions, as well as antigenomes, could be the RIG-I ligand in 
SeV infection (Baum et al., 2010). Small leader RNAs (leRNA) and trailer RNAs 
(trRNA) synthetized during viral RNA transcription could also be RIG-I ligands, as 
these structures possess 5’-triphosphate motifs (Gerlier and Lyles, 2011). If any of 
these mentioned molecules fail to become encapsidated, they then form secondary 
structures that are readily recognizable by RIG-I or MDA5, which then activate 
antiviral signaling as discussed below.  
 
1.2.3.2 IRF-3 and NF-κB activation in RLR signaling lead to antiviral and 
proinflammatory cytokines production 
The production and secretion of type I IFNs, which drives the establishment of 
the antiviral state, is the culminating event of the RLR signaling cascade. NF-κB, in 
combination with IRF-3, ATF-2 and c-Jun, the latter two forming the AP-1 
transcription factor, and the transcriptional enhancer Creb binding protein (CBP)/p300 
form the enhanceasome that directs IFNβ transcription (Panne 2008). Less is known 
about the activation of AP-1 following viral infection, and this section will thus focus 
on the events that culminate in the activation of IRF-3 and NF-κB TFs. These TFs are 
also implicated in the regulation of type III IFN expression (Onoguchi et al., 2007; 
Osterlund et al., 2007; Thomson et al., 2009). It is generally thought that IFNβ and 
IFNλ1 are among the first IFN species to be induced upon viral infection, and that they 
are heavily dependent on IRF-3. The transcription of further IFNα and IFNλ2−3 genes 
requires the IFN-mediated induction of another member of the IRF family, IRF-7. The 
	   23 
IRF-3/IRF-7 heterodimers formed subsequently regulate the expression of further 
IFNα and IFNλ2−3 species, thereby amplifying the IFN-induced antiviral response 
(Figure 7). 
Once RIG-I and MDA5 have bound viral RNA, these proteins interact with the 
downstream adaptor protein MAVS to form a MAVS-signalosome for further 
triggering of the antiviral signaling pathway (Belgnaoui et al., 2011). MAVS localizes 
to the mitochondria via a single-spanning Transmembrane domain (TM). Via its 
CARD domain, which protrudes into the cytoplasm, it interacts with RIG-I or MDA5 
(Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005). RIG-I or 
MDA5 interaction with MAVS initiates the recruitment of the MAVS-signalosome and 
approximately 30 MAVS-interacting partners have been described to date (Belgnaoui 
et al., 2011). Interacting proteins are involved in antiviral and proinflammatory 
responses, but MAVS also interacts with mitochondrial proteins, as well as with 
proteins involved in cell death and autophagy. It is noteworthy to mention that, besides 
being located at the mitochondria, MAVS can also be found at peroxisomes, where it 
functions in the induction of ISGs independently of type I IFN (Dixit et al., 2010). 
These two distinct intracellular pools of MAVS have been shown to be necessary for 
efficient clearance of viral infection.                                                                                           
Once MAVS homo-oligomerizes, it recruits members of the Tumor necrosis 
factor receptor-associated factor (TRAF) family: TRAF3 and TRAF6. These are E3 
ubiquitin ligases that assemble lysine 63-linked polyubiquitin chains, which constitute 
an important docking site for downstream signaling molecules (Belgnaoui et al., 2011). 
TRAF3, in complex with NF-κB modulator (NEMO), TRAF family member 
associated NF-κB activator (TANK) and NAK-associated protein 1 (NAP1), controls 
the activity of two non-canonical IKK-related kinases, TANK-binding kinase 1 
(TBK1) and inducible Inhibitor of κB (IκB) kinase (IKKi/IKKε), which phosphorylate 
the transcription factor IRF-3 (as will be discussed below) (Guo and Cheng, 2007; 
Sasai et al., 2006; Zhao et al., 2007). MAVS interaction with TRAF6 forms a complex 
consisting of Transforming growth factor beta-activated kinase 1 (TAK1) and TAK1-
binding protein 2 and 3 (TAB2 and TAB3), which dock onto the by TRAF6 generated 
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lysine K63-linked polyubiquitin chains. This leads to the activation of the IKK 
complex and consequent NF-κB activation. In addition, FAS-associated death domain-
containing protein (FADD) has been identified in a complex with MAVS, and a 
FADD/caspase-8-dependent pathway has been proposed to be required for the 
activation of NF-κB downstream of MAVS (Kawai et al., 2005; Takahashi et al., 
2006). Tumor necrosis factor receptor type 1-associated death domain protein 
(TRADD), an adaptor of the tumor necrosis factor receptor (TNFRI), is further 
recruited to MAVS and orchestrates the formation of a complex with TRAF3, TANK, 
FADD and Receptor interacting protein 1 (RIP1), which leads to the activation of IRF3 
and NF-κB (Michallet et al., 2008).  
IRF-3 activation. IRF-3 is a ubiquitously expressed TF. It is crucial in the early 
antiviral response due to its function in the regulation of genes such as type I and type 
III IFNs, but also IFN-independent ISGs as well as proinflammatory cytokines such as 
RANTES and IL-6 (Grandvaux et al., 2002; Lin et al., 1999; Matsukura et al., 2006). 
IRF-3 possesses an N-terminal DNA binding domain (DBD) and a C-terminal domain, 
termed the IRF association domain (IAD), which serves in homo- or 
heterodimerization with members of the IRF family. Transcriptional activity of IRF-3 
is controlled by C-terminal phosphorylation events in three clusters: Ser385 and 
Ser386 (cluster 1), Ser396 and Ser398 (cluster 2), and Ser402, Thr404, and Ser405 
(cluster 3) (Lin et al., 1998). The IKK-related kinases TBK-1 and IKKε have been 
shown to be responsible for phosphorylation of residues Ser386, Ser396 and Ser402 of 
IRF-3 (Fitzgerald et al., 2003; Fujii et al., 2010; Mori et al., 2004; Sharma et al., 2003). 
C-terminal IRF-3 phosphorylation consequently induces a conformational change in 
IRF-3 that allows homo- or heterodimerization, nuclear localization, binding to IRF-3 
or Interferon stimulated response element (ISRE) target sequences, and association 
with the co-activator CBP/p300 (Lin, Hiscott, MCB 1999) to regulate the expression of 
IRF-3 target genes. In the context of IRF-3 activation by phosphorylation, it is 
noteworthy to mention that other key residues have been identified recently. For 
instance, Ser173, a target for c-Jun-NH2-terminal kinase (JUNK), and Ser339 have 
been described in this context (Clement et al., 2008; Zhang et al., 2009a). 
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NF-κB activation. NF-κB is a homo- or heterodimeric transcription factor, 
consisting of two of the following subunits: p65/RelA, RelB, cRel, p50 and p52. Of 
note, in airway epithelial cells, NF-κB is composed preferentially of p65/RelA and 
p50. Each NF-κB subunit contains an N-terminal Rel homology domain (RHD) that 
serves in the binding of κB sequences in target gene promoters and a C-terminal 
Transactivation domain (TAD) that is necessary for activating gene transcription 
(Hayden and Ghosh, 2008; Vallabhapurapu and Karin, 2009). In unstimulated 
conditions, NF-κB is retained in the cytoplasm via its association with the IκBα 
inhibitor of NF-κB. Upon phosphorylation of IκBα at Ser32 and Ser36 by the activated 
IKK complex, composed of NEMO, IKKα and IKKβ and the resulting proteasome-
dependent degradation of IκBα, NF-κB translocates to the nucleus to activate 
transcription of target genes, such as TNFα, IL-8, and RANTES. It is noteworthy to 
mention that for full transactivation activity, NF-κB subunits have to undergo post-
transcriptional modification, such as phosphorylation and acetylation. In this context, it 
has been shown that depending on the stimuli, phosphorylation of NF-κB at Ser276, 
Ser311, Ser529, Ser536 and Ser576 can be important for enhancing NF-κB-mediated 
transcription of target genes (Chen and Greene, 2004). For instance, in the case of RSV 
infection, Mitogen-and-stress-related kinase 1 (MSK-1)-induced phosphorylation of 
the p65 subunit at Ser276 has been shown to be essential for NF-κΒ dependent target 
gene transcription by ensuring Lys310 acetylation of p65 and efficient transcriptional 
elongation of mRNA transcripts (Brasier et al., 2011; Jamaluddin et al., 2009).  
 
1.2.3.3 Viral detection by Toll-like receptors (TLRs) 
TLRs are PRRs that reside either on the cell surface or in the endosomal 
compartments of cells. Out of the 13 mammalian TLRs identified to date, 10 are 
present in humans. Each TLR recognizes a unique Pathogen associated molecular 
pattern (PAMP), including peptidoglycans (TLR1/2 and 2/6), Lipopolysaccharide 
(LPS) (TLR4), lipoteichoic acid (TLR1/2 and 2/6), lipoproteins, lipopeptides (both 
TLR1/2 and 2/6), fungal zymosan (TLR2/6), bacterial flagellin (TLR5), single-
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stranded (ss) (TLR7) or dsRNA (TLR3), and CpG DNA (TLR9) (Kawai and Akira, 
2008). Considering their specific detection pattern for nucleic acids, it is evident that 
TLR3 and TLR7 are important candidates for the recognition of RNA viruses (Arpaia 
and Barton, 2011). With regard to TLR3, it is known that RSV infection upregulates 
TLR3 in AECs and sensitizes them to further stimulation with nucleic acids 
(Groskreutz et al., 2006). Further, TLR3 is important for RSV-induced chemokine 
expression in AEC (Rudd et al., 2005). Additionally, extracellular TLR2, 4 and 6 have 
been implicated in the immune response against RSV (Kurt-Jones et al., 2000; 
Murawski et al., 2009; Rudd et al., 2005). However, most of these data demonstrate the 
importance for TLRs in cells of the immune system, where TLRs are expressed in 
much higher levels than in AECs. Thus, in the airway epithelium, RIG-I and MDA5 
are considered to be the main PRRs responsible for RSV and SeV detection.  
 
1.2.3.4 The IFN-induced JAK-STAT pathway 
When type I or III IFNs are secreted, they bind to their cognate receptors to 
trigger signaling cascades that mediate the induction of an antiviral state. Type I IFNs 
bind to the IFNα receptor (IFNAR), composed of a heterodimer of IFN-αR1 and IFN-
αR2 chains, and induce a JAK-STAT signaling cascade that culminates in the 
activation of the Interferon-stimulated gene factor (ISGF3) transcription factor 
complex and transcription of a vast quantity of ISGs (Figure 7) (Stark and Darnell, 
2012). Type III IFNs induce a JAK-STAT signaling cascade via their own specific 
receptor composed of a heterodimer of the IL-10 receptor 2 (IL-10R2) chain and IFN-
λR1 chain, which also results in JAK-STAT signaling (Kotenko, 2011). The 
intracellular domains of the IFNAR1 subunits are associated with Janus protein 
tyrosine kinases, Tyrosine kinase 2 (Tyk2) and Janus kinase 1 (Jak1). The binding of 
type I IFNs to their receptor results in cross-activation of these kinases, which then 
phosphorylate their downstream substrates, STAT1 and STAT2 (Stark and Darnell, 
2012). STAT1 and STAT2 heterodimerize and associate with IRF9 to form the ISGF3 
transcription factor complex (Stark and Darnell, 2012). This complex then translocates 
to the nucleus, where it binds to ISRE sequences (Levy et al., 1989; Levy et al., 1988). 
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This results in the expression of hundreds of ISGs, whose united action defines the 
antiviral state (Schoggins and Rice, 2011).  
In the context of type III IFN stimulation, the binding of IFNλ to its cognate 
surface receptors results in the activation of STAT1 and STAT2 by yet unknown 
kinases. These can, as is the case in type I IFN stimulation, participate in the formation 
of ISGF3 and its binding to target genes with ISRE sequences, or activate the 
expression of target genes that harbor γ-interferon activated sequences (GAS) in their 
promoters (Kotenko, 2011). 
 
1.2.3.5 Establishment of the antiviral state by ISGs 
The IFN-induced JAK-STAT pathway leads to the expression of hundreds of 
ISGs (Schoggins and Rice, 2011) that exert diverse functions to limit viral propagation. 
The list of ISGs is exhaustive and goes far beyond the scope of this thesis. Therefore, 
only a few classical ISGs, as well as new concepts in this field are discussed here. 
As mentioned, ISGs target several steps of the viral replication cycle. Protein 
kinase R (PKR), for example, shuts down protein translation by phosphorylating the 
translation initiation factor eIF2α (Toth et al., 2006); interferon-induced protein with 
tetratricopeptide repeats 1 (IFIT1)/ Interferon stimulated gene 56 (ISG56) also targets 
translation initiation (Fensterl and Sen, 2011); MxA targets viral transcription by 
forming spherical structures around the viral nucleoprotein (Haller et al., 2007); and 2’, 
5’-oligoadenylate synthetase 1 (OAS1), OAS2, OAS3 are capable of activating 
RNAseL, which functions in genome degradation (Kristiansen et al., 2011). Several 
ISGs have yet uncharacterized functions such as OASL and MxB to name but a few 
(Schoggins and Rice, 2011). It is noteworthy to mention that RIG-I and MDA5 are also 
ISGs. It is the combined action of these and the many other ISGs induced by a given 
viral infection that will determine the level of inhibition of viral infection. A novel 
concept in this field is that each virus has a unique, but partly overlapping “ISG 
profile” – a collection of genes that preferentially inhibits a given virus (Schoggins and 
Rice, 2011; Schoggins et al., 2011). A subset of ISGs, which includes RIG-I, MDA5, 
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several IRFs and STAT1 are themselves components of the IFN pathway machinery. 
This ensures a positive feedback on the antiviral IFN pathway. 
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Figure 7: The virus-induced IFN response. 
Upon recognition of the viral genome by the RLRs RIG-I and MDA5, a signaling platform is 
formed at MAVS adaptor protein, which is located at the mitochondria. TRAF6 and TRAF3 
recruitment to this complex results in the activation of the IKK complex and its homologues 
TBK1 and IKKe. The IKK complex phosphorylates IκBα, which thereafter undergoes 
proteasome-dependent degradation. This culminates in NF-κB liberation and translocation to the 
nucleus. TBK1 and IKKε phosphorylate IRF-3, which leads to its dimerization and nuclear 
translocation. NF-κB, together with IRF-3 and the AP-1 transcription factor, which is composed 
of ATF-2 and c-Jun, regulate the expression of type I and type III IFNs. In the early phase of viral 
infection, IFNβ, IFNα1 and IFNλ1 are the principally transcribed IFNs. These are then secreted 
and bind to their cognate receptors. Type I IFNs bind to the IFNAR1 and IFNAR2 chains of the 
type I IFN receptor, whereas the type III IFN receptor is made up of the IFN-λR1 and the IL-
10R2 chains. Binding to these receptors results in the activation of Tyk2 and JAK1, which 
phosphorylate their downstream targets, STAT1 and STAT2. Upon phosphorylation, STAT1 and 
STAT2 bind IRF9 to form the ISGF3 transcription factor complex. ISGF3 binds to ISRE 
consensus elements in its target gene promoters to upregulate the transcription of hundreds of 
ISGs. IRF-7 is also an ISGF3-regulated gene. In infected cells, IRF-7 heterodimerizes with IRF-
3, and in conjunction with NF-κB and AP-1 upregulates the many other isoforms of type I IFN as 
well as IFNλ2 and IFNλ3. This leads to the amplification of the IFN response and sustained ISG 
expression. 
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1.2.3.6 The TNF receptor 1 (TNFR1) signaling pathway 
As mentioned above, the activation of the transcription factor NF-κB during 
virus infection leads to the expression of various target genes. TNFα is a key 
proinflammatory cytokine whose expression is regulated by NF-κB in this context. 
Besides its proinflammatory role, TNFα has been attributed an antiviral function (Ito 
and O'Malley, 1987; Ruby et al., 1997; Wong et al., 1992). TNFα binds to TNFR1, 
which is expressed on most mammalian cells, whereas the second TNFα-specific 
receptor, TNFR2, is mainly expressed in oligodendrocytes, astrocytes, T cells, 
myocytes, thymocytes, endothelial cells and in human mesenchymal stem cells (Cabal-
Hierro and Lazo, 2012). One of the main TFs activated by the TNFα-induced signaling 
pathway is NF-κB itself. In general, early TNFα-induced signaling activates pro-
survival mechanisms, which are replaced with a pro-apoptotic program upon prolonged 
stimulation with TNFα, thereby regulating the survival and cell death by apoptosis of 
virus-infected cells. This is orchestrated via the consecutive formation of two different 
TNFR signaling complexes. The first complex (Complex I) controls the expression of 
anti-apoptotic proteins that prevent cell death, whereas the second complex (Complex 
II) triggers cell death processes after the internalization of the receptor (Micheau and 
Tschopp, 2003). 
The binding of TNFα to its receptor TNFR1 induces trimerization and the 
formation of a core complex composed of TRADD, RIP1 and TRAF2 (Cabal-Hierro 
and Lazo, 2012; Hsu et al., 1996). TRADD recruits TRAF2 via its N-terminal TRAF 
binding domain, and RIP1 via its C-terminal death domain (DD). Then, cellular 
Inhibitor of apoptosis 1 (cIAP1) and cIAP2 proteins are recruited to TRAF2 (Mahoney 
et al., 2008). TNFR1, TRAF2 and RIP1 subsequently undergo ubiquitination in this 
core complex and become linked to K63-conjugated ubiquitin chains or linear 
ubiquitin chains (Ea et al., 2006; Wu et al., 2006). TRAF2, cIAP1, and cIAP2 are all 
E3 ubiquitin ligases and are thought to be important for the generation of K63-linked 
polyubiquitin chains in this complex. Further, Linear Ubiquitin Chain Assembly 
Complex (LUBAC), whose recruitment is dependent on cIAP1/2-mediated 
ubiquitination of the core complex, catalyzes the formation of linear ubiquitin chains 
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onto this complex (Haas et al., 2009; Ikeda et al., 2011). This complex, while bound to 
the plasma membrane, triggers cellular pathways that lead to NF-κB and AP-1 
activation (Hsu et al., 1996; Mahoney et al., 2008; Micheau and Tschopp, 2003). 
Regarding NF-κB activation, the ubiquitination of the core complex recruits the 
downstream complexes NEMO-IKKα-IKKβ via NEMO interactions with the ubiquitin 
chains and TAK1-TAB2-TAB3 via the action of TAB2 recognizing and binding to 
ubiquitin chains (Ea et al., 2006; Kovalenko and Wallach, 2006). NEMO and TAK1 
are consequently ubiquitinated as well. TAK1 is then activated and its kinase activity 
executed on the IKK complex results in IKKα/β activation and consequent NF-κB 
activation, as previously outlined in section 1.2.3.2, via the proteasome-dependent 
degradation of IκBα. NF-κB then regulates the transcription of proinflammatory, but 
also anti-apoptotic genes (Wang et al., 1998). 
When NF-κB is activated it transcribes the anti-apoptotic Cellular FLICE-like 
inhibitory protein (c-Flip) that inhibits activation of caspase-8 (Micheau et al., 2001). 
When NF-κB activation is blocked, c-Flip is not produced and cells enter caspase-8-
mediated apoptosis downstream of TNFR1 signaling (Yeh et al., 2000). Under 
conditions were caspase-8 activity is inhibited such as during vaccinia virus infection, 
RIP1 and RIP3 kinases become phosphorylated and are recruited to yet a different 
complex, the necroptosome, which when formed triggers an inflammatory mode of 
programmed necrotic cell death termed necroptosis that is caspase-independent (Cho et 
al., 2009; Vandenabeele et al., 2010). Necroptosis is now viewed as a back-up death-
inducing cellular defense mechanism that helps to reduce virus persistence and 
propagation in instances when apoptosis is disabled by viruses (Cho et al., 2009). 
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Figure 8:  TNF-induced NF-κB activation.  
The binding of TNF to TNFR1 induces the trimerization of the receptor and recruitment of 
a protein complex (complex I) that includes the adapter protein TRADD, the protein 
kinase RIP1, and ubiquitin E3 ligases TRAF2, cIAP1, cIAP2, and LUBAC. Some or all of 
these E3 Ubiquitin ligases catalyze polyubiquitination of RIP1, which recruits and 
activates the TAK1 and IKK complexes. Deubiquitination of RIP1 by CYLD not only 
inhibits TAK1 and IKK activation but also facilitates the formation of a cytoplasmic 
complex (complex II or Ripoptosome) consisting of RIP1, FADD, and procaspase-8. 
Within this complex, pro-caspase 8 auto-cleaves itself to generate mature caspase-8, 
which then initiates apoptosis. However, caspase-8 is normally inhibited by caspase 
inhibitors such as c-FLIP, which is induced by NF-κB. Ubiquitin E3 ligases inhibit cell 
death indirectly by activating NF-κB and/or directly by blocking the formation of 
Complex II. From (Chen, 2012). With permission from John Wiley and Sons.  	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1.2.4 Viral modification and evasion of antiviral immunity 
 
In order for viruses to be able to survive, they must constantly co-evolve with the 
host organism they infect. Host mechanisms exist to counteract viral infection, and 
viruses have in turn evolved strategies to interfere with these mechanisms. It is now 
clear that the successful survival of viruses is ensured by interference with host 
antiviral mechanisms at various levels. The following section will discuss how 
Paramyxoviridae RSV and SeV interfere with early antiviral signaling pathways and 
the establishment of the antiviral state by AECs. Viral interference mainly targets the 
recognition of viral RNA by PRRs, and a number of viral molecules contribute to the 
global interference of innate and adaptive immunity. The combination of all of these 
events renders the viral infection effective and pathogenic at the same time.  
 
1.2.4.1 General viral evasion mechanisms 
The Paramyxoviridae family of viruses encodes various genes that are necessary 
for virus replication biology. Some of these proteins, however, have a negative impact 
on antiviral immune responses. By means of their designated action during the virus 
life cycle, they can indirectly foster the evasion from host immunity. One such 
example is the process of encapsidation of viral RNA by the N protein. Encapsidation 
of viral RNA prevents the formation of dsRNA molecules that could potentially 
activate RLR- and PKR-dependent antiviral mechanisms (Gerlier and Lyles, 2011). 
Additionally, encapsidation has the effect of shielding 5’-triphosphate moieties from 
recognition by RIG-I (Gerlier and Lyles, 2011). Further, the capping mechanisms of 
viral mRNAs ensured by the Paramyxoviridae L protein allows viral mRNAs to appear 
as cellular mRNAs, which consequently go unrecognized by the antiviral detection 
system (Gerlier and Lyles, 2011). An early report by Atreya et al. has suggested that 
one function of the RSV NS1 protein is to place a break on viral transcription and 
replication to certain levels, so that the ongoing virus life cycle can remain 
unrecognized by the cell (Atreya et al., 1998). A similar function is attributed to SeV C 
protein (Curran et al., 1992; Horikami et al., 1997). In the absence of C protein, viral 
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dsRNA accumulates during the SeV life cycle, which becomes recognized by PKR and 
leads to the shutdown of cellular translation and consequent viral replication (Takeuchi 
et al., 2008). RSV N protein has been shown to sequester PKR away from eIF2α, 
thereby inhibiting the phosphorylation of this translation initiation protein and 
preventing the shutdown of protein synthesis (Groskreutz et al., 2010).  
 
1.2.4.2 Blocking IFN production 
The blocking of initial type I IFN induction is an efficient early viral evasion 
mechanism to shut down the establishment of antiviral activities. Several key 
mechanisms of antiviral signaling are targeted in order to achieve this. 
RIG-I and MDA5, the two antiviral sensors for Paramyxoviridae RNA, are the 
first targets for viral evasion mechanisms. RSV NS2 protein has been shown to inhibit 
RIG-I association with MAVS via binding and sequestration of the N-terminal CARD 
domain of RIG-I, whereas SeV V protein interferes with MDA5 antiviral activity 
(Childs et al., 2007; Childs et al., 2009; Ling et al., 2009). Consequently, both, NS1 
and NS2 inhibit IFNα, IFNβ and IFNλ production in RSV-infected cells (Ramaswamy 
et al., 2006; Spann et al., 2004). Several other molecules in the RLR signaling pathway 
are inhibited by NS1 and NS2. For instance, NS1 or NS2 were shown to target TRAF3 
and IKKε (Swedan et al., 2009). RSV NS1 protein binds to a multitude of intracellular 
molecules with diverse function (Wu et al., 2012). In this screen, which attempted to 
identify interaction partners, NS1 was shown to interact with nucleotide-binding 
oligomerization domain (NOD), leucine rich repeat containing X1 (NLRX1), an 
essential regulatory molecule that prevents inductions of the RLR antiviral signaling 
pathway (Wu et al., 2012). However, the mechanistic consequence of this interaction 
remains to be fully determined.  
 
1.2.4.3 Evasion of the IFN-mediated induction of the antiviral state 
The induction of IFN gene expression is not the only target of viral evasion 
mechanisms. The downstream IFN-dependent activation of the JAK-STAT pathway, 
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which leads to the establishment of the antiviral state, is also targeted by 
paramyxoviruses. SeV C protein, for example, has been shown to inhibit the IFN-
mediated induction of the antiviral state (Garcin et al., 1999; Gotoh et al., 1999). It 
interferes with STAT2 phosphorylation, which could constitute a potential mechanism 
to explain SeV C inhibition of the IFN pathway (Gotoh et al., 2003). RSV NS1 and 
NS2 also target this pathway, mainly by interfering with or enhancing the degradation 
of the STAT1 and STAT2 transcription factors (Elliott et al., 2007; Lo et al., 2005; 
Ramaswamy et al., 2004). Besides NS1 and NS2, RSV G protein can regulate this 
antiviral innate immune pathway, since infection with a recombinant RSV lacking the 
G protein leads to an increase in IFNβ and Interferon Stimulated Gene 15 (ISG15) 
levels in infected cells. Mechanistically, it has been demonstrated that RSV G 
upregulates the negative regulators of the JAK-STAT pathway, Suppressors of 
cytokine signaling 1 (SOCS1) and SOCS3, to inhibit the IFN-induced induction of 
ISG15 (Moore et al., 2008).  
 
1.2.4.4 Interference with innate and adaptive immune responses 
Paramyxoviridae proteins do not only interfere with early antiviral signaling 
pathways. Events downstream of AEC cytokine secretion and antiviral state induction, 
which activate the innate and adaptive axes of the immune system, are also viral 
targets. In this context, interference by RSV results in significant immunoperturbance 
and RSV-associated pathology.  
RSV G protein has been shown to harbor potent immunomodulatory functions. 
This is based on its structural resemblance to the leukocyte-attractant chemokine 
fractalkine/CXCL3. As mentioned previously, infected cells not only express G 
proteins on their surface but also release a form of soluble G protein. G protein 
mimicry to fractalkine reduces pulmonary influx of immune cells to the site of 
infection, which can in turn influence the outcome of innate and adaptive anti-RSV 
responses (Harcourt et al., 2006). Soluble G protein is also associated with the 
inhibition of TLR2, TLR4 and TLR9 pathways in human monocytes, significantly 
suppressing the TLR-dependent immune responses of this cell type (Polack et al., 
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2005). Secretory G protein can further function as an antigen decoy mechanism that 
serves to foster the escape of the virus from neutralizing antibodies and reduces 
antibody-mediated clearance by immune cells (Bukreyev et al., 2012; Bukreyev et al., 
2008). RSV NS1 protein has been shown to suppress the activation of CD8+ and Th17 
T cells and skew the T cell response towards a Th2 response (Munir et al., 2011). RSV 
also infects and replicates efficiently in immune cells, such as dendritic cells, 
macrophages, eosinophils and T cells, where the expression of RSV proteins interferes 
with immune mechanisms initiated by these cells (Halfhide et al., 2011). 
Thus, RSV and SeV efficiently target and evade antiviral host mechanisms on 
several levels. Some of these mechanisms culminate in the alteration of innate and 
adaptive antiviral responses. In the case of RSV infection, a possible outcome is the 
establishment of severe immunopathology, as will be outlined in the following section. 
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1.3 RSV-induced pathology – a multifaceted syndrome  
 
RSV infects very early in life, with the peak incidence of severe disease before 
six months of age. Whereas in these young individuals RSV infection is associated 
with lower respiratory tract complications, such as respiratory wheezing, bronchiolitis, 
and pneumonia, which often requires hospitalization, healthy adults and older children 
may also become infected, but will mostly only develop cold-like symptoms. Thus, the 
clinical symptoms following RSV infection vary strongly depending on the patient’s 
age. Nevertheless, RSV remains a major health threat for pre-term infants, the elderly 
and immunocompromised individuals (Falsey et al., 2005; Hall et al., 2009).  
To date, no specific anti-RSV treatment or vaccine has been identified. High-risk 
individuals are subjected to prophylactic treatment with anti-RSV monoclonal 
antibodies, such as palivizumab (Mejias and Ramilo, 2008). Infected individuals 
receive antiviral therapy with ribavirin in combination with immunoglobulins and 
corticosteroids, although this treatment is only mildly effective and not recommended 
for routine treatment (Collins and Melero, 2011). Small anti-RSV molecules, mostly 
benzimidazole derivatives, are being developed and some of them are now at the stage 
of clinical trials (DeVincenzo, 2012). RNA interference (RNAi)-based strategies for 
RSV treatment are also in the testing phase (DeVincenzo, 2012). Vaccine development 
and testing involving RSV subunit vaccines, live-attenuated vaccines and virus-like 
particles are also underway (Hurwitz, 2011). It is noteworthy to mention that vaccine 
development was significantly complicated following a failed vaccination trial in the 
1960s in infants and young children using a formalin-inactivated RSV vaccine (FI-
RSV). The vaccine was poorly protective and vaccinees who were subsequently 
infected with RSV demonstrated major airway complications and required 
hospitalization. 
RSV-induced T cell memory is weak, as the virus can readily reinfect during the 
first few years of life, although reinfection is usually associated with less severe 
symptoms (Collins and Melero, 2011). Further, RSV infection can drive long-term 
complications in pulmonary function, such as a possible predisposition to asthma 
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development (Mailaparambil et al., 2009). RSV-induced complications and disease 
arise from a combination of various factors: firstly, direct viral damage in the afflicted 
airways contribute to airway obstruction; secondly, there is a strong 
immunopathogenic component implicated in RSV-induced disease; thirdly, viral 
interference with the innate immune system contributes to the development of 
pathology; lastly, host genetic, social and environmental factors are undoubtedly 
implicated in the determination of disease outcome (Figure 9) (Mailaparambil et al., 
2009). Thus, there is not just one single mechanism that contributes to RSV-induced 
pathology, but rather an accumulation of diverse mechanisms that potentially drive 
RSV-induced disease. These multifactorial aspects of RSV-induced immunopathology 
will be discussed in the following section.  
 
 
Figure 9: Factors influencing the pathogenesis and clinical disease caused by RSV 
infection in infants and children. From (van Drunen Littel-van den Hurk and Watkiss, 
2012), with permission from Elsevier. 
	   39 
1.3.1 RSV-induced airway obstruction 
 
RSV infection is generally limited to superficial epithelial cells and does not 
invade underlying cells as RSV preferentially buds from apical cells (Johnson et al., 
2007; Wright et al., 2005; Zhang et al., 2002). RSV infection itself, however, is not 
highly cytopathic; it is known to impair ciliary beating and cause sloughing of infected 
epithelial cells. This, in combination with peribronchial mononuclear cell infiltration, 
submucosal edema, basal cell hyperplasia and mucus secretion, contributes 
significantly to airway obstruction - a common consequence of RSV infection 
(Johnson et al., 2007; Reed et al., 2008). These symptoms play an even more 
devastating role in infants who have narrow airways and are still undergoing airway 
development. Syncytia formation may also be observed in the bronchoalveolar 
epithelium, but is not common. RSV has been shown to interfere with apoptotic 
processes, although this finding is not the general consensus (Bem et al., 2010; 
Groskreutz et al., 2007; Kotelkin et al., 2003; Thomas et al., 2002). However, the 
blocking of apoptosis might be a means of increasing the pool of infectious virions, 
which in turn contribute to RSV disease, as levels of replicating RSV correlate with 
disease severity (El Saleeby et al., 2011). 
 
 
1.3.2 Inflammation and infiltration of innate immune players  
 
Inflammation as a consequence of RSV infection serves to “[…] destroy, dilute 
and/or sequester the virus and the tissue that is injured […]”. However, much of the 
problematic of RSV-induced inflammation stems from the “[…] inability to limit and 
sequester damaged tissue and to proceed onwards to a resolution phase […]” in 
uncontrolled inflammation, also termed “cytokine storm” (Rosenberg and 
Domachowske, 2012).  
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Abundant evidence exists that inflammatory cytokines and chemokines are 
released into the airways by AECs and macrophages of infants and children with RSV 
disease, which then recruit and activate granulocytes (Everard et al., 1994). The 
neutrophil chemoattractant IL-8, TNFα, and the CC chemokines MIP-1α, MCP-1 and 
RANTES are among those that are detected most frequently in the airways and nasal 
passages of infected infants and children (McNamara et al., 2005; Mobbs et al., 2002). 
Upregulation of IL-8 is correlated with the severity of RSV disease, and leads to 
recruitment of neutrophils, which constitute the majority of infiltrating cells (at least 
84%) (Everard et al., 1994; McNamara et al., 2003; Rosenberg and Domachowske, 
2012; Smyth et al., 2002). While neutrophils mediate elimination of virus-infected 
cells, their high numbers, ability to secrete further cytokines and chemokines, and 
degranulation products may contribute to RSV-induced immunopathogenesis (Lukens 
et al., 2010). However, it is still unclear to which extend heightened inflammation, or 
increased neutrophil levels, are pathogenic in RSV infection (Bennett et al., 2007).  
RANTES serves to recruit eosinophils and RANTES levels are elevated in lungs 
of infected individuals (Harrison et al., 1999; Sheeran et al., 1999). Furthermore, 
polymorphisms in the RANTES promoter have also been shown to correlate with 
disease severity (Amanatidou et al., 2008). Thus, several data point towards a role of 
this cytokine in RSV-induced immunopathology. However, in infants, eosinophils 
present only 1-3% of airway leukocytes in RSV-infected infants (McNamara et al., 
2003). This is in strong contrast to the mouse model, where eosinophils constitute a 
major granulocyte population following RSV infection that contributes significantly to 
RSV clearance (Phipps et al., 2007; Tekkanat et al., 2002). These facts clearly show 
that data generated following RSV infection in the mouse model cannot always be 
transposed to human physiology so easily, an aspect that will be discussed further 
below. Thus, whether RANTES and eosinophils are major contributors to RSV-
induced disease in infants is still not clear. While increased eosinophilia often occurrs 
in very young patients following RSV infection and can lead to predisposition to 
asthma development in later years, contradictory studies exist on whether increased 
primary eosinophila influences the occurrence of wheezing and asthma upon infection 
at a later age (Castro et al., 2008; Kristjansson et al., 2006; Pifferi et al., 2001). There is 
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also in mice generated evidence that demonstrates the beneficial role of eosinophils, as 
this subset of leukocytes has been shown to contribute to innate antiviral immunity and 
promote clearance of RSV infection (Phipps et al., 2007).  
 
 
1.3.3 Adaptive immune responses 
 
Besides innate, inflammatory mechanisms, the adaptive immune response was 
suggested to be implicated in RSV pathology. More specifically, it has been proposed 
that immunopathology in RSV infection is due to a Th2 bias of CD4+ T cell responses 
(Collins and Melero, 2011). Excessive mucus production, airway plugging, wheezing, 
and long-term effects on lung function are all common manifestations of RSV disease 
that have some similarities with asthma, which involves a Th2 bias. Efficient virus 
clearance requires Th1-type T cell responses characterized by IFNγ and IL-2 
expression of CD4+ T cells, whereas a Th2 response is characterized by IL-4, IL-10 
and IL-13 gene expression (Becker, 2006; Bendelja et al., 2000; Roman et al., 1997). 
In this context, in young infants, where RSV generally strikes in the most severe 
manner, a Th2 biased response is predominant, as it is a left over from the prenatal 
period (Adkins et al., 2004; Kristjansson et al., 2005). However, it is noteworthy to 
mention that not all studies confirm a predominant Th2-biased T cell response 
(Brandenburg et al., 2000).  
Depletion studies in mouse models of RSV infection indicate that CD4+ and 
CD8+ T cells are important for RSV clearance, but CD8+ T cells may also contribute to 
RSV-induced immunopathology (Graham et al., 1991). In RSV-infected infants, 
however, the timing of the CD8+ T cell response is after the peak in clinical symptoms, 
and the magnitude of the CD8+ T cell response does not correlate with disease severity, 
making it questionable that this T cell subset plays a dominant role in RSV-
immunopathology (Heidema et al., 2007; Lukens et al., 2010).  
It is noteworthy to mention that a panoply of other studies exist in which the 
mechanisms contributing to RSV-induced pathology have been investigated. These 
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studies implicate populations such as NK cells and T regulatory cells (Tregs) (Fulton et 
al., 2010; Lee et al., 2010), however, their discussion would go beyond the scope of 
this thesis. It is important to stress that most of these results have been generated using 
the mouse model of RSV infection, and future studies are required to demonstrate if 
the findings are relevant to RSV-induced human immunopathology. The RSV-mouse 
model is particularly useful due to the availability of knockout strains and the 
possibility of immunodepletion experiments. However, mice are not the natural host of 
RSV and their airway physiology and RSV-induced pathology are quite unlike that of 
humans. This has pushed the field to start establishing more relevant models to study 
RSV infection in vivo. In this context, the use of newborn lambs has found its way into 
RSV research. The airway structure and function of newborn lambs are more similar to 
those of infants compared to mice. Furthermore, the pathology of RSV in lambs is 
similar to that in human infants, with mild peribronchiolar infiltrates of lymphocytes 
and plasma cells, and bronchiolitis characterized by degeneration and sloughing of 
epithelial cells, and major infiltrates of neutrophils (Derscheid and Ackermann, 2012; 
Sow et al., 2011). It is presently clear that the further characterization of this model 
will likely be quite useful in the study of the immunopathologic mechanisms that 
regulate RSV-induced disease. 
 
In the context of RSV infection, certain evidence suggests that Reactive Oxygen 
Species (ROS) could be a contributor to RSV-induced pathology. As will be mentioned 
in more detail in the following section, RSV infection leads to increases in ROS 
production (Casola et al., 2001; Hosakote et al., 2009). Furthermore, a positive 
correlation exists between the quantity of oxidative stress markers present and severity 
of bronchiolits in RSV-infected infants (Hosakote et al., 2011). Considering the 
importance that ROS might play in RSV disease, the following section is thus 
dedicated to an introduction of ROS, their mechanisms of generation and their action 
on processes taking place during viral infection. 
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1.4 ROS and their role in regulation of cellular signaling 
pathways 
 
ROS have for a long time been considered toxic and harmful to organisms, due to 
their reaction with essential metabolites such as lipids, proteins, carbohydrates and 
nucleic acids inside the cell as a mechanism of oxidative stress. The discovery of the 
oxidative burst in phagocytes and its essential role in pathogen killing was the first 
example of how ROS could actually be beneficial for a host organism (Baldridge and 
Gerard, 1932). However, from these discoveries it remained evident that highly ROS-
inducing mechanisms, such as the oxidative burst, needed to take place in confined 
cellular compartments, since damage of cellular macromolecules would be inevitable 
in such processes. It is only during the last decade of research on ROS that the notion 
that low levels of ROS, which are specifically produced upon stimulation and can 
influence cellular signaling pathways via oxidative modification of macromolecules, 
became accepted (D'Autreaux and Toledano, 2007). This level of ROS production is 
not considered harmful to the cell, but, on the contrary, is essential for keeping up 
cellular processes (Droge, 2002). In the following chapter, the nature of ROS and their 
origin will be discussed. With regard to this thesis, special emphasis will be placed on 
the Nicotinamide Adenine Dinucleotide Phosphate Hydrogen (NADPH) oxidase 
(NOX) family and its mechanism of ROS production. These enzymes are expressed in 
various tissues and contribute to basal or stimuli-induced ROS production, depending 
on the context. The mechanisms of how ROS function as subtle redox-regulators of 
cellular processes will be elucidated below, with an emphasis on events controlling 
cellular signaling pathways that drive antiviral innate immunity.  
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1.4.1 The nature of ROS 
 
ROS are chemically reactive molecules containing oxygen that by definition are 
more reactive than oxygen itself. Their elevated reactivity is partly due to the presence 
of an unpaired valence shell electron. The principal ROS species are superoxide anion 
O2-, hydrogen peroxide H2O2, and the hydroxyl radical HO. O2- is a byproduct of 
cellular respiration or other metabolic processes, or can be produced specifically by 
NADPH oxidases. The spontaneous dismutation of two O2- molecules or their 
dismutation catalyzed by superoxide dismutase (SOD) can lead to the formation of 
H2O2. HO is mostly generated by an iron-catalyzed Fenton reaction implicating H2O2 
(Figure 10) (Winterbourn, 2008). These radicals can react with other molecules to form 
highly oxidizing agents. For instance, O2- reacting with nitric oxide (NO) results in the 
formation of peroxynitrate (NO3-), a Reactive Nitrogen Species (RNS) (Winterbourn, 
2008). Furthermore, ROS can initiate oxidative chain reactions of unsaturated fatty 
acids, for example, which results in the creation of reactive fatty acid intermediates.  
The specificity of ROS action is determined based on the chemical reactivity, 
half-life, lipid solubility, and compartmentalization of the ROS produced (D'Autreaux 
and Toledano, 2007). Additionally, in the context of oxidative protein modification, the 
environment of the target residue confers specificity to redox modifications. In general, 
O2- is highly unstable, due to a preference for reactions with Fe-S clusters or 
dismutation to H2O2. O2- is a highly charged molecule, and thus does not diffuse 
readily across membranes. However, it has recently been identified that superoxide, 
generated either at the plasma membrane or on endosomes, can cross the membrane 
barrier through chloride anion channels (Hawkins et al., 2007; Mumbengegwi et al., 
2008). Thus, superoxide might constitute a suitable second messenger in cell areas 
where these channels are present. Due to its high reactivity, the effects of O2- are likely 
confined to the areas surrounding these channels. The even more reactive HO has a 
half-life of only about 10-9 seconds and therefore reacts with any kind of 
macromolecule (Halliwell and Gutteridge, 2007). It is thus implicated in the oxidative 
modification of macromolecules but considered an unsuitable second messenger. H2O2 
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on the contrary is a less reactive radical and much more stable than O2- with a cellular 
half-life is about 1ms. It readily diffuses across membranes, partly via aquaporin 
channels, making it fit for the role of a signaling molecule (Bienert et al., 2007). H2O2 
has a high preference for reactions with Cys and Met residues on target proteins. 
However, not all Cys residues are equally reactive to H2O2. Solvent exposed Cys 
residues or Cys residues with a pKa lower than the physiological pH of the cell, 
stabilized by neighboring positively charged amino acids, readily react with H2O2, 
thereby conferring specificity to the reaction of H2O2 with these amino acids 
(Winterbourn and Hampton, 2008). 
 
 
1.4.2 The origin of ROS 
 
ROS can be generated during enzymatic reactions, from which they can be 
produced as byproducts, but also deliberately, in specialized ROS-generating reactions. 
ROS can also be generated by chemical reactions inside the cell in environments that 
are high in iron and favor the reduction of O2. In the following paragraph, the 
mechanisms of ROS production will be outlined briefly. Of note, the mechanism of 
specialized ROS production by NADPH oxidases will not be mentioned in this section, 
but will be discussed in detail in later paragraphs.  
As previously mentioned, several cell-intrinsic enzymatic reactions produce ROS 
as byproducts. One such example is the mitochondrial respiratory chain. It generates 
ROS as a byproduct at the complex I and III of the mitochondrial respiratory chain 
(Drose and Brandt, 2012). Recently, complex II has also been attributed an important 
role in the regulation of mitochondrial ROS production (Ralph et al., 2011). It is 
noteworthy to mention that the respiratory chain is not the only source of 
mitochondrial ROS. The activities of the following mitochondrial proteins have been 
associated with mitochondrial ROS production: p66Shc, amine oxidases, α-
ketoglutarate dehydrogenase, pyruvate dehydrogenase, and glycerol-3-phosphate 
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dehydrogenase. The process of fatty acid β-oxidation also produces ROS (Brand, 2010; 
Migliaccio et al., 2006; Starkov et al., 2004).  
ROS production also takes place in peroxisomes, organelles specialized in 
peroxide metabolism, lipid biosynthesis and β-oxidation of fatty acids. The main 
source of H2O2 production in peroxisomes is oxidases that transfer hydrogen from their 
respective substrates to molecular oxygen. These include Acyl-CoA-oxidases from β-
oxidation of fatty acids. Oxidases from amino acid metabolism, as well as amine 
oxidase and xanthine oxidase. Xanthine oxidase catalyzes the oxidative hydroxylation 
of hypoxanthine to xanthine and of xanthine to uric acid, which contribute to 
peroxisomal ROS production (Schrader and Fahimi, 2004). 
Further enzymatic reactions that produce ROS as byproducts involve the 
cytochrome P450 enzymes that catalyze the oxidation of hydrophobic organic 
molecules, cyclooxygenases (COX) and lipoxygenases (LOX), which function in 
prostaglandin and arachidonic acid metabolism, respectively (Bae et al., 2011). 
One chemical, non-enzymatic reaction, that contributes to the formation of the 
highly reactive hydroxyl radical HO. from previously produced H2O2 is the Fenton 
reaction.  During this reaction, ferrous iron Fe2+ reacts with H2O2 to form ferric iron 
Fe3+ and a hydroxyl radical HO. This radical can oxidize macromolecules and induce 
various oxidative modifications in the cell. Fe2+ can also react with an oxygen 
molecule to produce a superoxide radical O2- and Fe3+. O2- then dismutates to H2O2, 
which can in turn feed the Fenton reaction. Thus, by generating the highly reactive 
hydroxyl radical, the Fenton reaction contributes significantly to an increase in cellular 
ROS and oxidative damage (Freinbichler et al., 2011).  
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1.4.3 The NADPH oxidase (NOX) family of enzymes 
 
NADPH oxidases are a family of enzyme complexes whose primary function is 
to catalyze the transfer of electrons from NADPH to molecular oxygen, thereby 
generating O2•−. As will be outlined in more detail, in some cases O2•− readily 
dismutates to H2O2, making this ROS the primarily detectable ROS. The NADPH 
oxidase family is made up of seven members, NOX1-5 and Dual oxidase 1 (DUOX1) 
and DUOX2. The different NOX/DUOX proteins vary in terms of their tissue 
expression pattern and mode of activation (Table 2) (Lambeth, 2004). Furthermore, 
they show specific subcellular localization but also generate distinct ROS. NADPH-
generated ROS are implicated in the regulation of  a great variety of cellular processes. 
Figure 10: ROS-generating and ROS-involving reactions. 
The addition of an electron to molecular oxygen leads to the formation of O2-. Its 
dismutation, which can be catalyzed by superoxide dismutase (SOD), generates H2O2. 
H2O2 and O2- are the origin of the very reactive OH produced the Fenton reaction. 
H2O2 can be detoxified by catalase. Peroxidase enzymes, such as lactoperoxidase (LPO) 
or myeloperoxidase (MPO) use H2O2 to form microbicidal compounds hypothiocyanate 
(OSCN-) and hypochlorous acid (HOCl). 	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Briefly, NOX2 is the major NADPH oxidase expressed in phagocytes and is essential 
for microbial killing in this context. NOX2 and NOX4 also play an important role in 
the vasculature, as they regulate angiogenesis. NOX1, which is highly expressed in 
vascular smooth muscle cells and the colon plays a predominant function in these 
compartments, potentially also in the context of mucosal immunity. NOX3 is 
expressed in the inner ear, where its function is associated with hearing and balance. 
NOX5 is highly expressed in the spleen, lymph nodes and testis, but also in cancerous 
tissues of the prostate and esophagus, where it plays a role in cancer development 
(Bedard et al., 2012; Bedard and Krause, 2007). DUOX1 and DUOX2 are essential 
NADPH oxidases in thyroid hormone synthesis, but also regulate antimicrobial 
defenses of the gastrointestinal and respiratory mucosae (De Deken et al., 2000; Dupuy 
et al., 1999; Fischer, 2009). More specifically, in polarized AEC cultures, DUOX2 is 
found at the apical cell pole of ciliated cells (Fischer, 2009). 
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Table II: NADPH oxidase expression pattern and dependency on regulatory 
subunits. Adapted from (Bedard and Krause, 2007). 
 High levels 
expression 
Intermediate to  
low level expression 
Subunit 
dependency 
Ca2+ 
sensitivity 
NOX1 colon smooth muscle  
endothelium  
uterus  
placenta  
prostate  
osteoclasts  
retinal pericytes 
NOXO1 
NOXA1 
p22phox 
 
NOX2 phagocytes B lymphocytes  
neurons  
cardiomyocytes  
skeletal muscle 
hepatocytes 
endothelium 
hematopoietic stem cells 
smooth muscle 
p47phox 
p67phox 
p40phox 
p22phox 
 
 
NOX3 inner ear fetal kidney 
fetal spleen  
skull bone  
brain 
p22phox  
NOX4 kidney 
blood vessels 
Osteoclasts 
Endothelium 
smooth muscle 
hematopoietic stem cells 
fibroblasts 
keratinocytes  
melanoma cells  
neurons 
p22phox  
NOX5 lymphoid tissue  
testis 
Endothelium 
smooth muscle 
pancreas 
placenta  
ovary  
uterus  
stomach 
various fetal tissues 
 + 
DUOX1 thyroid airway epithelia 
tongue epithelium 
cerebellum 
testis 
DUOXA1 + 
DUOX2 thyroid salivary and rectal glands 
gastrointestinal epithelia 
airway epithelia  
uterus 
gall bladder  
pancreatic islets 
DUOXA2 + 
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1.4.3.1 NADPH oxidase composition 
The NADPH oxidases are multicomponent protein complexes with varying their 
compositions among the individual members of the family. All NADPH oxidases have 
a NADPH- and Flavin adenine dinucleotide (FAD)- binding domain in the C-terminal 
cytosolic region. NOX1-5 enzymes have six transmembrane regions, DUOX1 and 
DUOX2 have seven. In NOX1-5’ third and fifth transmembrane domains, four heme-
binding histidines are conserved, and these conserved residues are found in the fourth 
and sixth transmembrane domain of DUOX1 and DUOX2 (Lambeth, 2004). The 
composition of the classical NOX2 complex will be outlined below and relevant 
differences with the other NOX members will be mentioned. NOX2 is made up of a 
core complex of a membrane-bound flavocytochrome b558 complex, composed of the 
gp91phox and the p22phox subunits. The p22phox subunit is essential for NOX2 ROS 
production and stability (DeLeo et al., 2000; Dinauer et al., 1990). NOX2 function 
requires cytosolic factors that, upon activation, assemble with the membrane bound 
core complex to induce functional ROS production. These subunits include p47phox, 
p67phox, as well as p40phox and the small GTPase proteins Rac1/2 (Sheppard et al., 
2005; Vignais, 2002).  
NOX1-4 generally have the same composition with regards to the core enzyme, 
as all these family members have been shown to depend on p22phox (Bedard and 
Krause, 2007; Kawahara et al., 2005). However, they differ in the implication and 
requirement of cytosolic subunits. For instance, NOX1 regulatory subunits were shown 
to be homologues of p47phox and p67phox, namely Noxo1 and Noxa1, which are 
constitutively associated with NOX1 and p22phox (Banfi et al., 2003). NOX4, 
however, does not require a cytosolic regulatory subunit for its activity (Geiszt et al., 
2000; Martyn et al., 2006). NOX5, which does not require p22phox or cytosolic 
regulators for ROS generation, has four intracellular N-terminal EF hand-Ca2+-binding 
domains, making this protein highly susceptible to Ca2+ regulation (Banfi et al., 2001; 
Banfi et al., 2004; Kawahara et al., 2005). This is also the case for DUOX1 and 
DUOX2, which contain the same core structure as NOX5, with an additional N-
terminal transmembrane domain and an extracellular N-terminal peroxidase domain 
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whose function remains controversial (Harper et al., 2006; Meitzler and Ortiz de 
Montellano, 2011). Additionally, DUOX1 and DUOX2 are not dependent on p47phox 
and p67phox, but proper transport to and expression at the membrane, as well as ROS 
production depend on activation factors DUOX activator 1 (DUOXA1) and DUOXA2 
(Ameziane-El-Hassani et al., 2005; Grasberger and Refetoff, 2006; Morand et al., 
2009). 
 
 
1.4.4 The NOX2 NADPH Oxidase 
  
1.4.4.1 Mechanism of ROS generation by NOX2 
NOX2-mediated ROS generation in the phagosome is tightly regulated through 
the requirement of cytosolic regulatory subunits. In the resting state, p40phox, p47phox 
and p67phox are found as a trimer in the cytosol. p67phox, through its C-terminal Src 
homology 3 (SH3) domain, is associated with the C-terminal proline-rich region of 
p47phox (Lapouge et al., 2002). Further, the SH3 domains of p47phox, which are 
necessary for its association with the C-terminal proline-rich region of p22phox, bind 
intramolecularly to the autoinhibitory region (AIR) present in the C-terminal half of 
p47phox, thereby interrupting binding to p22phox (Groemping et al., 2003). Rac1/2 is 
bound to GDP (Mizuno et al., 1992). Phagocytosis of bacteria or stimulation with 
phorbol ester first induces, Rac-GDP exchange to Rac-GTP, whereafter Rac 
translocates to the NOX2 assembly site; and then, the phosphorylation and 
conformational change of p47phox, which enables its binding to p22phox (Dusi et al., 
1993). The binding of p47phox to membrane-located phosphoinositides via the 
p47phox phox homology (PX) domain stabilizes p47phox localization to the 
cytochrome b558 complex (Nauseef, 2004). As p47phox relocalizes to the membrane, it 
brings p67phox and p40phox with it and p67phox consequently interacts with 
gp91phox and Rac1/2 (Koga et al., 1999). Interaction of p67phox’ activation domain 
with gp91phox results in the activation of electron transfer from NADPH to FAD 
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(Nisimoto et al., 1999). It is noteworthy to mention that several kinases have been 
shown to phosphorylate p47phox and p67phox under diverse stimuli conditions. These 
kinases include members of the Protein kinase C (PKC) family (α, δ, β, ψ, ζ), Protein 
kinase A (PKA), p21-activated kinase, Extracellular signal-regulated kinases 1 (Erk1) 
and Erk2, Akt and Phosphoinosite 3 kinase (PI3K) (Lam et al., 2010). The functions of 
p40phox are much less studied. However, it is believed that p40phox is necessary for 
p67phox transport to the membrane as its PX domain can interact with 
phosphoinositides at the membrane, and its C-terminus interacts with p67phox (Ellson 
et al., 2001; Honbou et al., 2007; Kanai et al., 2001). Although p40phox is basally 
phosphorylated, it also becomes phosphorylated on Ser315 and Thr154 upon NADPH 
oxidase activation (Bouin et al., 1998). Once the translocation of cytosolic components 
to the NOX2 enzyme is activated, electron transfer is initiated. In the first step, 
electrons are transferred from NADPH to FAD, a process that is regulated by the 
activation domain of p67phox (Nisimoto et al., 1999). In the second step, a single 
electron is transferred from the reduced flavin FADH2 to the iron center of the first 
heme. Then the first heme donates its electron to the second heme. Oxygen bound to 
the outer heme then accepts the electron and superoxide is produced (Doussiere et al., 
1996; Vignais, 2002).  
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1.4.4.2 Regulation of NOX2 expression 
The regulation of NOX2 expression has been studied mainly in myeloid 
compartments such as monocytes, macrophages and dendritic cells. While NOX2 is 
expressed constitutively in these cell types, its expression and ROS-producing activity 
can be augmented by certain stimuli. IFNγ is such a stimulus, and the upregulation of 
NOX2 expression by IFNγ has been demonstrated by various groups (Anrather et al., 
2006; Cassatella et al., 1990; Eklund et al., 1996). Interestingly, IFNγ also positively 
regulates the expression of p67phox (Eklund and Kakar, 1999). In addition, TNFα can 
lead to the induction of NOX2, as well as p47phox and p67phox expression in 
Figure 11: NOX2 structure and NADPH oxidase-dependent ROS production.  
In A, the structural organization of the NOX2 NADPH oxidase is presented. The enzyme 
possesses six transmembrane regions and C-terminal binding sites for FAD and NADPH. For 
proper ROS production, NOX2 requires the membrane-bound p22phox subunit, as well as 
cytosolic cofactors p47phox, p67phox, Rac1/2 and p40phox. In B, the mechanism of ROS 
generation by NADPH oxidases is presented. Electrons are donated from NADPH and 
transferred to FAD, reducing it to FADH2. A single electron is then transferred from FADH2 to 
the first heme center of the NADPH oxidase. This center can only accept one electron. Oxygen 
is bound to the second heme center and receives the electron from the inner first heme. One-
electron reduction of molecular oxygen (O2) generates superoxide anion (O2-), which is then 
dismutated to hydrogen peroxide (H2O2). From (Block and Gorin, 2012), with permission from 
the Nature Publishing Group. 
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monocytes (Gauss et al., 2007). Transcription factors that positively regulate the 
expression of NOX2 in the above-mentioned contexts are IRF-1, IRF-2, Elf-1, PU-1 
and NF-κB (Anrather et al., 2006; Gauss et al., 2007; Luo and Skalnik, 1996; Mazzi et 
al., 2004; Voo and Skalnik, 1999). GATA-1 has also been demonstrated to act as a 
transcriptional activator of NOX2 expression (Yang et al., 2000). Despite these data, in 
the context of AEC infection, no data exists to date that documents the regulation of 
NOX2 expression in this cellular compartment.  
 
 
1.4.5 The DUOX2 NADPH oxidase 
1.4.5.1 Mechanism of ROS generation by DUOX2 
Whereas the primary product of NOX2 is O2•−, DUOX2 releases mainly H2O2, 
and this despite its homology with NOX2 as well as fact that all NOX/DUOX enzymes 
function via a mono-electron transfer (Lambeth, 2004). However, O2•− formation has 
been detected during H2O2 generation in DUOX-expressing thyroid membrane 
fractions (Dupuy et al., 1991; Leseney et al., 1999; Nakamura et al., 1991). Thus, it is 
believed that O2•− dismutates to H2O2 intramolecularly. The DUOXA2 protein may be 
implicated in the decision of which final ROS species is produced by the DUOX2 
enzyme. A recent report by Hoste et al. determined that residues in the N-terminal 
region of DUOXA2 regulate DUOX2 ROS production. In studies with wild-type 
DUOXA2 sequences, the DUOX2-generated ROS species was H2O2, whereas 
mutation of this region resulted in superoxide leaking from the DUOX2 protein (Hoste 
et al., 2012). Further studies support the hypothesis that a functional DUOX2-
DUOXA2 complex fosters H2O2 production, whereas superoxide is formed when the 
formation of this complex is inhibited due to DUOXA2 retention in the endoplasmatic 
reticulum (ER) (Luxen et al., 2009; Morand et al., 2009). In this context, the 
physiological location of the DUOXA2 protein is still under debate. Whereas early 
findings localized it to the ER, where it functioned in the rapid ER to Golgi transport of 
correctly folded DUOX2, later studies have shown a necessity for DUOX2/DUOXA2 
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complexes at the plasma membrane for efficient DUOX2 expression and H2O2 
production (Grasberger et al., 2007; Grasberger and Refetoff, 2006; Luxen et al., 2009; 
Morand et al., 2009). Unfortunately, a pitfall of the former mentioned studies is the use 
of different overexpression constructs that might account for the diverging results. It 
will thus be necessary to determine the location and function of the DUOXA2 protein 
at the endogenous level of a specific cell type, before making conclusions about its 
implication in the ROS-generating activity of DUOX2. 
Due to the presence of two EF-hand Ca2+ binding motifs, DUOX2 activity is 
heavily regulated by Ca2+. Ca2+-dependent ROS production has been shown in various 
studies, especially via the use of agents capable of raising intracellular Ca2+ levels such 
as Adenosine Triphosphate (ATP), ionomycin, or thapsigargin (Ameziane-El-Hassani 
et al., 2005). Mutation of the EF-hand motifs also abolishes DUOX2 activity (Rigutto 
et al., 2009). The use of phorbol esters can induce DUOX2 activity in thyroid cells, via 
a PKC-mediated step that could possible involve direct phosphorylation of DUOX2 
(Rigutto et al., 2009).  
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1.4.5.2 Regulation of DUOX2 and DUOXA2 expression 
The DUOX2 and DUOXA2 genes are located on chromosome 15 in a head to 
head arrangement (Grasberger and Refetoff, 2006). In the human genome, the 
transcription start sites (TSS) of DUOX2 and DUOXA2 are only 163bp apart and the 
two genes are thought to share one bidirectional promoter (Xu et al., 2012). This 
arrangement implies that DUOX2 and DUOXA2 are regulated in a similar manner, 
which is supported by the fact that DUOX2 and DUOXA2 are indeed upregulated by 
similar stimuli, including IFNγ, flagellin and rhinovirus (RV) (Gattas et al., 2009; Joo 
et al., 2012; Schneider et al., 2010). In addition, both of these genes are repressed in 
lung carcinomas due to promoter hypermethylation (Luxen et al., 2008). Other stimuli 
that have been shown to positively regulate DUOX2 expression include TNFα, all-
trans retinoic acid (ATRA), IL-4 and IL-13. However, although TNFα induces 
DUOX2 expression in intestinal epithelial cells, it is not a DUOX2 inducer in 
pancreatic cancer cell lines or AECs, suggesting a strong cell-type specific expression 
Figure 12: Structural organization of the DUOX2 NADPH oxidase. 
DUOX2 possesses 7 transmembrane regions, C-terminal NADPH and FAD binding sites, 
two intracellular, N-terminal Ca2+ binding sites and an N-terminal extracellular peroxidase 
domain. DUOX2 function requires the presence of DUOXA2, whose location at the 
plasma membrane or at the ER is still a matter of debate. 
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pattern of DUOX2 depending on certain stimuli (Harper et al., 2005; Lipinski et al., 
2009; Wu et al., 2011). Cell type specific induction of DUOX2 also applies to IL-4/IL-
13 stimulations, since these cytokines upregulate DUOX2 in thryocytes and intestinal 
epithelial cells, but not on AECs (Raad et al., 2012). In the latter model, they have been 
shown to induce DUOX1 expression (Harper et al., 2005). Cell type specificity of 
DUOX2 expression is also maintained at the TF level. For instance, whereas STAT1 
binding to the DUOX2 promoter has been demonstrated in the IFNγ-mediated 
induction of DUOX2 expression in pancreatic cancer cells, STAT1 is completely 
dispensable for DUOX2 regulation in IFNγ-stimulated AEC (Hill et al., 2010; Wu et 
al., 2011). In the above-mentioned data on IL-4/IL-13 induced DUOX2 induction, a 
STAT6 implicating JAK-STAT pathway regulates DUOX2 expression. However, 
aside from these data, the identity of DUOX2-regulating TFs in other contexts, such as 
respiratory tract infection, remains enigmatic.  
 
 
1.4.6 Mechanisms of ROS action 	  
The following section will discuss the outcome of ROS production on the 
cellular environment. ROS can oxidize macromolecules such as lipids, DNA and 
proteins. Lipid and DNA oxidation are usually associated with oxidative stress and a 
loss of function of these molecules. Oxidative modification of proteins can have the 
same result. However, oxidative modification of proteins can also be considered to be a 
post-translational signal that regulates protein activity. The following paragraphs will 
focus mainly on oxidative protein modifications in the context of antiviral signaling.  
 
1.4.6.1 Oxidative Protein Modification 
Proteins can be modified by ROS in primarly two different ways, causing 
reversible and irreversible protein oxidations. While protein carbonylation is 
irreversible, the ROS-mediated attack on thiol groups can generate reversible oxidative 
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modifications (Antelmann and Helmann, 2011; Curtis et al., 2012). This kind of redox 
modification plays an important role in redox signaling. Protein carbonylation on the 
other hand is irreversible and is associated with oxidative damage of proteins.  
As concerns the reversible oxidative modification of thiol groups, Cys and Met 
residues are the main targets. Cys residues are often at the center of the catalytic site of 
an enzyme and play a crucial role in its function. Due to the surrounding environment 
in the catalytically active site, which is rich in positively charged aromatic amino acid 
side chains, redox-sensitive Cys residues have a low pKa value (D'Autreaux and 
Toledano, 2007). As a consequence of the intracellular physiological pH, these are 
present in a deprotonated and therefore highly reactive thiolate form (R-S-) (Brandes et 
al., 2009). Cys oxidation can thus easily occur on these residues. This form of 
posttranslational modification can therefore be a means of regulating the function of 
certain proteins.  
Several possible oxidative thiol modifications have been described so far: S-
thiolation (R-SS-R) by formation of intramolecular or intermolecular disulfide bonds 
or reaction with low molecular weight thiol-containing compounds, S-nitrosation (R-
SNO), S-glutathionylation (R-S-GSH), as well as the formation of sulfenic (R-SOH), 
sulfinic (R-SO2H) and sulfonic acid (R-SO3H). The latter two are irreversible oxidative 
modifications (Finkel, 2011).  
As regards irreversible protein carbonylation, the amino acid side chains of Pro, 
Arg, Lys and Thr are particularly susceptible (Curtis et al., 2012). Protein 
carbonylation results in semialdehyde formation on the amino acid side chain, which 
may change the tertiary structure of the protein and render the protein more prone to 
degradation. Further, protein carbonylation on the protein backbone via α-amidation 
can lead to peptide bond cleavage. Thus, protein carbonylation is generally thought to 
inactivate modified proteins (Dalle-Donne et al., 2006).  
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1.4.7 Evidence of ROS production in virus-infected cells 
Before going into the details of regulation of antiviral signaling pathways by 
ROS, it is necessary to discuss ROS production in the setting of viral infections. 
Increased ROS production has been documented in the context of various viral 
infections, including Human Immunodeficiency Virus (HIV) and Hepatitis C virus 
(HCV) infection (Schwarz, 1996; Stehbens, 2004). In the respiratory context, an 
increase in ROS production has also been reported in the setting of respiratory virus 
Figure 13: Redox modification of cysteine residues. 
Specific reactive Cys residues in the form of a thiolate anion within target proteins 
can be the subject of covalent redox modifications. Oxidation leads to the formation 
of sulfenic, sulfinic or sulfonic forms, where the latter two are irreversible. The 
thiolate anion can also be subject to intra- and intermolecular disulfide bond 
formation. Further, it can react with other low molecular weight thiols such as 
glutathione in the process of S-glutathionylation. From (Finkel, 2011). 
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infection, such as RSV, RV and influenza (Akaike et al., 1990; Casola et al., 2001; 
Comstock et al., 2011).  
It is important to note that an increase in cellular ROS levels and oxidative stress 
is not only generated by an increase in ROS production. An imbalance between ROS 
producing and antioxidant systems can also contribute to an increase in ROS levels. 
The latter phenomenon has indeed been observed in several viral infections. For 
instance, in RSV infection, the expression and/or activity levels of superoxide 
dismutase (SOD), catalase and Glutathione-S-transferase have been shown to be 
altered (Hosakote et al., 2009). A similar disruption of the antioxidant system has been 
reported in influenza infection (Hennet et al., 1992; Yamada et al., 2012). 
At this point it is necessary to mention that a multitude of assays exist to 
determine changes in ROS production in a given context. These are often fluorescence-
based techniques, some of which can discriminate between intra- and extracellular 
ROS production based on their capacity to enter cells. Some fluorescence-based 
techniques are specific for O2-, whereas others detect H2O2. However, this specificity 
is still a matter of debate (Wardman, 2007). For instance, Dichlorofluorescin diacetate 
(DCFDA), which is widely used as a probe for intracellular H2O2 in the above-
mentioned examples, can also react with many other ROS and Reactive Nitrogen 
Species (RNS) (Chen et al., 2010). Another difficulty in using these probes comes from 
the many interferants that can influence the ROS signal. For instance, cellular 
antioxidant systems have been shown to interfere with oxidized fluorescent dyes (Chen 
et al., 2010; Winterbourn, 2008). Additionally, ROS probes are pH sensitive and 
changes in intracellular pH, which are observed during viral infection, can potentially 
falsifye the signal (Ciriolo et al., 1997). Thus, the in literature available data on ROS 
production must be critically analyzed.  
 
 
1.4.8 Regulation of antiviral signaling pathways by ROS 
As mentioned beforehand, the recognition of virus entry by PRRs engages into 
signaling cascades that will ultimately lead to the activation of IRF-3 and NF-κB, 
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which are essential TFs for gene transcription of type I and III interferons. In the 
following section we outline the current knowledge on redox regulation of antiviral 
signaling pathways.	  	  
1.4.8.1 Redox regulation of the NF-κB signaling pathway 
The function of NF-κB has long been known to be highly sensitive to the cellular 
redox status in various physiological contexts (Morgan and Liu, 2011). In the context 
of virus infection, data exist that suggest NF-κB is subject to regulation in a redox-
sensitive manner. For instance, antioxidant treatment affected levels of NF-κB 
activation in RSV infection, strongly suggesting a redox-control of NF-κB in this 
setting (Hosakote et al., 2012; Jamaluddin et al., 2009; Mata et al., 2011). In these 
contexts, ROS have been associated with an increase in NF-κB activity. Further, 
although not demonstrated in the context of viral infection, oxidative modification of 
NF-κB has been studied in various other contexts, such as cytokine stimulation. In 
those settings, ROS have been associated with both - activation and inhibition - of 
either NF-κB directly or components of the NF-κB signaling pathway.   
Regarding direct oxidation of NF-κB by ROS it is generally accepted that the 
reducing environment found in the nucleus is important for the efficient activation of 
NF-κB target genes, whereas an oxidative environment ensures proper signaling in the 
cytosol (Kabe et al., 2005). In this context, it has been shown that NF-κB binding to 
DNA requires the reduced state of specific Cys residues in its N-terminal DNA 
recognition loop. More specifically, the Cys62 residue of the p50 subunit of NF-κB 
plays an important role. Cys62 is found oxidized in the cytoplasm, but reduced in the 
nucleus, which is necessary for DNA binding of NF-κB (Nishi et al., 2002). 
Furthermore, S-glutathionylation has been described for this residue (Pineda-Molina et 
al., 2001). These data demonstrate that Cys62 of p50 is a redox-sensitive residue that 
could also come into play in the context of viral infections. Besides the p50 subunit, 
the p65 subunit of NF-κB also possesses a redox-sensitive Cys at position 38. 
Alkylation of this residue has been demonstrated in an in vitro setting, however, the 
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physiological significance of this residue in the redox-regulation of NF-κB remains to 
be demonstrated (Garcia-Pineres et al., 2004). In a different study, this residue, as well 
as two other Cys residues in p65, Cys160 and Cys216, were targets for redox-
regulation following TNFα treatment in combination with a ROS-inducing 
prostaglandin. S-glutathionylation of p65 in this context abolished TNFα-induced p65 
nuclear translocation and Intercellular adhesion molecule 1 (ICAM1) expression (Lin 
et al., 2012). Thus, several evidence point to redox-sensitive residues in NF-κB that 
could come into play during the course of viral infection. 
A central step in the pathway to NF-κB activation is the degradation of IκBα. 
ROS have previously been shown to control this event. H2O2 treatment affects the 
phosphorylation of IκBα at Tyr42 and leads to IκBα proteasome-independent 
degradation, thereby supporting an alternative NF-κB activation pathway 
(Schoonbroodt et al., 2000). Thus, IκBα is also a potential redox-target in the NF-κB 
activation cascade. 
NF-κB activity is strongly under the control of post-translational modifications, 
for instance phosphorylation. The phosphorylation of Ser276 of p65 is necessary for 
the transcription of a subset of NF-κB target genes and for the interaction of p65 with 
the CBP/p300 activator. Upon stimulation with RSV it has been shown that this 
phosphorylation, which in this specific context is effectuated by cAMP dependent 
protein kinase A (PKAc), underlies a redox-sensitive mechanism (Jamaluddin et al., 
2009). However, the mechanistic details implicated in the redox regulation of this post-
translational modification remain to be explored. 
One reason for the existence of redox-sensitive phosphorylation sites in NF-κB 
or IκBα is a potential for redox-regulation of kinases that act upstream in the signaling 
pathway. For instance, the activity of the IKK complex is central in mediating NF-κB 
activation. As mentioned, NF-κB activation depends on IKKβ phosphorylation of 
IκBα at Ser32 and Ser36, which leads to its proteasome-dependent degradation and 
liberation of NF-κB for translocation to the nucleus. H2O2 has a potential for activating 
IKKs in some cell types. For instance, dimerization of NEMO was fostered by H2O2 
treatment through formation of disulfide bonds between Cys54 and Cys347 
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(Herscovitch et al., 2008). H2O2 has also been associated with IKK activation and 
potentiating Ser180 and Ser181 phosphorylations in the IKK activation loop (Kamata 
et al., 2002). Contrasting these reports on IKK activation by ROS, several reports have 
conversly shown that Cys179 of IKKβ is a target of oxidative modifications such as S-
nitrosylation or S-glutathionylation, which consequently shut down IKKβ kinase 
activity and inhibit NF-κB activation (Kapahi et al., 2000; Reynaert et al., 2004; 
Reynaert et al., 2006). Thus altogether, although the above-mentioned studies to not 
demonstrate a clear consensus regarding the activating or inhibiting action of ROS on 
the NF-κB signaling pathway, these data strongly demonstrate that this pathway 
represents a potential target for redox changes occurring during viral infection. 
At this point a word of caution needs to be mentioned regarding the interpretation 
of studies investigating NF-κB dependent redox regulation. Many of them relied and 
still rely on the use of H2O2 alone or in combination with NF-κB stimulants, such as 
cytokines. This led to the publication of partially contradictory data, whose 
interpretation remains valid but when compared to other literature becomes 
problematic due to the vast differences in experimental setups applied in the individual 
studies (H2O2 concentration and time of stimulation, method of H2O2 delivery, cell 
type, cell number, costimulation with NF-κB stimulants, etc.). Further, the use of 
antioxidants to study the importance of ROS in NF-κB signaling can lead to false 
results, as many of them have side effects that interfere with the correct interpretation 
of results. For instance, N-acetylcyteine (NAC) and Pyrrolidine dithiocarbamate 
(PDTC) have been shown to attenuate NF-κB activation independently of their 
antioxidant function (Hayakawa et al., 2003). This issue has been addressed 
extensively by Oliveira-Marques et al. and is likely the reason for the existence of 
discrepancies in the studies addressing the role or ROS in NF-κB activation (Oliveira-
Marques et al., 2009). 
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1.4.8.2 Redox regulation of the interferon response 
In the early antiviral signaling cascade, the TRAF family of proteins plays an 
important role in mediating the activation of kinases downstream of PRRs, which are 
in turn essential for TF activation. More precisely, TRAF3 and TRAF6 have been 
attributed important functions in this context. A recent publication by Gonzalez-Dosal 
et al. has demonstrated that TRAF3 and TRAF6 are subject to S-glutathionylation of a 
conserved Cys residue in the context of Herpes Simplex Virus 2 (HSV-2) infection in 
macrophages (Gonzalez-Dosal et al., 2011). S-glutathionylation of TRAF3/6 was 
important for the activation of IRF-3 and NF-κB during the course of viral infection. 
This example shows the importance and potential that oxidative modification of thiol 
residues has in the context of antiviral signaling.  
In terms of redox regulation of the IRF-3 antiviral transcription factor, existing 
data so far are scarce and partly contradictory. The study of Prinarakis et al. 
demonstrates that IRF-3, in the non-infected cell, is S-glutathionylated at a basal level. 
Upon SeV infection, IRF-3 becomes deglutathionylated by Glutaredoxin-1. The 
authors show that this process does not affect IRF-3 phosphorylation or nuclear 
accumulation, but association of IRF-3 with the CBP/p300 coactivator (Prinarakis et 
al., 2008). With regards to IRF-3’s redox sensitive Cys residues, Zucchini et al. 
attempted to analyze their importance in the context of SeV infection. While IRF-3 
Cys289 was shown to be potentially redox-regulated, the significance of this residue 
and its redox-modification could not be confirmed during in vivo infection studies. 
However, alkylating agents still had an effect on IRF-3 activation in vivo, thereby 
suggesting that a still uncharacterized redox-sensitive thiol in a protein found upstream 
in the IRF-3 activation pathway might play an important role in antiviral signaling 
(Zucchini et al., 2012). This last study also shows the importance of the experimental 
setup in studies investigating redox regulation, as there might be a high discrepancy 
between results generated during in vitro reactions of proteins and alkylating agents 
aimed at identifying potential redox-sensitive residues and their actual biological 
significance in an in vivo setting. 
Redox-sensitive mechanisms do not only regulate the early phase of the antiviral 
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response but equally the IFN-induced JAK-STAT signaling cascade. For instance, the 
JAK-STAT pathway can be activated by ROS (Simon et al., 1998). STAT 
phosphorylation is increased upon stimulation with H2O2 and one mechanism that 
could explain this phenomenon is the oxidative inactivation of tyrosine phosphatases 
implicated in the negative regulation of the JAK-STAT pathway. Protein phosphatases 
are highly prone to regulation by ROS, as they have a redox-sensitive Cys residue in 
their catalytic site (Ostman et al., 2011). Indeed, in the context of RSV infection, such 
a ROS-dependent inhibition of protein tyrosine phosphatases has been observed 
previously (Liu et al., 2004). One of the tyrosine phosphatases known to regulate the 
JAK-STAT pathway is Src-homology 2 containing protein phosphatase 2 (SHP-2) (Xu 
and Qu, 2008; You et al., 1999). Indeed, SHP-2 can become inactivated in the context 
of ROS exposure and a potential for reversible Cys oxidation has been demonstrated 
for this phosphatase (Boivin and Tonks, 2010; Kwon et al., 2005). Additionally, 
protein tyrosine phosphatase 1B (PTP1B) recognizes and dephosphorylates Tyk2 
involved in type I IFN signaling (Myers et al., 2001). Several studies have reported the 
oxidative regulation of this phosphatase in its active site indicating that also this 
phosphatase could be regulated by differential redox-statuses emerging during virus-
induced type I IFN signaling (Haque et al., 2011; Hirakawa et al., 2011). Last, STAT 
proteins themselves could be targets of redox-regulation. In this context, STAT3 
contains redox-reactive Cys that can become oxidized, thereby changing significantly 
the promoter binding proteins of this protein (Buettner et al., 2011; Li and Shaw, 
2004).  
 
 
1.4.9 NADPH oxidase-dependent regulation of NF-κB 
Considering, firstly, the key role NF-κB plays in the regulation of antiviral and 
inflammatory processes following an infection, and, secondly, its redox-sensitive 
regulation, as outlined in the previous paragraphs, it is now necessary to discuss 
evidence linking NADPH oxidases to NF-κB activation. The data describing redox-
regulation of this transcription factor by NADPH oxidases is vast, as it is crucial in 
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processes as diverse as inflammation, immunity, cell proliferation and apoptosis. 
Adding to complexity is the fact that a given NADPH oxidase is activated in a 
stimulus-specific and cell-type specific manner. To remain within the scope of this 
thesis, the discussion in the following paragraphs will limit itself mainly on data related 
to a pulmonary infection/inflammation setting. As will be outlined, in most cases 
NADPH oxidases exerce an activating function on NF-κB, although in a few esamples, 
NADPH oxidase action is associated with NF-κB inhibition. A special emphasis is 
given to data obtained in NADPH knockout models or by RNAi-mediated decrease of 
NADPH oxidase expression rather than data solely obtained from the use of non-
specific NADPH oxidase inhibitors or antioxidants.  
In the contexts of Pseudomonas aeruginosa or LPS stimulation p47phox 
knockout mice have proven useful. In both contexts, the absence of the 47phox protein 
ablated NF-κB activation in the lung (Koay et al., 2001; Sadikot et al., 2004). It is 
noteworthy to mention that two recent publications do not support this data on NADPH 
oxidase-mediated NF-κB activation in the context of LPS stimulation. In a similar 
model, NADPH oxidase deficiency was associated with a decrease in NF-κB activation 
(Han et al., 2013; Segal et al., 2010). Although this discrepancy is rather intriguing, 
especially since all the data were obtained from the same laboratory, differences in the 
LPS instillation methods (intraperitoneal vs. intratracheal) could account for it. In this 
line, another independent group demonstrated that NADPH oxidase were not involved 
in the regulation of NF-κB in heart, lung, liver or kidney following intraperitoneal LPS 
stimulation of p47phox and gp91phox knockout mice (Zhang et al., 2009b). 
Interestingly, in a follow-up study from the same group, applying TNFα to p47phox 
and and gp91phox knockout mice, only NF-κB of the lung tissue was activated in a 
NADPH oxidase-dependent manner (Zhang et al., 2011). Interestingly, in Peripheral 
blood monoclear cells (PBMCs) from patients suffering from Chronic Granulomatous 
Disease (CGD), a disease where genetic mutations in the subunits of NADPH oxidase 
components render this enzyme inactive (CGD will be discussed in more detail in the 
following chapter), major steps in the NF-κB activation pathway were functional 
(Bylund et al., 2007). Thus, from these data it is evident that the dependency of NF-κB 
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activation on NADPH oxidase needs to be evaluated on a context-specific basis, 
carefully taking into account the experimental differences used among different 
research groups. 
In a different context, the NOX2 NADPH oxidase has been implicated in the 
establishment of a cell-to-cell crosstalk between PMNs and lung vascular endothelial 
cells. NOX2-derived ROS from PMNs were necessary for NF-κB activation and 
consequent TLR2 and ICAM-1 expression in neighbouring lung endothelial cells (Fan 
et al., 2003). These data not only present yet another example of NOX2-dependent NF-
κB activation, they suggest that NOX2-generated ROS do not only exerce their 
function in the cell type where they are produced but are able to diffuse to affect 
cellular signaling pathways in secondary cell types. 
Although the above-mentioned data give clear examples of NOX2 function in 
NF-κB regulation in the lung tissue, the other NADPH oxidases in the lung have also 
been associated with regulation of NF-κB activity. For instance, DUOX1 influences 
NF-κB activation downstream of Epidermal Growth Factor Receptor (EGFR) signaling 
(Boots et al., 2009). Following TNFα stimulation of bronchial epithelial cells, lipid raft 
resident DUOX1 was found to be essential for NF-κB activation (Wang et al., 2011). 
Further, in human nasal epithelial cells, DUOX2 was implicated in the activation of 
NF-κB following stimulation with bacterial flagellin (Joo et al., 2012). 
Altogether, this presents clear evidence for a potential of redox regulation of NF-
κB by NADPH oxidases. 	  
 
In conclusion, as the previous paragraphs demonstrate, the alteration of the 
redox-balance observed in the context of viral infection has the potential to modulate 
antiviral signaling pathways via reversible oxidative modification of proteins. NF-κB 
is a redox sensitive transcription factor and its activation status is strongly influenced 
by NADPH oxidases in various contexts. The following last chapter will make an 
attempt to introduce specifically the role of the NADPH oxidases as ROS producers 
and regulators of antiviral defenses of the lung.  
	   68 
1.5 NADPH oxidases in antimicrobial lung defenses 
 
Airway epithelial cells are the very first cells exposed to airborne pathogens. As 
has been mentioned in the previous chapters, they are specialized in shielding off 
infection. However, once infection occurs, they are equally equipped for detecting 
pathogens and mounting defense mechanisms that will alarm surrounding cells as well 
as players of the innate immune system to clear the infection. This chapter will discuss 
the present knowledge about the implication of NADPH oxidases in the airway 
defense. The role of DUOX proteins in the antimicrobial defense as well as in 
inflammatory mechanisms at airway epithelial surfaces will be mentioned. The role of 
phagocyte NADPH oxidase NOX2 in diverse contexts of AEC defense will also be 
treated. 
 
 
1.5.1 The many roles of DUOXs in the airway epithelial immunity 
1.5.1.1 DUOXs contribute to airway antimicrobial defense 
The most prevalent NADPH oxidases found in the airway linings are DUOX1 
and DUOX2 (Forteza et al., 2005; Geiszt et al., 2003; Shao and Nadel, 2005). There, 
they exert diverse functions in the antimicrobial defense. First, a large number of 
evidence points to a major role of DUOX1/2 enzymes as part of an extracellular airway 
antimicrobial defense system involving DUOX-generated H2O2, lactoperoxidase (LPO) 
enzyme and the compound thiocyanite (SCN-). It was previously acknowledged that 
H2O2 is constitutively secreted into the airways, and later studies have associated the 
DUOX1/2 enzymes with this ROS-generating activity (Forteza et al., 2005; Gattas et 
al., 2009; Geiszt et al., 2003; Moskwa et al., 2007). As for LPO, airway gland cells also 
secrete this enzyme into the airway lumen (Gerson et al., 2000; Wijkstrom-Frei et al., 
2003) and LPO utilizes DUOX-generated H2O2 and SCN-, which is able to pass trough 
ion channels, such as the Cystic fibrosis transmembrane conductance regulator 
(CFTR), to form the microbicidal compound hypothiocyanate (OSCN-) (Gerson et al., 
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2000; Wijkstrom-Frei et al., 2003). Several studies have reported decreased bacterial 
burden in cell cultures upon the activation of a functioning DUOX2/LPO/OSCN- 
system (Gattas et al., 2009; Gerson et al., 2000; Moskwa et al., 2007). This 
antibacterial system is defective in diseases like cystic fibrosis, due to a defect in SCN- 
transport into the lumen of the airways but potentially also due to a decrease in 
DUOX2 expression in the lungs of Cystic Fibrosis (CF) patients (Moskwa et al., 2007; 
Wright et al., 2006). Further, it is targeted by Pseudomonas aeruginosa, an important 
etiologic agent in CF, via the expression of the redox-active virulence factor 
Pyocyanin. The latter inhibits DUOX upregulation but also DUOX activity by 
depleting intracellular NADPH levels since it causes intracellular O2- production. 
Pyocyanin is thus able to subvert P. aeruginosa killing by the DUOX/SCN-/LPO 
system (Rada et al., 2008; Rada and Leto, 2009).  
Interestingly, in cell free assays, OSCN- has also been associated with virucidal 
activities (Mikola et al., 1995). A recent study however contradicted these early results 
and suggested that despite the involvement of DUOX-generated H2O2 in antiviral 
defense, the virucidal action was exerted by hypoiodous acid rather than OSCN- 
(Fischer et al., 2011). Nevertheless, a role for DUOX enzymes was affirmed, making it 
clear that these NADPH oxidase members could indeed play a role in airway antiviral 
defenses. 
Besides the DUOX-based contribution to the formation of antibacterial OSCN-, 
other reports suggest that DUOX-based antimicrobial action relies on different 
mechanisms. Botteaux et al. postulate that DUOX2-produced H2O2 might act as a 
bacterial repellent holding off invasive bacteria from the cell surface and thereby 
leading to decreased cytoinvasion (Botteaux et al., 2009). Further, DUOX activity 
might contribute to H+ secretion into the airways and acidification of the airway lumen, 
which likely contributes indirectly to the LPO system, since LPO activity and 
antibacterial action are elevated at a pH around 6 (Schwarzer et al., 2004). Lastly, 
Harper et al. have proposed that the DUOX2 heme peroxidase domain is active, and 
could potentially contribute to antimicrobial mechanisms in a similar fashion as LPO 
(Harper et al., 2006). However, such a function has been contested by others who have 
	   70 
found that the mammalian peroxidase domain of DUOX was inactive (Meitzler and 
Ortiz de Montellano, 2011). 
Regarding the antimicrobial function of DUOX1/2 it is noteworthy to mention 
that further studies, which were mostly conducted in the gut, exist that link the action 
of DUOX to antimicrobial defenses. For instance, in Drosophila it was shown that 
dDuox-lacking Drosophila are severely susceptible to microbe-contaminated food. It 
was later revealed that DUOX is not only important in fostering Drosophila 
antimicrobial activity but also for regulating homeostasis to gut-resident commensal 
bacteria (Ha et al., 2009b; Ha et al., 2005). Additionally, Kumar et al. demonstrated a 
role for Anopheles gambiae DUOX in maintaining homeostasis with midgut bacteria 
by establishing tyrosin cross-links in the mucin layer of the midgut, which serve to 
shield off immune elicitors from gut-resident bacteria (Kumar et al., 2010). That host 
DUOX generated H2O2 can exert its action as far as to the invading pathogen, thereby 
changing the microbe’s virulence, was shown by Corcionivochi et al. In their 
interesting study they demonstrated that DUOX2-generated ROS regulate gut 
Campylobacter jejuni immunity by inactivating a bacterial kinase necessary for capsule 
formation (Corcionivoschi et al., 2012). Thus, the DUOX2-mediated antimicrobial 
action was conveyed by rendering a C. jejuni virulence factor less active.  
Altogether, these data strongly suggest an important role for DUOX-dependent 
antimicrobial action in the airways. Data generated in different organisms show that 
this antimicrobial action is of great importance and well conserved. Data generated in 
the intestinal model hint at possible mechanistic features on how DUOX might foster 
microbial balance also in the lung environment. 
Although all the above-mentioned data attribute a “positive” function for DUOX 
enzymes in the airway antimicrobial defense, a study published from Chattoraj et al. 
demonstrates that DUOX-derived H2O2 can also lead to complications associated with 
bacterial infections. The authors demonstrated that during RV infection DUOX2-
derived H2O2 permitted the spread of P. aeruginosa planktonic bacteria from biofilms, 
thereby causing an exacerbated inflammatory cytokine production and increased 
bacterial transmigration across the airway epithelium (Chattoraj et al., 2011). This 
	   71 
could explain RV-induced bacterial exacerbations of CF patients chronically infected 
with P. aeruginosa.  
 
1.5.1.2 DUOXs and airway inflammation 
Besides the above-mentioned role of DUOXs in antimicrobial defenses, DUOX 
enzymes control several aspects of pathogen-induced inflammation. One mechanism of 
DUOX-mediated control of inflammation acts via the regulation of A Disintegrin and 
Metalloproteinase 17 (ADAM17), also called TNFα-converting enzyme (TACE). 
TACE is a membrane-bound enzyme that cleaves cell surface proteins, such as 
cytokines or their respective receptors. Via activities such as TNFα-, TNFR-, IL-6 or 
Epidermal growth factor α (EGFα) cleavage TACE is able to either inhibit or promote 
inflammatory processes (Scheller et al., 2011). In this context, a study of Yu et al. 
showed that DUOX2 was necessary for TNFR1 shedding upon TLR3 stimulation with 
poly I:C in AEC (Yu et al., 2011). This could constitute an important 
immunomodulatory mechanism in the context of viral infections. How exactly DUOX2 
or ROS in general might regulate TACE activity is still under debate, but could involve 
oxidation of the inhibitory prodomain of TACE or oxidative regulation of TACE-
activity promoting intracellular signaling pathways (Scott et al., 2011; Zhang et al., 
2001b). The DUOX2 homologue DUOX1 has also been attributed an important role in 
TACE activation following phorbol-12-myristate-13-acetate (PMA) and Human 
Neutrophil Elastase (HNE) stimulation of AEC. Shao et al. demonstrated that DUOX1-
produced ROS were necessary for release of Tumor Growth Factor α (TGFα), which 
culminated into Mucin 5AC (Muc5AC) expression (Shao and Nadel, 2005). Later, 
Boots et al. demonstrated a similar involvement of DUOX1 in LPS and asialo-GM1 
(ASGM1) receptor-mediated IL-8 production (Boots et al., 2009). The mechanism of 
DUOX1-dependent IL-8 and Vascular Endothelial Growth Factor (VEGF) production 
via a TACE-TGFα-Epidermal Growth Factor Receptor (EGFR) signaling axis was 
confirmed by other groups following stimulation of TLR2, TLR3, TLR4, TLR5 and 
TLR6 as well as PMA (Koff et al., 2008; Nakanaga et al., 2007). Thus, from these 
studies it is evident that the DUOX1/2 enzymes are important regulators of TACE-
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mediated shedding of diverse cell surface molecules and that by these mechanisms they 
might be implicated in the most diverse action of airway inflammation.  
 
A recent study has placed the NADPH oxidase DUOX2 into the NF-κB 
activation pathway of flagellin-induced TLR5 signaling in normal human nasal 
epithelial cells. Joo and collegues demonstrated that DUOX2 positively influences 
flagellin-induced IL-8 and Muc5A levels, necessary for neutrophil recruitment and 
airway surface defense, via the regulation of NF-κB. More detailed experiments 
suggest that TLR5 and DUOX2 colocalize, implying that the proximity of TLR5 and 
DUOX2 is important in this system. However, no mechanism on how DUOX2 fosters 
NF-κB activation was presented. On the other hand, their work included the very first 
data obtained in DUOX2 knockout mice challenged with flagellin, which showed that 
DUOX2 is able to influence the expression of various cytokines and chemokines as 
well as IFN-related genes culminating in a decreased neutrophil infiltration in DUOX2 
knockout mice (Joo et al., 2012). Although from the latter studies on knockout models 
it is difficult to dissect the importance of DUOX2 in the hematopoietic vs. non-
hematopoietic compartment, it is clear that this NADPH oxidase has an important role 
in regulating airway epithelial defense mechanisms.  
 
1.5.1.3 NOX/DUOX enzymes as regulators of airway epithelial integrity 
The respiratory epithelium serves as an important barrier that protects the 
organism from invading pathogens. To conserve this function during stress, infection 
and injury, repair mechanisms must function properly to ensure the continuity of 
airway epithelial integrity. Wound repair is equally important for the resolution of 
infection and inflammation in airway tissues. The NADPH oxidase DUOX1 has a 
major implication in the process of wound healing. It is known that DUOX1-produced 
H2O2 mediates wound closure (Gorissen et al., 2013). This involves the above-
mentioned EGFR signaling pathway of EGFR leading to the activation of Erk and 
Matrix metalloprotease 9 (MMP9) expression (Wesley et al., 2007). In this line of 
evidence, Pseudomonas LPS also generates a DUOX1-dependent wound repair process 
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in the airway epithelium. LPS led to PKC-dependent DUOX1 activation that 
culminated in a TACE-TGFα-EGFR signaling cascade to initiate cellular repair 
mechanisms (Koff et al., 2006). In this context, a more recent publication suggests that 
this involves DUOX1-dependent oxidation of Src and TACE (Sham et al., 2013). An 
interesting study conducted in the zebrafish model links DUOX-generated H2O2 
production at the site of the wound to leukocyte recruitment, a necessary event for 
wound repair. Wounded epidermal tissue might thus use DUOX-generated H2O2 not 
only to activate its own repair program but H2O2 could serve as an essential 
extracellular second messenger for communication of wounded cells with the 
hematopoietic compartment thereby contributing to the activation of further repair 
mechanisms.  
 On the contrary to the above-mentioned positive contribution to airway 
epithelial integrity by epithelium-based DUOX1, another member of the NADPH 
family, NOX1, might play an adverse effect on epithelial barrier function. Comstock et 
al. showed that loss of airway epithelial barrier function during RV infection is 
attributable to NOX1-derived ROS. These were found to be responsible for virus-
induced breakdown of tight junction complexes (Comstock et al., 2011).  
 
 
1.5.2 The role of NOX2 in airway immunity 
 
Upon lung infection, lung resident innate immune cells play a major role in the 
recruitment of further innate and adaptive immune players into the lung. Among these, 
professional phagocytes, such as macrophages, neutrophils, eosinophils and dendritic 
cells express NADPH oxidase NOX2 (Babior et al., 1976; Elsen et al., 2004). A major 
function of NOX2 in airway immunity and immunity in general is the destruction of 
pathogens during the process of oxidative burst in phagocytes. This mechanism is 
essential for eliminating bacterial and fungal pathogens that are engulfed during 
phagocytosis.  
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The importance of NOX2 is shown in the context of Chronic granulomatous 
disease (GCD), a disease where genetic mutations in the subunits of NADPH oxidase 
components render this enzyme inactive. The predominant form of GCD results from 
mutations in the CYBB gene encoding gp91phox (NOX2), which is inherited in a X-
linked recessive manner. Other mutations affect p22phox, p40phox, p47phox, and 
p67phox, which are inherited in an autosomal recessive manner (Bylund et al., 2010). 
Patients affected by this disease have a deficiency in oxidative burst production and 
therefore suffer from recurrent infections. Additionally, these patients also show 
increased inflammation and granuloma formation in organs. These are cellular 
structures that center around microorganisms or cells containing intracellular 
microorganisms, and are bordered by a cellular barrier. The increased number of 
granuloma and the increased inflammatory status in GCD patients imply the 
implication of NOX2 in processes other than the oxidative burst (Kuijpers and Lutter, 
2012). Studies conducted with samples from patients suffering from CGD or studies 
conducted in mouse GCD models have been valuable in the elucidation of these 
additional functions of NOX2.  
 
1.5.2.1 NOX2 controls inflammation 
In CGD, an increase in the inflammatory environment is a major complication of 
the disease. This increased inflammation is present at a basal level, as PBMCs from 
CGD patients show elevated levels in secreted proinflammatory cytokines, even in the 
absence of microbial infection (Kobayashi et al., 2004). In addition, granulomas found 
in CGD patients are often sterile, thus not containing microorganisms, which strongly 
suggests a dysregulation of the proinflammatory setting (Schappi et al., 2008). The 
exact molecular reason for the increased inflammatory status is not yet clear, but it is 
evident that the NOX2 complex is implicated in the regulation or dampening of 
inflammatory processes.  
The implication of NOX2 in the regulation of viral infection-related 
inflammation has been studied by several groups in the context of influenza infection. 
Infection of NOX2 knockout mice with influenza virus is associated with a reduction 
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in viral titer (Snelgrove et al., 2006; Vlahos et al., 2011). However, while Vlahos et al. 
documented a reduction of overall inflammation, the number of BALF macrophages, 
MCP-1 levels and apoptosis, Snelgrove et al. described elevated proinflammatory 
cytokines with a Th1 bias, expanded neutrophils, macrophages and T cell infiltrates, 
and elevated MCP-1 levels. Thus, although these two studies diverge on the results 
regarding the inflammatory status, both present reduced lung damage, improved lung 
function and improved disease outcome in the absence of NOX2. Thus, NOX2 seems 
to have a negative impact on resolution of viral infection. Whereas Snelgrove et al. 
proposed the reduced virus titers were due to increased macrophage numbers in the 
airways in the Nox2−/− mice and presumably enhanced clearance of the virus by these 
cells, the study of Vlahos et al. shows a reduction in macrophages in the Nox2−/y lungs, 
which is thus unlikely to explain the reduction in viral titers observed in their study. It 
is noteworthy to mention that these divergences as well as those observed related to the 
inflammatory status could be due to different factors such as genetic background, 
gender, and viral dose, all of which were not homogenous in the mentioned studies. 
Regarding the issue of gender, Miller et al. previously showed significant gender 
differences for NOX2 activity in the setting of experimental stroke in mice, and such 
differences could come into play during influenza infection (Miller et al., 2007). 
Regarding role of NOX2 in the regulation of virus-induced inflammation, a positive 
contribution of NOX2 to inflammation has been demonstrated by another group. 
Decreased inflammation and acute lung injury were observed upon challenge of 
p47phox knockout mice with a highly virulent H5N1 strain (Imai et al., 2008). The 
authors of this study elucidated that acute lung injury was caused by the presence of 
oxidized phospholipids, which in turn can induce a TLR4-TRIF-TRAF6-IL-6 signaling 
cascade culminating into increased airway inflammation. In the absence of p47phox, 
these oxidized phospholipids were not detected. Thus, in the context of viral infection, 
NOX2 appears to promote proinflammatory processes, which in cases of highly 
virulent infection may lead to major airway complications.  
A similar phenomenon is observed in bacterial infections, where NOX2 is 
associated with increased inflammation as measured by an increase in pulmonary 
proinflammatory cytokine levels and increased neutrophil infiltration into the affected 
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lung (Gao et al., 2002; Segal et al., 2010; Zhang et al., 2009b). However, again the 
underlying mechanisms resulting in increased inflammation and proinflammatory 
cytokine levels are still unclear. NF-κB, which transcriptionally regulates the 
expression of proinflammatory cytokines in these settings was previously shown to be 
either positively, negatively or not at all regulated by components of the NADPH 
oxidase complex (Sadikot et al., 2004; Segal et al., 2010; Zhang et al., 2009b). Thus, 
the molecular details by which NOX2 contributes to increased inflammation in viral 
infections still need to be investigated. 
 
1.5.2.2 NOX2, a pleiotropic regulator of innate immunity 
The previous sections discussed the role of NOX2 in driving inflammatory 
processes during viral and bacterial airway infections. It is noteworthy to mention that 
NOX2 regulates other immunomodulatory processes that are likely to come into play 
during the course of viral infections but that have not yet been explored in such a 
context.  
First, NOX2 has been implicated in the mechanism of antigen-crosspresentation 
in DCs to CD8+ T cells. NOX2-deficient mice and DCs from patients suffering from 
CGD show decreased cross-presentation of antigenic peptides due to a deregulation of 
the pH in phagosomic vacuoles. Indeed, for efficient cross-presentation to occur, 
NOX2 activity must sustain an alkalic pH in the DC phagosomic compartment, which 
limits the activity of proteases and favors the generation of peptides that have the 
appropriate length for cross-presentation (Mantegazza et al., 2008; Savina et al., 2006). 
A similar defect of cross-presentation is observed in p47phox deficient mice exposed 
to Aspergillus antigens, due to defective DC endosomal alkalization and autophagy 
(De Luca et al., 2012).  
Further, NOX2 has been implicated in the regulation of autophagy by another 
study. The authors found that NOX2-generated ROS are necessary for LC3 recruitment 
to phagosomes, a process necessary for the correct formation of the autophagosome 
and consequent microorganism killing (Huang and Brumell, 2009). It is noteworthy to 
mention that autophagy, besides being a proposed mechanism for intracellular bacteria 
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elimination, can also impact on viral infections in pro- or antiviral ways, depending on 
the virus. In the context of RSV infection, autophagy has been shown to be essential 
for RSV-induced cytokine stimulation, activation and antigen presentation in dendritic 
cells (Morris et al., 2011). Thus NOX2 can likely impact airway immunity via 
autophagy regulation following respiratory virus infection. 
 
1.5.2.3  Polyvalent functions of NOX2 in lung structural cells 
The above-mentioned paragraphs discussed the ample functions that NOX2 plays 
in regulating lung immunity to virus infection. NOX2 is strongly expressed in cells of 
the immune compartment, which generates a strong bias towards the discussion of 
NOX2 in cells of the immune compartment. However, NOX2 is also expressed, albeit 
to lower levels, in lung structural cells, such as the lung epi- and endothelium, as well 
as in lung fibroblasts. There, it regulates various physiological processes. At this point 
some of these processes relevant to an infectious setting will be discussed.  
Firstly, the lung mucosa hosts so-called pulmonary Neuroepithelial bodies 
(NEBs), which function in oxygen sensing and mediate responses to hypoxic or 
hyperoxic conditions. In this context, NOX2 acts as an oxygen sensor and controls the 
activity of K+ channels (Buttigieg et al., 2012; Fu et al., 2000). In an infectious context, 
where changes in oxygenation are likely to occur, NOX2 might thus exerce its oxygen 
sensing function. 
NOX2 is also implicated in the maintenance of lung fluid balance. The latter is 
essential for proper gas exchange but also for efficient functioning of airway immune 
mechanisms. The quantity of lung fluid in the luminal space is controlled by the 
activity of Epithelial sodium channels (ENaCs). This balance can be perturbed in the 
context of respiratory virus infection (Song et al., 2010). Recent investigations have 
shown that NOX2 controls ENaC activity and therefore ensures a properly moist 
luminal space (Goodson et al., 2012; Takemura et al., 2010). 
Besides the importance of the lung epithelium, the lung endothelium also plays a 
vital role in supporting airway defenses. It is strongly implicated in the orchestration of 
inflammatory processes following viral infection (Teijaro et al., 2011). The NADPH 
	   78 
oxidase NOX2 is implicated in the regulation of endothelial inflammatory processes 
following LPS stimulation or P. aeruginosa infection (Fu et al., 2013; Pendyala et al., 
2009). More specifically, following LPS stimulation, endothelial NOX2 regulates the 
activation of key kinases TAK1 and IKKβ in the NF-κB activation pathway (Menden 
et al., 2013). 
NADPH oxidases also appear to play a role in the regulation of the immune 
response of lung fibroblasts to rhinovirus infection. However, human lung fibroblasts 
do not express NOX2, but rather NOX4 (Dhaunsi et al., 2004). Future studies will 
demonstrate if this NADPH oxidase replaces the polyvalent NOX2 in this subset of 
lung cells. 
 
In conclusion, NADPH oxidases are pertinent players in the airway microbial 
defense mechanisms. Not only do they impact pathogen-induced inflammatory 
responses, as has been shown for DUOX1/2 and NOX2, but these enzymes directly 
contribute to pathogen elimination in the airway lumen as well as in phagocytes. Many 
of the data suggest a role for NADPH oxidases in the context of viral infections. We 
therefore sought to unravel the implication of the NADPH oxidases in Paramxoviridae 
infection of AEC. 
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1.6 Study hypothesis and strategy 	  
As outlined in the previous sections, AEC are important regulators of airway 
immune responses following microbial challenge. They are responsible for pathogen 
detection and the integration of this event to trigger a series of processes that result in 
the activation of innate and adaptive airway defense mechanisms. Upon AEC viral 
infection, an antiviral and proinflammatory state is generated that is at the very heart of 
the viral clearance process. NF-κB is a key transcription factor implicated in the 
generation of AEC antiviral and proinflammatory responses. To optimally generate 
these responses, their establishment is tightly regulated at several steps of signaling 
chain. As we have seen, phosphorylation events are major contributors to the activation 
of NF-κB. Besides this, the antiviral signaling pathways also come under a different 
mode of regulation – redox regulation. Importantly, ROS are produced following RSV 
infection (Casola et al., 2001). Data using chemical inhibitors suggest that NF-κB is a 
potential target for redox-regulation by ROS in RSV-infection of AEC (Carpenter et 
al., 2002; Casola et al., 2001; Castro et al., 2006; Roebuck et al., 1999). These data also 
show that ROS might contribute to the inflammatory process following infection with 
RSV. NADPH oxidases have previously been demonstrated to regulate NF-κB 
activation in diverse settings, however, no data so far links them to NF-κB activation 
following Paramyxoviridae infection (Boots et al., 2009; Joo et al., 2012; Sadikot et 
al., 2004).  
Based on this evidence, our study hypothesis was that NADPH oxidases 
regulate NF-κB and contribute to NF-κB-mediated proinflammatory mechanisms 
following Paramyxoviridae infection of AEC. Since the above-mentioned data does 
not reveal a NADPH oxidase candidate implicated in these processes we aimed to 
identify which NOX was responsible for NF-κB regulation following viral 
infection of AEC. Further, we aimed to determine the mechanism by which NOX 
regulated NF-κB in this context. 
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The results generated during the characterization phase of NADPH oxidase 
expression in our cell model revealed an increased DUOX2 expression in AEC upon 
SeV infection. The finding of DUOX2 induction of gene expression following virus 
infection of AEC is supported by other data demonstrating DUOX2 induction in the 
context of rhinovirus infection (Harper et al., 2005). Hundreds of ISGs are upregulated 
following viral infection during the antiviral interferon response in order to combat 
infection, limit viral spread and favor viral clearance (Schoggins and Rice, 2011). The 
literature demonstrated an essential role for DUOX2 in antimicrobial defenses (Gattas 
et al., 2009; Moskwa et al., 2007). Based on these data our hypothesis in a second 
instance was that DUOX2 is an ISG induced upon viral infection which functions 
in the antiviral defense.  
In order to adress these questions, we decided to study the importance of the 
NADPH oxidases in SeV- and RSV-infected AEC. As mentioned, the 
Paramyxoviridae family contains several important etiologic agents of respiratory tract 
disease, such as RSV. This virus not only interferes with antiviral immunity, it also 
induces several aspects of immunopathology, among which the so-called “cytokine 
storm” is believed to be a main contributor to RSV disease. SeV, although not a health 
threat to humans, readily infects AEC and induces a robust antiviral response. Thus it 
has become a common model in the study of the antiviral response.  
Our main cell model of study consisted of the AEC line A549, which is a type II 
alveolar cell line. Although this subset of AEC is not the major target of natural RSV 
infection (which are ciliated bronchial epithelial cells), A549 are commonly used to 
study the airway antiviral response. Further, it was important for us to stay in a model 
with which we would be able to compare our data to already existing findings. 
However, we were well aware of this limitation and we have used other models when 
avalaible (i.e. other airway cell lines or primary AEC).  	  
 
 2 Results 
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2.1 Dual role of NOX2 in Respiratory Syncytial virus- and 
Sendai virus-induced activation of NF-κB in airway 
epithelial cells 
 
2.1.1 Context and resume of results 
The cellular response to viral infection is strongly driven by the activation of 
intracellular TFs, which regulate the expression of genes that will further drive this 
response by triggering an antiviral state and activating innate and adaptive immune 
axes. Among these TFs, NF-κB plays a central role, firstly, via its regulation of 
proinflammatory cytokines expression, but also via its capacity to regulate the 
expression of antiviral-state inducing interferons. Redox-regulation of NF-κB has long 
been described in various physiological settings (Gloire and Piette, 2009; Yao et al., 
2007). Further, previous to our study, evidence existed which demonstrated that NF-κB 
activity underlied similar regulatory mechanisms in the context of viral infections. 
Indeed, it was shown that in the AEC model, NF-κB activation and the expression of 
its target genes were regulated in a redox-sensitive manner following infection with 
RSV (Carpenter et al., 2002; Casola et al., 2001; Mastronarde et al., 1995; Roebuck et 
al., 1999). Further, AEC infected with RSV elicited increased ROS production (Casola 
et al., 2001). Importantly, mice challenged with RSV in the presence of antioxidants 
showed a different inflammatory status, decreased viral burden and an overall 
decreased disease outcome compared to control mice (Castro et al., 2006). Thus, 
targeting ROS promised to be beneficial for the outcome of viral infection. However, 
the source of ROS production was not addressed in the mentioned studies. Work 
conducted in influenza-infected, NOX2-deficient mice however demonstrated that the 
NADPH oxidases, and more specifically NOX2, could play an important role in 
regulating antiviral and proinflammatory responses following viral infection of AEC 
(Snelgrove et al., 2006). Importantly, these data were since confirmed by a second 
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group (Vlahos et al., 2011). However, these data gave no idea on the importance of 
NOX2 in the regulation of antiviral and proinflammatory processes specifically in 
AEC. Thus, the importance of the NADPH oxidase family members in the setting of 
AEC viral infection needed to be evaluated. Hence, our study sought to identify the 
NADPH oxidase family member responsible for NF-κB regulation in a redox-sensitive 
manner following infection of AEC with Paramyxoviridae RSV and SeV. Briefly, 
using a combination of chemical NADPH oxidase inhibitors and NOX2-targeting 
RNAi applied to airway epithelial cell lines as well as primary AEC, we were able to 
demonstrate a role for NOX2 in the regulation of NF-κB. More specifically, we 
identified that NOX2 was necessary for fostering phosphorylation events of IκBα and 
the NF-κB subunit p65, cumulating in NF-κB activation and target gene expression.  
Altogether, our results demonstrate that NOX2 is a key regulator of airway antiviral 
immunity and inflammation. 
 
2.1.2 Author contributions 
I (KF) began working on the data for this article during my Master’s studies with 
Anton-Soucy Faulkner (ASF). Experiments were planned under the supervision of and 
guidance by my research supervisor Nathalie Grandvaux (NG). My research 
contributed to seven out of eight figures (for details, see below) of this article. Annick 
Duval (AD) worked closely with me to finalize experiments, conduct revision 
experiments and RSV purifications. Alexis Martel (AM) initiated real time PCR 
experiments and helped me with certain IκBα part of figures. I contributed, in 
collaboration with Nathalie Grandvaux, to the writing of the article. This article was 
published in the Journal of Immunology, 2008,180(10):6911-22. 
 
Figure 1 : KF/AD/NG  
Figure 2 : AD 
Figure 3 : KF/AM 
Figure 4 : KF/NG et AD (panel E et F) 
Figure 5 : AD/KF/AM 
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Figure 6 : KF/AD 
Figure 7 : KF/NG 
Figure 8 : KF 
Purification RSV : AD 
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Abstract 
Human Respiratory Syncytial Virus (RSV), a member of the Paramyxoviridae 
family, is the most important viral agent of pediatric respiratory tract disease 
worldwide. Human Airway Epithelial Cells (AEC) are the primary targets of RSV. 
AEC are responsible for the secretion of a wide spectrum of cytokines and chemokines 
that are important mediators of the exacerbated airway inflammation triggered by the 
host in response to RSV infection. NF-κB is a key transcription factor responsible for 
the regulation of cytokine and chemokine genes expression and thus represents a 
potential therapeutic target. In the present study, we sought to delineate the role of 
RSV-induced reactive oxygen species (ROS) in the regulation of the signaling 
pathways leading to NF-κB activation. First, we demonstrate that besides the well-
characterized IκBα-dependent pathway, phosphorylation of p65 at Ser536 is an 
essential event regulating NF-κB activation in response to RSV in A549. Using 
antioxidant and RNA interference strategies, we show that a NOX2-containing 
NADPH oxidase is an essential regulator of RSV-induced NF-κB activation. Molecular 
analyses revealed that NOX2 acts upstream of both the phosphorylation of IκBα at 
Ser32 and of p65 at Ser536 in A549 and Normal Human Bronchial Epithelial Cells 
(NHBE). Similar results were obtained in the context of infection by Sendai virus 
(SeV), thus demonstrating that the newly identified NOX2-dependent NF-κB 
activation pathway is not restricted to RSV amongst the Paramyxoviridae. These 
results illustrate a previously unrecognized dual role of NOX2 in the regulation of NF-
κB in response to RSV and SeV in human AEC.  
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Introduction 
Respiratory Syncytial Virus (RSV), an enveloped, negative-sense single-
stranded RNA virus of the Paramyxoviridae family, is the most important viral agent 
of pediatric respiratory tract disease worldwide. Clinical manifestations following RSV 
infection range from rhinitis, otitis or pneumonia to bronchiolitis, an acute lower 
respiratory tract infection associated with cough and wheezing and substantial 
morbidity and mortality (reviewed in (1, 2)). Moreover, RSV infection is associated 
with long-term complications, such as recurrent wheezing and asthma (reviewed in 
(3)).  
The mechanisms underlying RSV-induced airway diseases and long-term 
consequences are still largely unknown. However, experimental evidence suggests that 
an excessive inflammatory response triggered by the host plays a major role in the 
development of the clinical manifestations of RSV infection (4). Airway Epithelial 
Cells (AEC) of large and small airways are the primary targets of RSV infection and 
replication. In vitro and in vivo studies revealed that AEC are mainly responsible for 
the secretion of a wide spectrum of cytokines and chemokines which include, but are 
not restricted to, RANTES, MIP-1α, MCP-1, Interleukin (IL)-8 and IP-10, that have 
profound immune and inflammatory functions, and thus determine the elimination or 
progression of the infection and/or inflammation of airway mucosa (4-10). Chemokine 
levels in the lung of RSV-infected mice parallel the intensity of lung cellular 
inflammation (11). Moreover, IL-8, RANTES, and MIP-1α levels in bronchoalveolar 
lavages of children infected with RSV correlate with the severity of the disease (12, 
13). Thus, chemokines are considered major players in the RSV-induced respiratory 
pathogenesis. 
The Nuclear Factor (NF)-κB transcription factor plays a pivotal role in 
inflammatory processes triggered by various stimuli through regulation of the 
expression of genes encoding numerous proinflammatory cytokines and chemokines 
(reviewed in (14)). Substantial data support a role of NF-κB in the regulation of 
cytokine and chemokine genes, such as TNFα, RANTES and IL-8, in AEC following 
RSV infection (4-10). Thus, NF-κB is considered a preferred target in the development 
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of therapeutic interventions aimed at limiting the inflammatory response. However, the 
lack of a complete understanding of the pathways leading to its activation is a barrier in 
achieving this goal. 
NF-κB is a ubiquitous family of homo- and heterodimers of Rel proteins, 
consisting of p65, cRel, RelB, p50 and p52. The Inhibitor of NF-κB (IκB) forms a 
complex with NF-κB dimers, mainly p65/p50 in epithelial cells, that shuttles between 
the nucleus and the cytoplasm, with a predominant cytoplasmic localization in 
unstimulated cells (15). The central event of the classical NF-κB activation cascade 
following exposure to proinflammatory stimuli is the activation of the IκB kinase 
(IKK) complex, composed of two catalytic subunits IKKα and IKKβ and a regulatory 
subunit IKKγ (16). In turn, IKK phosphorylates IkBα at Ser32 and Ser36 to promote 
its polyubiquitination and subsequent proteasome-mediated degradation, thereby 
allowing the freed NF-κB to translocate to the nucleus, bind to kB consensus sequences 
and transactivate target genes (17). A negative feedback loop involves NF-κB-
dependent new synthesis of IκB (15). Recently, additional steps in the activation 
cascade have been identified, which involve phosphorylation and acetylation of the Rel 
subunits to fine-tune the control of nuclear localization, DNA-binding affinity, 
coactivator/corepressor association, and transactivation capacity (reviewed in (18, 19)). 
Thus far, inducible phosphorylation of cRel in the transactivation domain (TD) and of 
p65 at Ser residues 276 or 311 in the Rel homology domain or at Ser residues 468, 529, 
535 or 536 in the TD have been observed in a stimuli- and cell type-dependent manner 
(reviewed in (18, 19)). In some conditions, direct phosphorylation of NF-κB subunits 
was found to define an alternative mechanism of NF-κB activation independently of 
IκBα degradation. Rather, phosphorylation of NF-κB subunits was found to control 
NF-κB nuclear accumulation by inducing NF-κB/IκBα complex dissociation (20-23). 
RSV infection induces a persistent activation of NF-κB, which likely leads to excessive 
NF-κB-mediated inflammatory genes expression (24, 25). Activation of the classical 
NF-κB activation pathway in RSV-infected AEC is supported by in vitro and in vivo 
studies that revealed IKK activation, proteolysis of IκB, and p65 DNA-binding (24-
32). Interestingly, a temporal dissociation between IκB phosphorylation and NF-κB 
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DNA-binding activity suggested the existence of an IκB-independent regulation 
induced by RSV (26). RSV-induced phosphorylation of p65 at Ser276 and Ser536 was 
previously reported, but its physiological significance in NF-κB activity was not 
evaluated (33).  
In the past decade, the concept that sub-toxic levels of reactive oxygen species 
(ROS), such as superoxide anion and hydrogen peroxide, act as cellular switch for 
signaling cascades leading to regulation of gene expression has emerged. ROS regulate 
a variety of physiological processes, including cell proliferation, apoptosis and immune 
and proinflammatory responses (reviewed in (34)). There is now compelling evidence 
that ROS participate in the regulation of NF-κB activation in a cell type- and stimuli-
specific manner (reviewed in (35)). Several data support a role of ROS in the activation 
of NF-κB in response to RSV infection in AEC. First, RSV infection was shown to 
trigger ROS production in AEC (36). Moreover, antioxidants, including butylated 
hydroxyanisol (BHA) or N-acetylcysteine (NAC), blocked IL-8, RANTES or MCP-1 
genes expression in human AEC (29, 36-38). Use of NAC suggested that redox-
sensitive p65 DNA-binding was responsible for the observed IL-8, RANTES and MCP-
1 gene expression (29). However, conflicting results proposed that the Activator 
Protein (AP)-1 transcription factor, but not NF-κB, was responsible for the redox 
regulation of RSV-induced IL-8 gene expression in AEC (39). 
ROS generating enzymes include the mitochondrial respiratory chain, 5-
lipoxygenase, xanthine oxidase and the NADPH oxidases. The most potent source of 
ROS is the recently discovered family of NADPH oxidase enzymes, which are now 
known to be functionally expressed in a number of cells, including AEC (reviewed in 
(40)). In phagocytes, the NADPH oxidase is a multi-subunit complex composed of a 
membrane bound flavocytochrome b558, consisting of NOX2/gp91phox and p22phox 
subunits, as well as of the cytosolic regulatory subunits, p47phox and p67phox. NOX2-
containing NADPH oxidase complex is widely reputed for its role in bacteria killing 
during phagocytosis (reviewed in (41)). Six functionally distinct homologues of 
NOX2, namely NOX1, NOX3, NOX4, NOX5, DUOX1 and DUOX2, and homologues 
of the cytoplasmic subunits, NOXO1 and NOXA1, have been identified (reviewed in 
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(40). Recent functional data have emerged that suggest the involvement of several of 
these isoforms in the innate host response to invading microorganisms, including 
innate immune and proinflammatory responses (reviewed in (42)). Surprisingly, while 
the role of NADPH oxidase enzymes in virus infections, including infection by RSV, is 
suggested by the use of antioxidants or cells derived from patients with a genetic defect 
in one of the phagocytic NADPH oxidase subunits (reviewed in (42)), the identity of 
the NADPH oxidase responsible for ROS production and its functional significance are 
barely documented. Interestingly, it was recently shown that the absence of NOX2 led 
to reduced virus titer, increased Th1 cytokines in the airways and a reduced 
inflammatory infiltrate into the lung parenchyma in Influenza virus-infected mice (43). 
Similarly, antioxidant treatment was recently found to improve the final outcome of 
RSV infection in mice by significantly reducing cytokines and chemokines production 
and recruitment of inflammatory cells, especially neutrophils, to the lung (44), but the 
source of ROS in this context remains elusive.  
Given the observed potential of targeting ROS production to limit the RSV-
induced inflammatory response (44), we examined the molecular mechanisms involved 
in the redox-regulation of cytokine and chemokine genes expression in AEC. This 
study focuses on the identification of the biological source of ROS and its implication 
in the regulation of NF-κB. To determine whether this redox regulation was limited to 
RSV or can be extended to other members of the Paramyxoviridae family, we also 
evaluated the existence of this redox-dependent signaling mechanism in the context of 
Sendai virus (SeV) infection, which is widely used as a model of Paramyxoviridae in 
gene regulation studies. We demonstrate for the first time that a NOX2-containing 
NADPH oxidase is essential for RSV- and SeV-induced NF-κB activation in human 
AEC. NOX2 not only plays a role in the regulation of the classical IκBα-dependent 
NF-κB signaling pathway, but also regulates p65Ser536 phosphorylation, which 
appears to be essential for NF-κB activity following RSV and SeV infection. 
Altogether, this study identifies for the first time NOX2 as a specific source of ROS 
responsible for the oxidant-dependent regulation of NF-κB observed in RSV and SeV 
infection, thereby contributing to a better comprehension of NF-κB activation 
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pathways. Moreover, these results highlight a novel role of NOX2 in host defense in 
non-phagocytic cells. 
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Material and Methods 
Reagents  
Diphenyleneiodonium (DPI), Dimethyl Sulfoxide (DMSO), Tween 20, albumin 
from bovine serum (BSA) were purchased from Sigma-Aldrich. Human Thyroid Total 
RNA, Human Fetal Kidney Total RNA, Human Colon Total RNA, and Human Spleen 
Total RNA were purchased from Clontech. Oligonucleotides used in PCR reactions 
(Table I) were purchased from Invitrogen. RNAi oligonucleotides (Table II) were 
purchased from Dharmacon. 
 
Plasmids  
pCMV-flag-p65 and pCMV-flag-p65S536A plasmids were obtained from Dr. 
M. Servant, University of Montreal, Montreal. pRL-null reporter plasmid was from 
Promega. P2(2X)TK-pGL3 NF-κB luciferase reporter construct was obtained from Dr. 
J. Hiscott, McGill University, Montreal. Plasmids used for cytokine copy number 
determination, generated by cloning of the +169 to +872nt fragment of the TNFα 
transcript (NM_000594) and the +65 to +332nt fragment of the RANTES transcript 
(NM_002985) into the pCR2.1-TOPO vector using EcoRI, were a kind gift of Dr. D. 
Lamarre, University of Montreal, Montreal.  
 
Virus  
Initial stock of RSV A2 strain was obtained from Advanced Biotechnologies 
Inc. Amplification was performed in HEp-2 cells (ATCC) at a Multiplicity of Infection 
(MOI) of 0.1 until 50% cytopathic effect was observed. Virus was purified on 30% 
sucrose cushion after precipitation using polyethyleneglycol (45). Virus titer was 
determined by methylcellulose plaque assays as previously described (46). Sendai 
virus (SeV) Cantell strain was obtained from Charles River Laboratories.  
Cell culture, plasmid transfection and luciferase assays  
HEp-2 cells (ATCC) were cultured in DMEM medium (Gibco) supplemented 
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with 10% heat-inactivated Fetal Bovine Serum (HI-FBS, Gibco). A549 cells (ATCC), 
used as a cell line model of human AEC, were cultured in F-12 Nutrient Mixture 
(Ham) medium (Gibco) supplemented with 10% HI-FBS and 1% L-Glutamine 
(Gibco). Normal Human Bronchial Epithelial Cells (NHBE) were obtained from 
Clonetics, cultured in BEGM medium (Clonetics) and used between passage 2 and 4.  
Transfection of A549 cells was performed with the TransIT-LT1 Transfection Reagent 
(Mirus) according to the manufacturer’s instructions. For luciferase assays, 
subconfluent cells in 24-well plates were transfected with 50 ng of pRL-null reporter 
(renilla luciferase, internal control), 100 ng of P2(2X)TK-pGL3 NF-κB reporter 
construct (firefly luciferase) and the indicated amounts of expression plasmids. Cells 
were assayed for reporter gene activities after 24h using the Dual Luciferase Reporter 
Assay System (Promega) according to the manufacturer’s protocol. Relative luciferase 
activities represent the ratio of firefly luciferase normalized to renilla luciferase and are 
presented as fold over the non-stimulated condition. 
Infections 
Subconfluent A549 cells were infected with RSV at a MOI of 3 in culture 
medium containing 2% HI-FBS. SeV infection (40 HAU/106 cells) was carried out for 
2h in serum-free medium and was further cultured for the indicated time in complete 
medium. Infection of NHBE cells was performed similarly in BEGM medium. In 
experiments where DPI was used, the reagent or the corresponding vehicle DMSO was 
added at the indicated concentration for 1h before infection and maintained at this 
concentration throughout the infection except in Figure 4F. 
RNAi oligonucleotides transfections  
RNAi oligonucleotides (Table II) transfection was performed as previously 
described (47) using Oligofectamine reagent (Invitrogen) and pursued for 62h before 
viral infection as described above. Where RNAi transfection preceded a luciferase 
reporter gene assay, transfection with reporter plasmids using TransIT-LT1 
Transfection Reagent as described above was performed 48h after transfection of the 
RNAi.  
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Immunoblot Analysis  
Whole cell extracts (WCE) were prepared in Nonidet P-40 lysis buffer as 
previously described (48) and subjected to SDS-PAGE electrophoresis and 
immunoblot analysis as performed in (49) using the primary antibodies anti-IκBα-
phosphoSer32 (1/1000, Cell Signaling), anti-p65-phosphoSer536 (1/1500, Cell 
Signaling), anti-actin (1/10000, Chemicon International), anti-IκBα (1/1000, Cell 
Signaling), anti-p65 (1/400, Santa Cruz Biotechnology), anti-Flag M2 (1mg/ml, 
Sigma-Aldrich), anti-SeV (1/10000, obtained from Dr. J. Hiscott, McGill University, 
Montreal) or anti-RSV (1/2000, Chemicon) diluted in PBS containing 0.5% Tween and 
either 5% nonfat dry milk or 5% BSA for phosphospecific antibodies. Immunoreactive 
bands were visualized by enhanced chemiluminescence using the Western Lightning 
Chemiluminescence Reagent Plus (Perkin Elmer Life Sciences). In between IκBα-
phosphoSer32 and IκBα antibodies, as well as p65-phosphoSer536 and p65 antibodies, 
the membrane was stripped in 0.2% SDS, 62.5 mM Tris-HCl pH 6.8, 0.1 mM b-
mercaptoethanol for 20 minutes at 50°C, washed three times in PBS and blocked in 
blocking solution.  
RNA extraction, RT-PCR and real-time PCR  
Total RNA was extracted from A549 using the RNAqueous-4PCR Isolation Kit 
(Ambion) and treated to remove genomic DNA using either the DNase1 treatment 
included in the RNAqueous-4PCR Isolation Kit or the reagent included in the 
QuantiTect Reverse Transcription Kit (Qiagen). Total RNA (1 µg) was subjected to 
reverse transcription using 0.5 µg of oligo(dT)12-18 primers (Invitrogen) and 200 units 
M-MLV Reverse Transcriptase (Invitrogen) or using the QuantiTect Reverse 
Transcription Kit. PCR amplifications were performed using the QuantiTect SYBR 
Green Kit (Qiagen) in the presence of 2 µM specific primers, except for NOX2 
amplification, which was performed using 1 µM specific primers, and β-actin, TNFα 
and RANTES amplifications, which were performed using 0.4 µM specific primers. 
MgCl2 concentration in all assays was 2.5 mM, except for NOX1L amplification, 
which required 5 mM MgCl2. Sequences and annealing temperatures for gene-specific 
primers are listed in Table I. The absence of genomic DNA contamination was verified 
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with each of the primer sets by PCR in a reaction without reverse transcriptase. When 
analyzed on agarose gel, PCR reactions were performed in a T Gradient Cycler 
(Biometra) for the indicated number of cycles previously established to be in the linear 
detection range for each gene. For real-time PCR analyses, detection was performed on 
a Rotor-Gene 3000 Real Time Thermal Cycler (Corbett Research). For TNFα and 
RANTES gene expression, standard curves of absolute quantification expressed as copy 
number and PCR efficiencies were obtained using serial dilutions of pCR2.1-TOPO-
TNFα and pCR2.1-TOPO-RANTES plasmids. For β-actin, NOX1L, NOX2 and NOX5 
genes expression, standard curves and PCR efficiencies were obtained using serial 
dilutions of cDNA prepared from cells used as a positive control as described in Figure 
5. TNFα and RANTES data are presented as absolute copy numbers normalized to β-
actin used as a reference gene. NOX1L expression was normalized to β-actin and is 
presented as relative fold expression of NOX1L from NOX1-RNAi sample versus 
CTRL-RNAi sample. Relative NOX2 and NOX5 fold expression values were 
determined applying the ΔΔCt method (50).  
Statistical analyses 
All analyses were performed using the SigmaStat 3.5 software. 
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Results 
Phosphorylation of p65 at Ser536 is a key event in the activation of NF-κB triggered 
by RSV and SeV infection in A549 
Activation of the classical NF-κB pathway, involving IKK-mediated 
phosphorylation of IκBα and its subsequent degradation, is well documented in the 
context of RSV and SeV infections (49, 51). However, the importance of p65 
phosphorylation is still barely documented in these contexts. Thus, we first reevaluated 
the activation of NF-κB by monitoring not only IκBα but also p65 phosphorylation in 
RSV- and SeV-infected A549. IκBα phosphorylation at Ser32 and p65 phosphorylation 
at Ser536 were analyzed by immunoblot using phosphospecific antibodies. As shown 
in Figure 1, IκBαSer32 and p65Ser536 phosphorylations were both detected with 
similar kinetic patterns during RSV (Figure 1A and C) or SeV (Figure 1B and D) 
infection. P65 phosphorylation at Ser276 was neither detected in RSV nor SeV 
infection (data not shown). Thus, our data reveal that RSV and SeV infection of A549 
trigger activation of NF-κB at two levels, namely IκBα and p65Ser536 
phosphorylation. 
To determine whether p65Ser536 phosphorylation is essential for NF-κB 
activity in the context of RSV and SeV infection, the effect of Ser536 mutation into 
Ala (p65S536A), which abrogates phosphorylation at this particular residue, was 
analyzed by luciferase reporter gene assay. A549 were cotransfected with the NF-κB-
responsive P2(2X)TK-pGL3 luciferase reporter gene and the pRL-null renilla internal 
control plasmids, together with the empty vector, or vector encoding flag-tagged-p65 
or -p65S536A and were either left untreated or infected with RSV or SeV. As shown in 
Figure 2, expression of p65 in non-infected cells resulted in a 53-fold induction of the 
NF-κB reporter activity, whereas p65S536A only exhibited a minimal effect with a 5-
fold induction. RSV and SeV infection of A549 cells resulted in a 14- and 13-fold 
stimulation of the reporter activity, respectively. These inductions were strongly 
enhanced by the ectopic expression of p65 to 191- and 179-fold, respectively. On the 
other hand, RSV and SeV stimulation of the promoter in the presence of p65S536A 
only reached 43- and 35-fold, respectively. Together, these results demonstrate that 
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phosphorylation of p65 at Ser536 during RSV and SeV infection in A549 cells is 
essential to trigger full activation of NF-κB transactivation potential.  
 
DPI inhibits RSV- and SeV-induced NF-κB activation  
In a first attempt to determine whether NF-κB activation in the context of 
infection by RSV and SeV was dependent on ROS production by a NADPH oxidase, 
we analyzed the effect of Diphenyleneiodonium (DPI), an inhibitor of flavoproteins 
widely used to target NADPH oxidases. The expression profile of NF-κB target genes, 
TNFα and RANTES, was monitored by real-time PCR in A549 cells either left 
untreated or infected with RSV or SeV for 6h in the absence or presence of 30 mM 
DPI. As shown in Figure 3A and B, TNFα mRNA levels were strongly induced 
following RSV and SeV infection of A549 cells. However, pretreatment with DPI 
reduced TNFα expression by 66% and 78% in RSV and SeV infection, respectively. 
Analysis of RANTES gene expression gave similar results, with reduction of RSV and 
SeV induced RANTES mRNA levels by 4 and 1.6 log, respectively (Figure 3C and D). 
 
As p65Ser536 phosphorylation appears to be essential for NF-κB activation 
(Figure 2), we next assessed whether abrogation of NF-κB-dependent gene expression 
by DPI correlated with inhibition of p65Ser536 phosphorylation. A549 cells were 
infected with RSV for 8h in the presence of increasing doses of DPI. As shown in 
Figure 4A, RSV-induced p65Ser536 phosphorylation was inhibited by DPI in a dose-
dependent manner reaching 72.6 ± 8.2% inhibition at 30mM DPI. Kinetic analysis of 
p65Ser536 phosphorylation during RSV infection in the absence or presence of 30µM 
DPI confirmed the inhibition of p65Ser536 phosphorylation by DPI over time (Figure 
4B). Similarly, DPI inhibited SeV-induced p65Ser536 phosphorylation in a dose-
dependent manner and over the course of infection (Figure 4C and D). Importantly, the 
effect of DPI is not attributable to an effect on viruses. Indeed, neither RSV nor SeV 
replication were affected by DPI treatment as demonstrated by the detection of viral 
protein level by immunoblot (Figure 4E). Moreover, identical effects were observed 
when DPI was present in the medium during the infection (protocol I, Figure 4F) or 
when DPI was preincubated with the cells and washed off before infection (protocol II, 
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Figure 4F). Altogether, these results demonstrate the importance of ROS, most likely 
from a NADPH oxidase origin, in NF-κB activation through p65Ser536 
phosphorylation in RSV- and SeV-infected A549.  
 
Various subunits of NADPH oxidases are expressed in RSV- and SeV-infected A549  
Several NADPH oxidase subunits might be responsible for the observed DPI-
mediated inhibition of p65 phosphorylation at Ser536 during RSV and SeV infection. 
As expression of NADPH oxidase subunits appears to be cell type specific, we 
monitored which of the NOX1-5 and DUOX1-2 catalytic subunits, p22phox and 
regulatory subunits p47phox, p67phox, NOXO1 and NOXA1 were expressed in A549 
during RSV and SeV infection. For this purpose, A549 were infected with RSV and 
SeV and NOX mRNA expression was analyzed by RT-PCR (Figure 5A) using primers 
specific for each subunit (Table I). NOX1, NOX2 and NOX5 mRNA were detected in 
unstimulated A549 and their expression remained steady during virus infection. Using 
a specific set of primers, the long isoform of NOX1, NOX1L (52, 53), was found to 
follow the same pattern of expression as total NOX1. On the other hand, the long 
isoform of NOX5, NOX5L, was not detected in any conditions, thus suggesting that 
the NOX5 mRNA represent the NOX5S isoform (54). NOX3 and NOX4 mRNA were 
neither detected in unstimulated nor in virus-infected A549. Noteworthy, DUOX2 
mRNA, but not DUOX1 mRNA, was expressed at the basal level and its expression 
was stimulated by RSV and SeV infection. p22phox mRNA expression was detected at 
an equal level in all conditions. As shown in Figure 5B, NOXO1, NOXA1, p47phox 
and p67phox regulatory subunits mRNA were all expressed at the basal level and 
p67phox mRNA was strongly inducible following RSV and SeV infections. In 
conclusion, these results demonstrate that NOX1L, NOX2, NOX5S and DUOX2 
catalytic subunits of NADPH oxidase family members, p22phox, and regulatory 
subunits NOXO1, NOXA1, p47phox and p67phox are expressed in A549 during RSV 
and SeV infection.  
 
RNA interference with NOX2 expression inhibits NF-κB transactivation potential in 
RSV and SeV infection  
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Based on the observation that several members of the NOX/DUOX family of 
enzymes, namely NOX1L, NOX2 and NOX5S, are expressed at the basal level in 
A549, we hypothesized that one of these isoforms might be responsible for the 
observed redox-dependent regulation of NF-κB following RSV and SeV infection 
(Figure 3 and 4). To verify our hypothesis, specific interfering RNA (RNAi) 
oligonucleotides (Table II) were used in A549 to down-regulate the expression of 
NOX1, NOX2 and NOX5. As shown in Figure 6A, NOX1-, NOX2- (NOX2(1)) and 
NOX5- RNAi efficiently inhibited the corresponding NOX expression by 82, 64 and 
90%, respectively, as evaluated by real-time PCR. The effect of interference with the 
expression of each isoform on RSV- and SeV-induced NF-κB transcriptional activity 
was evaluated using a luciferase reporter gene assay. RNAi-transfected A549 were 
further transfected with the P2(2X)TK-pGL3 luciferase reporter as well as the pRL-
null renilla luciferase (internal reference) constructs and were either left untreated or 
infected with RSV or SeV. As shown in Figure 6B, interference with NOX1 and 
NOX5 expression did not affect endogenous NF-κB ability to stimulate gene 
transcription. However, as shown in Figure 6C and D, when NOX2 expression was 
reduced by NOX2(1)- RNAi, RSV- and SeV-induced NF-κB transactivation potential 
was significantly inhibited. RSV-induced NF-κB activity in a time-dependent manner 
with a 26 ± 1.37 fold stimulation at 16hpi (hours post-infection), while in the presence 
of NOX2(1)-RNAi, NF-κB stimulation remained lower over time reaching a 9.67 ± 
1.62 fold at 16hpi (Figure 6C). Similar results were observed in SeV infection (Figure 
6D). Indeed, stimulation of NF-κB activity was of 11.94 ± 1.16 fold in CTRL-RNAi-
transfected A549 at 16hpi, whereas it was decreased to 6.68 ± 0.3 fold in NOX2(1)-
RNAi transfected cells. Taken together, these results demonstrate that NOX2 is an 
essential component of the signaling pathway triggering NF-κB activation following 
RSV and SeV infection in A549. 
 
Interference with NOX2 expression inhibits RSV- and SeV-induced NF-κB activation 
through diminution of IκBαSer32 and p65Ser536 phosphorylation in A549 
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Inhibition of NF-κB transactivation potential (Figure 6C and D) in the presence 
of NOX2-RNAi suggested that upstream events leading to NF-κB activation might be 
altered by the absence of NOX2 expression. Therefore, RNAi-mediated NOX2 
inhibition was further used to investigate the role of NOX2 in NF-κB activation 
following RSV and SeV infection. A549 were transfected with CTRL- or NOX2-
specific RNAi, NOX2(1), and were then left untreated or infected with RSV or SeV for 
various times. IκBα phosphorylation at Ser32 and p65 phosphorylation at Ser536 were 
evaluated by phosphospecific immunoblot and the ratio of phospho-IκBα vs total IκBα 
and phospho-p65 vs total p65 was determined by densitometric quantification (Figure 
7). RSV- (Figure 7A) and SeV-induced (Figure 7B) IκBαSer32 and p65Ser536 
phosphorylations were significantly inhibited by reduced NOX2 expression. An 
identical experiment with a second NOX2-specific RNAi, NOX2(2) (Figure 8A), 
yielded similar results (Figure 8B). To ascertain that the observed effects on NF-κB 
activation were not resulting from an effect of the RNAi on virus replication, viral 
proteins expression in various conditions was evaluated by immunoblot using anti-
RSV (Figure 7A and 8B) and anti-SeV (Figure 7B) antibodies. Neither NOX2(1)- nor 
NOX2(2)-RNAi interfered with virus replication. NOX1- and NOX5-RNAi did not 
alter p65Ser536 phosphorylation (data not shown), thus demonstrating the specific role 
of NOX2 in this pathway. In conclusion, our results demonstrate that NOX2 plays an 
essential role in RSV- and SeV-induced NF-κB regulation at two critical steps, namely 
IκBαSer32 and p65Ser536 phosphorylation in A549. 
 
Dual role of NOX2 in RSV- and SeV-induced NF-κB regulation in NHBE  
Although A549 cells are widely considered a cell line model of human AEC, 
we verified the existence of the newly identified NOX2-dependent pathway of NF-κB 
regulation in primary NHBE cells. First, NOX2 mRNA expression was analyzed by 
RT-PCR in NHBE during RSV and SeV infection. Similarly to the observation made 
in A549, NOX2 mRNA was detected in unstimulated NHBE and its expression 
remained steady during RSV and SeV infection (Figure 9A). More importantly, 
interference with NOX2 expression using the NOX2(1) RNAi oligonucleotide (Figure 
9B) resulted in significant inhibition of both RSV- and SeV-induced IκBαSer32 and 
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p65Ser536 phosphorylation as evaluated by phosphospecific immunoblots and 
phospho-IκBα vs total IκBα and phospho-p65 vs total p65 ratios (Figure 9C and D). 
These results highlight the important dual role of NOX2 in the regulation of NF-κB 
during Paramyxoviridae infections in the context of normal AEC. 
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Discussion 
NF-κB plays an essential role in the RSV-induced exacerbated inflammatory 
response through the regulation of cytokines and chemokines expression and thus 
constitutes an interesting therapeutic target. However, the molecular mechanisms 
controlling the persistent RSV-induced NF-κB activation in AEC are still far from 
being deciphered. Although it has long been a matter of debate, cell type- and stimuli-
specific redox-regulation of NF-κB is now well documented (reviewed in (35)). 
Previous studies have shed a light on the possible ROS-dependent regulation of NF-κB 
following RSV infection in AEC. First, RSV triggers ROS production in AEC (36). 
Second, RSV-induced expression of genes encoding the chemokines IL-8, RANTES, 
and MCP-1, which are known NF-κB-target genes, were found to be dependent on a 
redox sensitive pathway(s) in A549 (29, 36-38). In addition, ROS were found to be 
involved in the regulation of IκBα degradation, nuclear translocation and in vitro 
DNA-binding activity of p65 in RSV-infected AEC (24, 29). Although these studies 
support a role of ROS in RSV-mediated NF-κB activation, they did not address two 
major questions: 1) the biological source of ROS and 2) the steps in the NF-κB 
signaling pathway that are redox sensitive. Here, we provide the first evidence that 
RSV triggers NF-κB activation through a NOX2-containing NADPH oxidase in A549 
and primary NHBE. This pathway is essential for IκBαSer32 and p65Ser536 
phosphorylation events. Furthermore, we demonstrate that this pathway is not 
restricted to RSV amongst Paramyxoviridae as similar results were obtained with SeV. 
Thus, our results highlight a novel signaling pathway mediating NF-κB activation in 
AEC infected with RSV or SeV that involves a NOX2-containing NADPH oxidase as 
a central regulator. 
Attempts to identify the origin of RSV-induced ROS in AEC were previously 
limited to a recent study that suggested the involvement of an uncharacterized NADPH 
oxidase based on the observation that RSV-induced activation of the Interferon 
Regulatory Factor (IRF)-3 transcription factor was inhibitable by DPI (55). Although 
the effect of DPI is widely considered as an indicator of a potential role of a NADPH 
oxidase, other ROS-generating flavoproteins, including the mitochondrial respiratory 
chain, could explain the effects observed with DPI (56). Therefore, to definitively 
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conclude on the involvement of a NADPH oxidase activity, we used selective RNAi 
against NOX1, NOX2 and NOX5, and provide the first direct proof that a NOX2-
containing enzyme specifically participates in the redox-sensitive regulation of RSV- 
and SeV-induced NF-κB signaling in A549 and NHBE.  
Our study shows that transcripts of NOX1, NOX2, NOX5 and DUOX2 
together with the small transmembrane subunit p22phox and the various regulatory 
subunits, p47phox, p67phox, NOXO1 and NOXA1 are expressed in A549 (Figure 5). 
Previous studies describing the expression of NOX/DUOX isoforms in various AEC 
cell lines, including Calu-3 submucosal gland cell line, hTE human tracheal surface 
epithelial cell line and NCI-H292 human pulmonary cell line, highlighted significant 
discrepancies (57-59). It is noteworthy that NOX4 was not detected in our study 
(Figure 5), while its basal expression and inducibility following exposure to diesel 
exhaust particules in A549 was recently reported (60). Expression of alternative NOX4 
splice variants was also documented (61). Comparison of our results with the one 
described by Amara and coll. (60) should be made with caution. Indeed, in their study 
NOX4 mRNA was only expressed as fold over ubiquitin and not as absolute values and 
thus the amount of NOX4 might in fact be very low. Here, the use of primers expected 
to amplify the various potential variants failed to detect NOX4 mRNA in uninfected 
and infected A549 (Figure 5). Similar results were obtained using a second set of 
primers (data not shown). These variations in NOX/DUOX detection in cell lines is of 
particular significance as these cell lines are frequently used as a model of AEC. Here, 
we focused our functional studies on the role of NOX isoforms and demonstrated a 
selective role of NOX2. In order to clarify the role of NOX2, it was of importance to 
verify the expression status of NOX2 in primary AEC. Here, we demonstrate that 
NOX2 transcripts are expressed in NHBE cells (Figure 9), thus confirming the 
relevance of the A549 model. Moreover, RNAi experiments allowed us to confirm the 
role of NOX2 in NF-κB regulation during the course of RSV and SeV infections in 
NHBE (Figure 9). 
With the recent description of the NOX/DUOX family, data are emerging that 
link NADPH oxidase enzymes activity to NF-κB activation and downstream 
proinflammatory response. In the context of infectious diseases, different NOX 
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isoforms, including NOX4 and NOX2, were found to act downstream of Toll-like 
receptors (TLR) to trigger proinflammatory signals (reviewed in (42)). NOX isoforms 
were also identified as inflammatory regulators in a few other contexts. Following 
stimulation of MCF7 cells by IL-1β, NOX2-dependent ROS production in the 
endosome was shown to be essential for recruitment of the TRAF6 adaptor to trigger 
an IKK-dependent NF-κB activation (62). In vascular smooth muscle cells (VSMC), 
NOX4 was shown to orchestrate C-reactive protein-mediated inflammatory activities 
through regulation of AP-1 and NF-κB (63). Taken together, these data and our study 
reveal that NOX isoforms are important inflammatory signaling molecules in non-
phagocytic cells and that NOX constitute potential anti-inflammatory therapeutic 
targets. 
The majority of studies that report ROS-dependent regulation of NF-κB support 
a role of ROS in the activation of NF-κB (reviewed in (35)). The use of H2O2 as a 
stimulus revealed that IKK is under redox control in epithelial cells. H2O2 was found to 
trigger IKKa and IKKβ phosphorylation and activation in HeLa cells. More recently, 
IKK activation in response to H2O2 in HeLa cells was shown to be dependent on a 
Src/PKCd/PKD signaling cascade (64, 65). Conflicting results came from studies 
performed in C10 immortalized alveolar type II cells, where H2O2 inhibited TNFα- or 
LPS-mediated IKK activation (66). However, our data showing NOX2-dependent IκBα 
phosphorylation at Ser32 support a ROS-dependent activation of IKK upon RSV or 
SeV infection in AEC. Although this discrepancy may only reflect stimulus-specificity 
of the response, one also needs to consider that the use of H2O2 does not necessarily 
reflect physiological concentrations of ROS triggered by physiological stimuli.  
The molecular mechanisms regulating NF-κB activation following RSV 
infection of AEC have not yet been completely elucidated. A temporal dissociation 
between NF-κB DNA-binding and IκBα degradation (26), suggest that an IκBα-
independent mechanism might be involved in early activation of NF-κB. Activation of 
the non-canonical pathway of NF-κB activation, which involves cleavage of p100 to 
form the p52 subunit, was recently described following RSV infection (67) and it was 
proposed that it might be responsible for early activation of NF-κB. Although it might 
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indeed be relevant for early cytokine genes transcription, it does not explain the early 
p65 DNA-binding (26). Our data confirm previous reports (31) that degradation of 
IκBα is only observed between 12 and 24 hours post-infection (hpi) following RSV 
infection. We now show that p65 Ser536 phosphorylation occurs in vivo as early as 3 
hpi (Figure 1 and 7) and that it is essential for RSV- and SeV-induced p65 activation 
(Figure 2). The Ser536 residue of p65 is evolutionary conserved and is phosphorylated 
in response to numerous stimuli, including DNA-damaging agents, T cell 
costimulation, Angiotensin (Ang) II and LPS (21, 68-70). Substantial literature 
supports a function of p65Ser536 phosphorylation in the regulation of p65 affinity to 
IκBα rather than of its transcriptional activity (reviewed in (18)). A study recently 
suggested that in fact Ser536 phosphorylated p65 does not interact at all with cytosolic 
IκBα and regulates a distinct set of target genes (23). Thus, this pathway constitutes a 
likely candidate to explain the early NF-κB activation prior to IκBα degradation 
triggered by RSV in AEC. Although redox regulation of this pathway was previously 
suggested by the observed inhibition of TNFα-induced p65Ser536 phosphorylation by 
NAC in endothelial cells (71), our data constitute the first identification of the 
biological source of ROS responsible for its regulation.  
Characterization of the signaling molecules targeted by ROS is still barely 
documented. However, the oxidation of thiol groups in the catalytic sites of kinases 
and phosphatases appears to be an important posttranslational modification that affects 
the function of signaling proteins (72). It is thus tempting to hypothesize that NOX2-
derived ROS regulate the activation of kinases/phosphatases acting upstream of 
IκBαSer32 and p65Ser536 in RSV and SeV infections. Oxidation of IKKβ at Cys179 
was found involved in negative regulation of NF-κB following anti-inflammatory 
stimuli (73). Thus, it is more likely that upstream regulators might be targeted by thiol 
modification to trigger its activation. However, kinases and phosphatases acting 
upstream of IKK in the context of RSV and SeV infection remain to be identified. 
Similarly, the signaling pathway leading to p65Ser536 phosphorylation during RSV 
and SeV infections is still unknown. Five kinases were previously found to 
phosphorylate p65 at Ser536. IKKα/β phosphorylate p65Ser536 in vivo in response to 
various stimuli, including LPS, Ang II, TNFα or lymphotoxin b receptor signaling (68, 
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74-76). Additionally, the IKK homologues TBK1 and IKKε, that have recently been 
found to be involved in the phosphorylation of the IRF-3 and IRF-7 transcription 
factors following virus infections (47, 77), also phosphorylate p65 at Ser536 in 
response to TNFα or IL-1 (78, 79). Finally, the RSK-1 kinase was also identified as a 
p65Ser536 kinase following Ang II stimulation or in response to p53 (21, 80). Which 
of these kinases is involved in RSV- and SeV-induced p65Ser536 phosphorylation and 
their redox regulation is currently under investigation.  
The importance of the redox regulation of cytokines and chemokines 
production in RSV pathology was recently illustrated by an in vivo study in a mouse 
model. Indeed, treatment of mice with BHA significantly reduced RSV-induced 
cytokines and chemokines production and recruitment of inflammatory cells, especially 
neutrophils, to the lung (44). However, this study used a general antioxidant and did 
not target the specific source of ROS responsible for NF-κB regulation. Our data now 
demonstrate that NOX2 represents a potential target to limit the excessive 
inflammatory response triggered by RSV. During the course of our work, it was shown 
that absence of NOX2 led to a reduced virus titer, increased Th1 cytokines in the 
airways and a reduced inflammatory infiltrate into the lung parenchyma in influenza-
infected mice (43). These results are in line with the concept raised by our study that 
inhibiting NOX2 might be a means of controlling the inflammatory response triggered 
by Paramyxoviridae infection.  
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Figure Legends 
Figure 1. RSV and SeV infection trigger IκBαSer32 and p65Ser536 
phosphorylation in A549. A549 cells were left untreated or infected with RSV 
(MOI=3) (A and C) or SeV (40 HAU/106 cells) (B and D) for various times, as 
indicated. WCE were generated and resolved by SDS-PAGE. After transfer onto 
nitrocellulose, proteins were immunoblotted (IB) with anti-IκBαSer32 phosphospecific 
(IκBα-P-Ser32), anti-IκBα (A and B) anti-p65Ser536 phosphospecific (p65-P-Ser536) 
and anti-p65 antibodies (C and D). Equal loading was verified using anti-actin 
antibody. The data are representative of at least three experiments. Hpi: hours post-
infection. 
 
Figure 2. p65Ser536 phosphorylation is essential to mediate fully active NF-κB 
transactivation potential in response to RSV and SeV infection of A549. A549 were 
cotransfected with empty vector or plasmid encoding flag-tagged p65 or flag-tagged 
p65S536A mutant together with the P2(2X)TK-pGL3 NF-κB reporter firefly luciferase 
and the pRL-null reporter constructs (renilla luciferase used as an internal control). 
Cells were either left untreated or infected with RSV and SeV for 16h. A/ Luciferase 
activity was measured and expressed as fold activation over the non-stimulated cells 
transfected with empty plasmid after normalization with renilla luciferase activity. 
Each value represents the mean ± SE of triplicate independent samples. Statistical 
comparison was performed using a two-way ANOVA-Tukey multiple comparison test 
between p65Ser536A- and p65-transfected A549 (***, p< 0.001). The data are 
representative of three different experiments. B/ Expression of flag-tagged p65 or flag-
tagged p65S536A mutant were analyzed by immunoblot (IB) using anti-flag antibody. 
Equal loading was verified using anti-actin antibody. 
 
Figure 3. DPI inhibits RSV- and SeV-induced TNFα and RANTES mRNA 
expression. A549 were left non-stimulated (NS) or infected with RSV (MOI=3) (A and 
C) or SeV (40 HAU/106 cells) (B and D) for 6h in the absence or presence of 30µM 
DPI. Total RNA was prepared, subjected to reverse transcription and analyzed by 
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SYBR Green-based real-time PCR using TNFα, RANTES and β-actin-specific 
primers. Absolute TNFα (A and B) and RANTES (C and D) mRNA copy numbers 
were quantified using standard curves generated with pCR2.1-TOPO-TNFα and 
pCR2.1-TOPO-RANTES plasmids. Results are presented as absolute copy numbers of 
target gene mRNA normalized versus β-actin mRNA used as a reference gene. Data 
are representative of two experiments performed in independent triplicates. Data are 
expressed as mean ± SE. Statistical comparison was performed by a t-test using 
DMSO-treated, RSV-infected A549 as control (***, p< 0.001). 
 
Figure 4. DPI inhibits RSV- and SeV-induced p65Ser536 phosphorylation in A549. 
A549 were pretreated with DMSO (vehicle) or DPI at the indicated concentrations 
before being left untreated or infected with RSV at a MOI of 3 (A, B, E and F) or SeV 
at 40 HAU/106 cells (C, D, E and F) for the indicated times. In A to E, DPI was kept in 
the medium during the infection. In F, DPI was either kept in the medium during the 
infection (protocol I) or washed after 1 hour preincubation before infection (protocol 
II). WCE were resolved by SDS-PAGE, transferred onto nitrocellulose membrane and 
immunoblotted (IB) using anti-p65Ser536 phosphospecific (p65-P-Ser536), anti-p65, 
anti-SeV, anti-RSV and anti-actin antibodies. In anti-SeV and anti-RSV immunoblots, 
the Nucleocapsid viral protein (N) is shown. In A to D, data were quantified by 
densitometric analysis using the ImageJ software. Data are representative of at least 
three independent experiments. Representative immunoblots are shown. Quantification 
data are expressed as mean ± SE. In A and C, statistical comparison was performed 
using a one-way ANOVA-post hoc Dunnett’s test using DMSO-treated, RSV-infected 
A549 as control (*, p<0.05). In B and D, black bars correspond to DMSO treated cells 
and white bars correspond to DPI treated cells. Statistical comparison was performed 
using a two-way ANOVA-Tukey multiple comparison test between NOX2-RNAi- and 
CTRL-RNAi-transfected A549 (*, p<0.05; **, p< 0.01; ***, p< 0.001). Hpi: hours 
post-infection.  
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Figure 5. Expression of NADPH oxidase subunits in A549 during RSV and SeV 
infection. A549 were either left untreated or infected with RSV (MOI=3) for 24h and 
SeV (40 HAU/106 cells) for 16h. Total RNA was extracted, treated with DNase1 and 
subjected to reverse transcription as described in Material and Methods. Expression 
was evaluated by RT-PCR analysis using primers (Table I) specific for each membrane 
subunit (A) or cytosolic factor (B). Specific positive controls (Ctrl+) were used for 
each gene: total RNA from colon was used for NOX1, NOX1L, NOXO1 and NOXA1; 
total RNA from DMSO differentiated HL60 was used for NOX2, p22phox, p47phox 
and p67phox; total RNA from human fetal kidney was used for NOX3; total RNA 
from MRC-5 were used for NOX4; total RNA from human spleen was used for NOX5 
and NOX5L, total RNA from thyroid was used for DUOX1 and DUOX2. Results were 
reproduced three times and representative data are shown. 
 
Figure 6. Interference with NOX2 expression, but not interference with NOX1 and 
NOX5 expression inhibits RSV- and SeV-induced NF-κB transactivation potential. 
A549 were transfected with Control (CTRL)-, NOX1-, NOX2 (NOX2(1))- and NOX5-
specific RNAi oligonucleotides (Table II) as described in the Material and Methods 
section. In (A), NOX1, NOX2 and NOX5 mRNA levels were quantified by real-time 
PCR using specific primers (Table I). NOX1L expression is presented as fold of 
NOX1-RNAi- vs CTRL-RNAi-transfected cells after normalization to β-actin. NOX2 
and NOX5 fold expression values were determined using the ΔΔCt method (50). In 
(B), CTRL-, NOX1- and NOX5-RNAi-transfected A549 were further transfected with 
the P2(2X)TK-pGL3 NF-κB firefly luciferase and the pRL-null renilla luciferase 
(internal control) reporter constructs and either left unstimulated (NS) or infected with 
RSV or SeV for 16h. Luciferase activity was measured and expressed as fold over the 
non-stimulated CTRL-RNAi transfected A549 after normalization with renilla 
luciferase activity. In C and D, CTRL- and NOX2(1)-RNAi transfected A549 were 
cotransfected with P2(2X)TK-pGL3 and pRL-null constructs and either left 
unstimulated or infected with RSV (C) or SeV (D) for the indicated times. Luciferase 
activity was measured and expressed as fold over the non-stimulated CTRL-RNAi 
transfected A549 after normalization with renilla luciferase activity. Each value 
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represents the mean ± SE of triplicate independent samples subjected to different RNAi 
exposure. Statistical comparison was performed using a two-way ANOVA-Tukey 
multiple comparison test between NOX2-RNAi- and CTRL-RNAi-transfected A549 
(*, p<0.05; **, p< 0.01; ***, p< 0.001). 
 
Figure 7. Interference with NOX2 expression using NOX2(1)-RNAi oligonucleotide 
inhibits RSV- and SeV-induced IκBαSer32 and p65Ser536 phosphorylation in A549. 
CTRL- and NOX2(1)-RNAi (A and B) transfected A549 were infected with RSV at a 
MOI of 3 (A) or SeV at 40 HAU/106 cells (B) for the indicated times. WCE were 
resolved by SDS-PAGE, transferred onto nitrocellulose membrane and proteins were 
immunoblotted (IB) using anti-IκBαSer32 phosphospecific (IκBα-P-Ser32), anti-IκBα, 
anti-p65Ser536 phosphospecific (p65-P-Ser536), anti-p65, anti-RSV (A), anti-SeV (B) 
and anti-actin antibodies. Phosphorylation of IκBα at Ser32 and p65 at Ser536, 
expressed as a ratio vs the total amount of IκBα and p65, respectively, was quantified 
by densitometry using the ImageJ software, and expressed as fold over the CTRL-
RNAi transfected, unstimulated condition. Data are representative of three independent 
experiments. Representative immunoblots are shown. Quantification data are expressed 
as mean ± SE. Statistical comparison was performed using a two-way ANOVA-Tukey 
multiple comparison test between NOX2-RNAi- and CTRL-RNAi-transfected A549 
(*, p<0.05; **, p< 0.01; ***, p< 0.001). Black bars correspond to CTRL-RNAi 
transfected cells and white bars correspond to NOX2(1)-RNAi transfected cells. Hpi: 
hours post-infection. 
 
Figure 8. A second NOX2 specific RNAi oligonucleotide (NOX2(2)) inhibits RSV-
induced IκBαSer32 and p65Ser536 phosphorylation in A549. A549 were transfected 
with Control (CTRL)- and NOX2-specific (NOX2(2)) RNAi oligonucleotides (Table 
II) as described in the Material and Methods section. In (A), NOX2 mRNA levels were 
quantified by real-time PCR using specific primers (Table I) and expressed as fold 
expression determined using the ΔΔCt method (50). The data are representative of 
three different experiments. In (B), CTRL- and NOX2(2)-RNAi-transfected A549 were 
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further infected with RSV for the indicated time and analyzed by immunoblot as 
described in Figure 7. Quantifications were performed using the ImageJ software and 
expressed as fold over the CTRL-RNAi transfected, unstimulated condition. 
Representative immunoblots are shown. Quantification data are expressed as mean ± 
SE. Statistical comparison was performed using a two-way ANOVA-Tukey multiple 
comparison test between NOX2-RNAi- and CTRL-RNAi-transfected A549 (*, p<0.05; 
**, p< 0.01; ***, p< 0.001). Black bars correspond to CTRL-RNAi transfected cells 
and white bars correspond to NOX2(2)-RNAi transfected cells. Hpi: hours post-
infection. 
 
Figure 9. Interference with NOX2 expression inhibits RSV- and SeV-induced 
IκBαSer32 and p65Ser536 phosphorylation in NHBE. In A, NHBE were either left 
untreated or infected with RSV (MOI=3) or SeV (40 HAU/106 cells) for 16h. Total 
RNA was extracted, treated with DNase1 and subjected to reverse transcription. 
Expression of NOX2 mRNA was evaluated by RT-PCR analysis using specific primers 
(Table I). In B, C and D, NHBE were transfected with Control (CTRL)- or NOX2-
specific (NOX2(1)) RNAi oligonucleotides (Table II) before being left untreated or 
infected as described in (A). In B, NOX2 mRNA levels were quantified by real-time 
PCR and expressed as fold expression. In C and D, WCE were analyzed by 
immunoblot as described in Figure 7. Representative immunoblots are shown. 
Quantification data are expressed as mean ± SE of three independent experiments. 
Statistical comparison was performed using a two-way ANOVA-Tukey multiple 
comparison test between NOX2-RNAi- and CTRL-RNAi-transfected NHBE (*, 
p<0.05; **, p< 0.01; ***, p< 0.001). Black bars correspond to CTRL-RNAi transfected 
cells and white bars correspond to NOX2(1)-RNAi transfected cells. Hpi: hours post-
infection. 
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Table I.  List of primers used to monitor the expression of NADPH oxidase subunits and 
cytokine genes in RT-PCR or real-time PCR analyses a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Amplification specificity of primers for the corresponding NADPH oxidase  
was verified using Amplify3X software.  
b Hybridization temperature (° C) 
 
Gene  Sequence (5’-3’) Thybb 
S gtacaaat tccagtgtgcagaccac NOX1 
AS cagactggaatatcggtgacagca 
62 
S tggaggaat taggcaaagtg NOX1L 
AS caaaggaggt t t tc tgt t tcag  
63 
S tgt tcagcta tgaggtggtga NOX2 
AS tcagat tggtggcgt ta t tg  
60 
S tcacaaactggtcgccta tg NOX3 
AS agggt tcct tgccagaaaat  
63 
S c tcagcggaatcaatcagctgtg  NOX4 
AS agaggaacacgacaatcagcct tag 
62 
S gtgctacatcgatgggcct ta tg NOX5 
AS ccccgtgatggagtct t tc t tc t  
65 
S ggaggatgccaggtggctccggt  NOX5L 
AS agccccactaccacgtagccc  
64 
S cgacat tgagactgagt tga  DUOX1 
AS ctggaatgacgt tacct tc t  
62 
S cgacat tgagactgagt tga  DUOX2 
AS cagagagcaatgatggtgat  
62 
S cgctggcgtccggcctgatcctca  p22phox 
AS acgcacagccgccagtaggtagat  
60 
S tgccaactacgagaagacctc  p47phox 
AS acagaaccaccaaccgctct  
62 
S cggacaagaaggactggaag p67phox 
AS acatgcagccaatgt tgaag 
62 
S t tc tc tgtgcgctggtcaga NOXO1 
AS tc t tgagctgcctgaat tcgt  
62 
S tgggaggtgctacacaatgtg NOXA1 
AS t tggacatggcctccct tag 
60 
S accacagtccatgccatcac  GAPDH 
AS tccaccaccctgt tgctgta  
58 
S acaatgagctgctggtggct  Actin 
AS gatgggcacagtgtgggtga 
58 
S taccatgaaggtctccgc RANTES 
AS gacaaagacgactgctgg 
60 
S cagagggcctgtacctcatc  TNFα 
AS ggaagacccctcccagatag 
55 
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Table II. List of RNAi oligonucleotides used for inhibition of NOX expression 
 	  
 
 
 
 
 	  	  
 
a Sequences of NOX1-, NOX2(1)-, NOX2(2)- and CTRL-RNAi were predesigned by 
Dharmacon.  
b NOX5 specific RNAi was previously described (81). 
 
 
 
 
Target genes Sequences 
target 5’-nngcacaccuguuuaacuuug-3’  
sense oligonucleotide 5’-gcacaccuguuuaacuuuguu-3’  NOX1
a 
antisense oligonucleotide 5’-caaaguuaaacaggugugcuu-3’  
target 5’-nngaagacaacuggacaggaa-3’  
sense oligonucleotide 5’-gaagacaacuggacaggaauu-3’  NOX2(1)a 
antisense oligonucleotide 5’-uuccuguccaguugucuucuu-3’  
target 5’-nnguggaugccuuccugaaau-3’  
sense oligonucleotide 5’-guggaugccuuccugaaauuu-3’  NOX2(2)a 
antisense oligonucleotide 5’-auuucaggaaggcauccacuu-3’  
target 5’-nngguggacuuuaucuggauc-3’  
sense oligonucleotide 5’-gguggacuuuaucuggaucdtdt-3’  NOX5b 
antisense oligonucleotide 5’-gauccagauaaaguccaccdtdt-3’  
target 5’-nncauagcguccuugaucaca-3’  
sense oligonucleotide 5’-cauagcguccuugaucacauu-3’  CTRLa 
antisense oligonucleotide 5’-ugugaucaaggacgcuauguu-3’  
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2.2 IFNβ /TNFα synergism induces a non-canonical 
STAT2/IRF9-dependent pathway triggering a novel 
DUOX2 NADPH Oxidase-mediated airway antiviral 
response 	  
2.2.1 Context 
The detection of an invading virus by its target cell is the basis for the 
establishment of a major antiviral state. Hundreds of ISGs are specifically induced 
following viral infection, which serve to eliminate the virus from infected cells or 
diminish the spread of the virus to surrounding cells. During the course of our early 
studies of the antiviral response of AEC, an induction of gene expression of the 
DUOX2 NADPH oxidase family member was observed upon SeV infection. This 
result - virus-induced DUOX2 induction - added to previous data that demonstrated 
DUOX2 upregulation by RV infection or stimulation with a dsRNA mimetic polyI:C 
(Harper et al., 2005). At that point it was also known that DUOX2, a protein highly 
expressed in the airways, was associated with antibacterial function (Moskwa et al., 
2007). From these results the hypothesis arose that DUOX2 might be a previously 
uncharacterized ISG family member serving in the antiviral defense. To study this 
hypothesis, two questions needed to be unraveled. Firstly, what were the regulatory 
mechanisms that drove DUOX2 expression during viral infection; and secondly, was 
DUOX2 implicated in an antiviral mechanism and what was the nature of its 
contribution to the antiviral state. Our results demonstrate that during AEC infection by 
SeV secreted IFNβ and TNFα synergize to engage a non-canonical signaling pathway 
that is IRF9- and STAT2-dependent, but entirely STAT1-independent. This pathway 
culminates in the upregulation of DUOX2 and its maturation factor DUOXA2, which 
belong to late-induced genes. Functional analysis revealed that DUOX2 is essential for 
AEC to mount a late antiviral state triggered by the synergism between IFNβ and 
TNFα, at least through regulation of type I and type III IFNs levels. Further, our results 
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reveal that the human pathogen Respiratory Syncytial Virus (RSV) is able to subvert 
DUOX2 induction. Thus DUOX2 a novel antiviral player in the respiratory mucosal 
linings. 
 
2.2.2 Author contributions 
The data presented in the following article results from my investigations started 
during my Ph.D. studies. Experiments were planned under the supervision of and 
guidance by my research supervisor Nathalie Grandvaux (NG). My research (KF) 
contributed significantly to the publication of this article. During the pre-submission 
phase I received assistance from Stefany Chartier (SC) in conducting experiments. 
Once in revision phase, Esperance Mukawera (EM) and Lydie Martin (LM) helped 
significantly to finalize necessary experiments. Esperance did all the RSV purifications 
throughout this study. I contributed, in collaboration with Nathalie Grandvaux, to the 
writing of the article. This article is accepted for publication in Cell Research. 
  
Figure 1 : KF/SC (panel F and G) 
Figure 2 : KF/SC (panel D)/ LM (panel E) 
Figure 3 : KF/EM (panel D)/ SC (panel B) 
Figure 4 : KF/LM (panel D) 
Figure 5 : KF/EM 
Figure 6 : KF 
Figure 7 : KF 
Figure 8 : KF/SC (panel C and F) 
Purification RSV: EM 	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Abstract 
 
Airway epithelial cells are initial key innate immune responders in the fight 
against respiratory viruses, primarily via the secretion of antiviral and proinflammatory 
cytokines that act in an autocrine/paracrine fashion to trigger the establishment of an 
antiviral state. The current paradigm is that the early antiviral state in airway epithelial 
cells primarily relies on IFNb secretion and subsequent activation of the ISGF3 
transcription factor complex, composed of STAT1, STAT2 and IRF9, which regulates 
the expression of a panoply of Interferon Stimulated Genes encoding proteins with 
antiviral activities. However, in the setting of virus infections, the specific pathways 
engaged by the simultaneous action of different cytokines, as well as the thereof 
resulting distinct physiological outcome, are still ill-defined. Here, we unveil a novel 
delayed airway antiviral defense mechanism, which is initiated by the synergistic 
autocrine/paracrine action of IFNβ and TNFα and signals through a non-canonical 
STAT2- and IRF9-dependent, but entirely STAT1-independent, cascade. This pathway 
ultimately leads to the late induction of the DUOX2 NADPH oxidase expression. 
Importantly, our study uncovers that the development of the resulting antiviral state 
relies on DUOX2-dependent H2O2 production. Key antiviral pathways have proven to 
be targeted by evasion mechanisms evolved by various pathogenic viruses. In this 
regards, the importance of this novel DUOX2-dependent antiviral pathway is 
underlined by the observation that human Respiratory Syncytial Virus is able to 
subvert DUOX2 induction.  
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Introduction 
 
The mucosal linings of the airways are constantly exposed to an array of 
microbial pathogens, including life-threatening respiratory viruses. Control of the host-
microbe homeostasis at the mucosal epithelia is essential to prevent microorganisms-
triggered inflammatory diseases. More than just a physicochemical barrier, airway 
epithelial cells (AEC) are also responsible for key immune responses in the fight 
against viruses. AEC rapidly recognize invading respiratory viruses to actively trigger 
the production of antiviral substances, including mucus, peptides and cytokines that 
limit invasion and spread of the pathogen. Additionally, AEC produce 
proinflammatory cytokines and chemokines that recruit and activate immune cells to 
the site of infection. Thus, the molecular pathways engaged upon viral infection of 
AEC, and the thereof resulting antiviral state, are crucial for the clearance of the 
pathogen and host recovery. 
The current picture of the innate immune response proposes that in AEC, viral nucleic 
acids are sensed by pattern recognition receptors (PRR) of the Toll-like receptors 
(TLRs) and RIG-I-like receptors (RLRs) families. Downstream signaling cascades 
culminate into the activation of the NF-κB and IRF-3 transcription factors (TF), which 
regulate the expression of genes encoding proinflammatory cytokines, such as TNFα, 
and antiviral cytokines, primarily type I (α and b) and type III (λ1-3) interferons 
(IFNs) [1]. Secreted type I IFNs bind to their cognate receptors (IFNAR) resulting in 
the autocrine/paracrine activation of the JAK/STAT signaling pathway, which 
ultimately leads to the formation of the ISGF3 TF complex composed of STAT1, 
STAT2 and IRF9. ISGF3 activation is a prerequisite for the establishment of a robust 
antiviral state through the induction of numerous interferon-stimulated genes (ISGs), 
which encode antiviral proteins that modulate protein synthesis, cell growth arrest and 
apoptosis [2]. Understanding the molecular mechanisms underlying the establishment 
of the antiviral state in AEC is the focus of intensive research aimed at identifying 
novel antiviral genes and their regulatory pathway.  
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The NADPH oxidase enzymes Dual oxidase 1 and 2 (DUOX1 and DUOX2) 
were originally identified in the thyroid, but have since been shown to be expressed in 
epithelial tissues, including the microbe-exposed barrier epithelia, such as respiratory 
and intestinal tract, in mammals [3]. Increasing evidence support a role of DUOX1 and 
DUOX2 in the host defense against invading bacteria at the mucosal surfaces through 
generation of H2O2 [3, 4]. However, analysis of the inducibility profile of DUOX 
expression in AEC suggests that DUOX2 might also be part of the host defense against 
virus infection. While DUOX1 is induced following stimulation with IL-4 and IL-13, 
typical T helper (Th) 2 cytokines, DUOX2 is induced by the Th1 cytokine IFN-γ [5]. 
Additionally, DUOX2 is upregulated following infection with rhinovirus (RV) or 
Paramyxoviridae viruses and in response to stimulation with poly (I:C), a synthetic 
double stranded RNA analog [6, 7].  
In this study, we uncover that DUOX2 is a late antiviral gene induced by an 
autocrine/paracrine pathway specifically triggered in AEC by the synergistic action of 
two major cytokines, IFNβ and TNFα, secreted upon Sendai virus (SeV) infection, a 
model of Paramyxoviridae viruses. Detailed analysis of DUOX2 regulation allowed us 
to unveil that the combination of IFNβ and TNFα signals through a novel, non-
canonical signaling pathway dependent on STAT2 and IRF9, but entirely independent 
on STAT1. Functional analysis revealed that DUOX2-derived H2O2 is essential for 
AEC to mount an antiviral state specifically triggered by the synergism between IFNβ 
and TNFα. Importantly, we also reveal that Respiratory Syncytial Virus (RSV), the 
most important etiological viral agent of pediatric respiratory tract diseases worldwide, 
has evolved mechanisms to counteract DUOX2 expression, allowing RSV to escape 
the DUOX2-mediated antiviral response. This observation highlights the importance of 
DUOX2 as a key molecule in the antiviral innate immune response.  
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Materials and Methods 
 
Chemicals 
The JAK inhibitor AG490 and the Tyk2-specific inhibitor Bayer-18 inhibitors were 
obtained from Enzo life Sciences and Symansis, respectively. 
 
Cell culture  
All media and supplements were purchased from Gibco, except for primary cell culture 
for which reagents were obtained from Clonetics. A549 cells (American Type Culture 
Collection, ATCC) were grown in F-12 nutrient mixture (Ham) medium supplemented 
with 10% heat-inactivated fetal bovine serum (HI-FBS) and 1% L-glutamine. Calu-3 
cells (ATCC) were grown under submerged conditions in MEM medium supplemented 
with 10% HI-FBS, 1% L-glutamine, 1% sodium pyruvate and 1% non-essential amino 
acids. For Air-Liquid Culture (ALI), Calu-3 cells were plated at a density of 0.2x106 
cells/cm2 onto Greiner Transwell inserts coated with collagen VI (Sigma-Aldrich) for 
at least 16h. Calu-3 cells were kept under submerged conditions for 48h before 
medium in the apical compartment was removed. Cells were kept in ALI (ALI-Calu-3) 
culture for 10-14 days before conducting Transepithelial Electric Resistance (TEER) 
measurement with a Voltohmmeter (World Precision Instruments). Experiments were 
performed using ALI-Calu-3 having TEER measures equal to or higher than 800 
Ω.cm2. NHBE were obtained from Clonetics, cultured in BEGM medium (Clonetics) 
and used until maximum passage 3. Vero cells (ATCC) were cultured in DMEM 
medium supplemented with 10% HI-FBS and 1% L-glutamine. 
 
Virus infections 
SeV Cantell strain was obtained from Charles River Laboratories. The initial stock of 
RSV A2 strain was obtained from Advanced Biotechnologies, Inc. The initial stock of 
recombinant RSV encoding GFP (RecRSV-GFP) was a generous gift from Dr. P. L. 
Collins (NIH, Bethesda). Amplification and purification of RSV and RecRSV-GFP 
was performed as previously described [8].  
SeV infection was conducted at 40 hemagglutinin units (HAU) per 106 cells in serum 
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free medium (SFM) for 2h, after which the medium was supplemented with 10% HI-
FBS. RSV or RecRSV-GFP infection was conducted at a MOI of 3 or 1, respectively, 
in medium containing 2% HI-FBS. Infection of ALI-Calu-3 was conducted the day 
after TEER measurement using viruses diluted in SFM (SeV) or 2% HI-FBS 
containing medium (RSV) and added apically onto Transwells. After 2h, the apical 
medium was taken off and the infection was pursued in ALI condition. SeV infection 
of NHBE was conducted with 40 HAU/106 cells in BEGM. 
 
Preparation of supernatant from infected cells 
For generation of supernatant from SeV- or RSV-infected cells, A549 cells were 
infected as described above. At 2 hours post-infection (hpi), the virus was taken off and 
the medium was replaced with Opti-MEM Reduced Serum media (Invitrogen). The 
infection was pursued for 22h. Thereafter, the supernatant was harvested and cell 
debris eliminated by centrifugation. Where indicated, the supernatant was treated with 
UV for 20min. To generate SN from A549 cells treated with Z-VAD-FMK 
(Calbiochem), A549 cells were pretreated with 0.1 mM Z-VAD-FMK or DMSO 
(vehicle) for 1h before infection. Z-VAD-FMK was present throughout the infection. 
For heat treatment, SN-SeV-UV was either left untreated or heated for 15 min at 80°C. 
 
 
 
Stimulation with recombinant cytokines 
Recombinant IFNβ and TNFα (Feldan) were used at a final concentration of 1000-
5000 IU/mL and 10-50 ng/mL, respectively, in F12 nutrient mixture (Ham), 
supplemented with 2% HI-FBS. Where indicated, cells were pretreated with AG490 
(100mM) or Bayer 18 (100mM) or the corresponding vehicle DMSO for 1 h before 
cytokine stimulation. 
 
Virus titration by plaque forming unit assay 
The supernatant of A549 cells infected with RecRSV-GFP was harvested 72hpi. Serial 
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dilutions of the supernatant were performed in DMEM (Gibco) containing 2% HI-FBS 
and used to infect confluent Vero cells for 2h. Following this period, the medium was 
replaced with 1% methylcellulose in DMEM containing 2% HI-FBS. Infection was 
pursued for 7 days and fluorescent lysis plaques were visualized using a Typhoon 
apparatus (Molecular Dynamics) and counted using the ImageQuantTL colony 
counting analysis tool.  
siRNA Transfection 
RNAi oligonucleotides (see Table 1 for sequences) were purchased from Dharmacon, 
except for siDUOX2(1), which was from Invitrogen. Transfection was performed as 
previously described [9] using Oligofectamine reagent (Invitrogen) and pursued for 
48h before viral infection or SN or cytokines stimulation. 
Immunoblot analysis 
Whole-cell extracts (WCE) were prepared on ice in Nonidet P-40 (Igepal; Sigma) lysis 
buffer [10], quantified by a Bradford protein assay (Bio-Rad), and resolved by SDS-
PAGE, followed by immunoblot analysis. Proteins were immunodetected using anti-
actin (Millipore), anti-ISG56 (IFIT1; Novus Biologicals), anti-IRF1 (Santa Cruz), anti-
IRF9 (BD Transduction Laboratories), anti-parainfluenza (obtained from Dr. J. Hiscott, 
McGill University, Montreal, Canada), anti-PARP (Cell Signaling), anti-RSV 
(Chemicon International), anti-IκBα-P-Ser32, anti-IκBα, anti-STAT1-P-Tyr701, anti-
STAT2-P-Tyr690, anti-STAT1, anti-STAT2 (all from Cell Signaling), and anti-a-
tubulin (Santa Cruz) antibodies diluted in phosphate-buffered saline (PBS) containing 
0.5% Tween (Sigma Aldrich) and either 5% nonfat dry milk or 5% BSA (Sigma 
Aldrich). For DUOX2 and TNFRI immunodetection, WCE were prepared at room 
temperature in 125mM Tris/HCl (pH 6.8), 10% glycerol, 2% SDS and 0.1 M DTT 
followed by sonication (2x20s) and heating to 70°C for 10 min. WCE were quantified 
using a RC/DC protein assay (Bio-Rad). 150µg were resolved by SDS-PAGE. DUOX2 
was immunodetected using the anti-DUOX1/2 specific antibodies previously described 
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in [11]. TNFRI was immunodetected using the anti-TNFRI/TNFRSF1A antibodies 
(R&D Systems). The membranes were further incubated for 1h with horseradish 
peroxidase (HRP)-conjugated secondary antibodies (Kirkegaard & Perry Laboratories 
or Jackson Immunoresearch Laboratories). Immunoreactive bands were visualized by 
enhanced chemiluminescence using the Western Lightning Chemiluminescence 
Reagent Plus (Perkin-Elmer Life Sciences) and detected using a LAS4000mini CCD 
camera apparatus (GE healthcare).  
 
Quantitative RT-PCR (qRT-PCR) analyses 
Total RNA was prepared using the RNAqueous-96 Isolation Kit (Ambion) following 
the manufacturer's instructions. Total RNA (1µg) was subjected to reverse transcription 
using the QuantiTect Reverse Transcription Kit (Qiagen). PCR amplifications were 
performed with the Fast start SYBR Green Kit (Roche). Sequences of oligonucleotides 
(Invitrogen) are presented in Table 2. Absence of genomic DNA contamination was 
analyzed using a reaction without reverse transcriptase. Detection was performed on a 
Rotor-Gene 3000 Real Time Thermal Cycler (Corbett Research). For DUOX2, 
DUOXA2, IFNΒ, IL28, IL29, IFIT1, TNFα, β-actin and S9 genes qRT-PCR 
amplifications, standard curves of absolute quantification expressed as copy number 
and PCR efficiencies were obtained using serial dilutions of DUOX2-HA-pcDNA3.1 
(a generous gift from Dr. Grasberger, University of Michigan, Ann Harbor, USA), 
DUOXA2-pCR4-TOPO, IL28-pCR4-TOPO, IL29-pCR4-TOPO, β-actin-pCR2.1-
TOPO, ISG56-pCR2.1-TOPO, IFNβ-pCR2.1-TOPO, TNFα-pCR2.1-TOPO, and S9-
pCR2.1-TOPO. Gene specific absolute mRNA copy numbers were normalized to β-
actin or S9 mRNA absolute copy numbers. For IFNAR1 real time amplification, serial 
dilutions of cDNA derived from IFNAR1 expressing A549 cells where used to 
determine primer efficiency and linearity of PCR reaction. IFNAR fold induction was 
calculated using the DD Cycle threshold (Ct) method [12].  
Multiplex ELISA 
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SeV and RSV infections were conducted in Opti-MEM Reduced Serum media 
(Invitrogen). Where applicable, virus infection was performed 48h post-siRNA 
transfection. Fifty µL of SN were analyzed using the VeriPlexTM Human Interferon 
Multiplex ELISA (PBL Interferon) according to the manufacturer’s instructions. The 
ELISA plate was imaged with the Q-View Imager and data analysis was performed 
using the Q-View Software (Quansys Biosciences). 
 
H2O2 measurement 
Extracellular H2O2 production was measured using homovanillic acid (HVA)-based 
fluorimetric assay as previously described [13]. Briefly, following stimulation, cells 
were incubated in Krebs-Ringer-Hepes solution containing 0.44mM HVA and 
0.1mg/mL horseradish peroxidase for 2h at 37 C. Where indicated, catalase was added 
at 400U/mL. At the end of the incubation period, fluorescence was quantified with an 
excitation wavelength of 315nm and an emission wavelength of 425nm on a HT 
Synergy (Biotek) plate reader. H2O2 concentration values were assigned using a H2O2 
standard curve. 
 
Statistical analyses 
All quantification data are presented as the mean ± standard deviation (SD). Statistical 
significance for comparison was assessed using the Prism 5 software (GraphPad). 
Statistical significance was evaluated using the following p values: p < 0.05 (*), p < 
0.01 (**) or p< 0.001 (***). 
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Results 
 
SeV infection induces DUOX2 and DUOXA2 expression in AEC. 
We previously reported using RT-PCR that SeV infection of the A549 alveolar 
epithelial cell line triggered induction of DUOX2 mRNA [7]. Here, a detailed 
characterization of DUOX2 mRNA and protein expression following SeV infection 
was performed in different cell line models of AEC and non-transformed primary 
normal human bronchial epithelial cells (NHBE). First, A549 cells were infected with 
SeV for various times. Quantitative RT-PCR (qRT-PCR) analysis revealed significant 
induction of DUOX2 mRNA levels starting at 24 hpi (Figure 1A). Interestingly, 
induction of the classic early antiviral IFIT1 gene peaked between 6hpi and 9hpi 
(Figure 1A). Thus, DUOX2 belongs to a category of late virus-induced genes. DUOX2 
induction was confirmed at the protein level by immunoblot using anti-DUOX1/2 
antibodies (Figure 1B). Although we and others previously established that DUOX1 is 
not expressed in non-infected and SeV-infected A549 cells [7, 14], the specific 
detection of DUOX2 was confirmed using small interfering RNA (siRNA)-mediated 
knockdown of DUOX2 (Figure 3, 5 and 6). Functional expression of DUOX2 at the 
plasma membrane is dependent on the concomitant expression of its maturation factor 
DUOXA2 [15]. DUOX2 and DUOXA2 genes are individually transcribed from the 
same bidirectional promoter [15], making DUOXA2 expression pattern likely to 
resemble the one of DUOX2. In accordance with this observation, DUOXA2 mRNA 
was induced in SeV-infected A549 cells following a kinetic similar to that of DUOX2 
(Figure 1C). Infection of A549 cells with UV-treated SeV, which is unable to 
replicate, failed to induce DUOX2, indicating that virus replication is essential for 
DUOX2 expression (Figure 1D). To further demonstrate that DUOX2/DUOXA2 genes 
are responsive to SeV in AEC, polarized Calu-3 cells cultured at an Air-Liquid 
Interface (ALI-Calu-3) forming a tight monolayer, were used. This serous gland cell 
line of sub-bronchial origin is widely used in the study of airway barrier function and 
ion secretion, and was more recently shown to be a suitable model for the study of 
virus infections [16]. Monolayers of Calu-3 exhibiting good integrity, as monitored by 
a transepithelial electric resistance (TEER) of ≥800 Ωcm2, were used in the 
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experiments. Infection of ALI-Calu-3 with SeV on the apical side resulted in DUOX2 
and DUOXA2 mRNA induction starting at 24hpi (Figure 1E and G) and detectable 
DUOX2 protein levels at 48hpi (Figure 1F). Importantly, DUOX2 and DUOXA2 
mRNA induction was confirmed in primary NHBE infected with SeV for 24h (Figure 
7A and B).  Altogether, these results demonstrate that DUOX2/DUOXA2 are late-virus 
induced genes in human AEC.  
 
SeV-mediated induction of DUOX2/DUOXA2 results from an autocrine/paracrine 
mechanism.  
The delayed induction of DUOX2/DUOXA2 during SeV infection suggested that their 
expression might be dependent on a mechanism requiring de novo synthesis and/or 
secretion of regulatory factor(s). To test this hypothesis, the supernatant of SeV-
infected A549 cells was harvested (SN-SeV) and submitted to UV treatment (SN-SeV-
UV) to impair the capacity of newly secreted virions to replicate and thereby induce 
DUOX2 as shown in Figure 1D. Stimulation of fresh A549 cells with SN-SeV-UV 
(Figure 2A) led to induction of DUOX2 and DUOXA2 mRNA to levels corresponding 
to 64 +/- 12% and 88 +/- 33% of those induced by the corresponding direct SeV 
infection, respectively (Figure 2B and D). Treatment with SN-SeV-UV also 
efficiently upregulated DUOX2 protein expression (Figure 2C). Heat inactivation of 
SN-SeV-UV abolished DUOX2 mRNA and protein induction (Figure 2E). These 
results pointed to a major role of factors of protein nature released into the SN of 
infected cells in the induction of DUOX2/DUOXA2. Next, the possibility that apoptosis 
of infected cells could contribute to the release of these factors was ruled out. The SN-
SeV was generated in the presence of the pan-Caspase inhibitor Z-VAD-FMK to block 
apoptosis as demonstrated by the efficient inhibition of PARP cleavage (Figure 2F). 
Blockade of apoptosis failed to interfere with the capacity of SN-SeV-UV to induce 
DUOX2 mRNA levels (Figure 2F), thus demonstrating that DUOX2 induction does 
not result from caspase-dependent apoptotic processes triggered by SeV infection. 
Altogether, these results highlight for the first time that DUOX2/DUOXA2 induction in 
virus-infected AEC results from an autocrine/paracrine mechanism.  
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IFNβ and TNFα synergize to regulate DUOX2 and DUOXA2 expression. 
Next, we sought to determine the identity of the soluble factor(s) responsible for SeV-
mediated induction of DUOX2/DUOXA2. Type I and type III IFNs are the most 
abundant cytokines secreted following viral infection, but stimulation of A549 cells 
with recombinant IFNβ (Figure 3A and B) or IFNα2b, IL28 or IL29 (data not shown) 
failed to induce significant increase in DUOX2 or DUOXA2 mRNA levels. 
Interestingly, previous reports revealed that IFNβ can synergize with TNFα to induce a 
late antiviral state distinct from the early state induced by IFNβ alone [17, 18]. Thus, 
the possibility that DUOX2/DUOXA2 induction could be driven by the combination of 
IFNβ and TNFα  was addressed. Multiplex ELISA analysis confirmed the presence of 
both IFNβ and TNFα in the SN-SeV derived from A549 cells (Figure 3C). 
Interestingly, stimulation of A549 cells with a combination of recombinant IFNβ and 
TNFα  led to a significant increase in DUOX2 and DUOXA2 mRNA and DUOX2 
protein levels as compared to stimulation with either cytokine independently (Figure 
3A and B). Similar results were observed in primary NHBE (Figure 7B). Several 
other combinations of IFNα, IFNβ or TNFα with IFNλ (IL28/IL29) were tested, but 
none of them resulted in DUOX2 induction (Figure S1). To demonstrate the 
importance of IFNβ and TNFα  in the capacity of SN-SeV-UV to induce 
DUOX2/DUOXA2, knockdown of type I IFN receptor chain 1, IFNΑR1, and TNFα 
receptor, TNFRSF1A, was achieved by siRNA. Downregulation of either of the 
receptors led to decreased DUOX2 mRNA induction following treatment with SN-
SeV-UV as compared to control cells (Figure 3D). Importantly, the combination of 
IFNβ and TNFα, similarly to SeV infection, induced catalase-sensitive H2O2 
production (Figure 3E). H2O2 induction was also dramatically reduced by silencing of 
DUOX2 using specific siRNA, thereby demonstrating that DUOX2 is a main source 
for IFNβ and TNFα-stimulated H2O2 generation (Figure 3E). Altogether, these results 
unveil the synergistic action of IFNβ and TNFα in the autocrine/paracrine regulation of 
DUOX2/DUOXA2 during virus infection.  
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DUOX2 induction is mediated by a non-canonical, STAT2/IRF9-dependent, but 
STAT1-independent pathway. 
To further identify the mechanisms involved in virus-mediated induction of DUOX2 
expression, a siRNA strategy was pursued to individually downregulate each subunit of 
the ISGF3 complex, STAT1, STAT2 and IRF9. Surprisingly, while knockdown of 
STAT2 and IRF9 strongly diminished SN-SeV-UV-induced DUOX2 mRNA and 
protein expression compared to control cells, STAT1 knockdown did not impair 
DUOX2 induction (Figure 4A). Similar results were obtained using a second STAT1-
specific siRNA (Figure 4B). While STAT1(1) siRNA led to induction of DUOX2 
mRNA expression, this increase was not reproduced with the second STAT1(2) siRNA 
and was therefore not considered significant. Contrarily, both STAT1-specific siRNA 
efficiently inhibited IFNg-induced IRF1 expression (Figure 4C). In the ISGF3 
complex, activated STAT2 is phosphorylated on Tyr690. To evaluate whether STAT2-
Tyr690 phosphorylation is also required in the non-canonical pathway leading to 
DUOX2 expression, the JAK kinases inhibitor, AG490, and the specific inhibitor of 
the JAK member Tyk2, Bayer-18, were used. Both inhibitors efficiently inhibited 
STAT2-Tyr690 phosphorylation in IFNβ and TNFα-stimulated cells and dramatically 
reduced DUOX2 induction (Figure 4D). Interestingly, kinetic analysis of STAT2 
phosphorylation in response to a combination of IFNβ and TNFα or to either cytokine 
independently, revealed that TNFα alone is not sufficient to trigger STAT2 
phosphorylation, but in its presence maximum IFNβ-induced STAT2 phosphorylation 
is achieved during an extended period of time. Additionally, TNFα alone is able to 
stimulate IRF9 expression (Figure 4E). The impact of TNFα on IRF9 expression and 
on STAT2 phosphorylation most likely contributes to the activation of the non-
canonical STAT2/IRF9 pathway during costimulation by IFNβ and TNFα. TNFα is 
well known to trigger NF-κB-dependent gene expression. However, no differences 
were observed in IκBα phosphorylation and degradation in response to TNFα alone or 
in response to IFNβ and TNFα costimulation (Figure 4E). Additionally, inhibition of 
the NF-κB pathway through expression of the widely used super-repressor of NF-κB, 
IκBα2NΔ4 [19], did not prevent SN-SeV-UV-mediated induction of DUOX2 (Figure 
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S3) strongly suggesting that NF-κB is unlikely to be involved in IFNβ and TNFα-
mediated induction of DUOX2. Hence, a non-canonical signaling pathway involving 
phosphorylated STAT2 and IRF9, but not STAT1, mediates the IFNβ and TNFα-
dependent induction of DUOX2 in AEC during SeV infection.  
 
DUOX2 is essential for AEC to mount an antiviral defense.  
Whether DUOX2 is part of the numerous virus-induced genes that allow the host to 
mount an antiviral response has not yet been assessed. To evaluate the antiviral role of 
DUOX2, SN-SeV-UV generated from A549 cells or a combination of IFNβ and TNFα 
were used to stimulate fresh A549 cells previously transfected with CTRL- or two 
different DUOX2-specific siRNA (siDUOX2(1) and siDUOX2(2)). In these 
conditions, target cells mount an antiviral response that differs by the presence or 
absence of DUOX2. The antiviral states were next monitored through their capacity to 
limit replication of recombinant RSV encoding GFP (RecRSV-GFP) (Figure 5A). As 
shown in Figure 5B, CTRL siRNA-transfected, SN-SeV-UV-treated cells efficiently 
restricted RecRSV-GFP replication as compared to CTRL siRNA-transfected cells. 
Importantly, in the absence of DUOX2, SN-SeV-UV-treated cells only partially 
impaired RecRSV-GFP replication compared to CTRL siRNA-transfected, SN-SeV-
UV-treated cells. Thus, in the absence of DUOX2, cells mount a less efficient antiviral 
response following stimulation with SN-SeV-UV. Similar results were obtained in the 
context of IFNβ and TNFα costimulation (Figure 5C). Importantly, DUOX2 siRNA 
did not alter the antiviral state induced by IFNβ alone (Figure 5C), which does not 
trigger DUOX2 expression (Figure 3A). This highlights the specific role of DUOX2 in 
the antiviral state mounted in response to IFNβ and TNFα costimulation. Additionally, 
the antiviral effect triggered by IFNβ and TNFα was abrogated by treatment with 
catalase, thereby demonstrating that the antiviral state relies on H2O2 production 
(Figure 5D). The role of DUOX2 in the establishment of the IFNβ and TNFα-
dependent antiviral response was also confirmed in primary NHBE (Figure 7B). 
Altogether, these results are the first to unveil the contribution of DUOX2 to the 
development of the antiviral state.  
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Next, to start elucidating how DUOX2 enhances the antiviral state, Multiplex ELISA 
analysis of type I (α and β) and type III (λ1-3) IFNs levels, the main antiviral 
cytokines secreted during virus infection of AEC, in the SN of A549 cells transfected 
with CTRL-, DUOX2(1)-, or DUOX2(2)-specific siRNA and infected with SeV were 
performed. Interestingly, absence of DUOX2 significantly diminishes levels of IFNβ 
 at 24hpi and 32hpi and those of IFNλ  at 32hpi (Figure 6A). On the other hand, TNFα 
levels were not significantly changed (Figure 6A). Despite the observation that 
DUOX2(1)-mediated downregulation of DUOX2 expression tends to diminish TNFα 
levels, although not significantly, this was not confirmed when knockdown of DUOX2 
was achieved using siDUOX2(2) (Figure 6A). Similar results were observed in 
primary NHBE (Figure 7C). Importantly, none of the cytokine levels were altered at 
6hpi, thereby suggesting that DUOX2 controls sustained levels of IFNβ and IFNλ 
specifically at late stages of viral infection. Importantly, differences in cytokines levels 
could not be explained by a decrease at their respective mRNA levels (Figure 6B). 
Thus, our results demonstrate that DUOX2 is a key player in the establishment of an 
antiviral state triggered by the synergism between IFNβ and TNFα, at least through 
regulation of IFNβ and IFNλ protein levels at late time points of infection.  
 
RSV interferes with the expression of DUOX2.  
The aforementioned data clearly highlight a new antiviral pathway occurring in the 
airway epithelium mediated by the synergism between IFNβ and TNFα involving 
induction of DUOX2. Key antiviral pathways have proven to be targeted by evasion 
mechanisms evolved by pathogenic viruses, including RSV [20]. Thus, we next sought 
to determine whether RSV is capable of evading the DUOX2-dependent antiviral 
response. First, A549 cells were infected with RSV for various times. As shown in 
Figure 8A, RSV infection induced only weak levels of DUOX2 mRNA compared to 
SeV. These low levels of mRNA translated into undetectable levels of the DUOX2 
protein, even when the multiplicity of infection (MOI) was increased from 3 to 10 
(Figure 8B). Analysis of DUOXA2 mRNA expression levels again revealed a barely 
detectable induction during RSV infection, thus significantly lower than the one 
observed during SeV infection (Figure 8C). Similar results were observed in the ALI-
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Calu-3 cell model (Figure 8D-F). Importantly, IFNβ and TNFα levels in the SN of 
RSV-infected A549 cells were close to those observed in the supernatant of SeV-
infected A549 cells (Figure 8G vs. Figure 3C). Hence, the decreased DUOX2 and 
DUOXA2 induction during RSV infection could not be attributed to a deficiency in the 
production of IFNβ or TNFα. Interestingly, UV-treated supernatant derived from RSV-
infected A549 cells (SN-RSV-UV), used as in Figure 2A, induced DUOX2 mRNA 
levels corresponding to 305 +/- 125% of those induced by direct RSV infection 
(Figure 8H) and detectable levels of DUOX2 protein (Figure 8I). Similarly to our 
observation in the context of SeV infection, knockdown of STAT2 and IRF9, but not 
of STAT1, prior to stimulation with SN-RSV-UV, impaired DUOX2 induction (Figure 
8J). Altogether, these results demonstrate that cytokines secreted in response to RSV 
infection are capable of inducing DUOX2, but that the presence of virus in the cell 
interferes with DUOX2 induction, allowing RSV to escape the DUOX2-mediated 
antiviral response.  
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Discussion 
 
AEC are the first line of defense against respiratory virus infection. The 
efficiency of the innate antiviral state mounted by AEC critically influences the 
outcome of viral infection. In the current paradigm, the antiviral state in infected AEC 
is primarily dependent on type I IFN-mediated activation of the JAK/STAT signaling 
cascade ultimately leading to the transcriptional control of ISGs by the ISGF3 
complex. Here, we highlight a novel antiviral pathway occurring in AEC, which is 
initiated by the synergistic autocrine/paracrine action of IFNβ and TNFα, and which 
signals through a non-canonical IRF9- and STAT2-dependent, but entirely STAT1-
independent, cascade to establish a late antiviral state mainly controlled by the DUOX2 
NADPH oxidase (Figure 9).  
Virus infections trigger the secretion of multiple antiviral and proinflammatory 
cytokines, which bind to their cognate receptor to engage specific signaling pathways. 
Although it seems intuitive that secreted cytokines do not act independently, but rather 
simultaneously to foster the antiviral response, the specific outcome resulting from 
their cooperation has barely been described. The synergism between IFNβ and TNFα 
was first reported in 1988 [21]. However, it was only recently discovered, through 
microarray profiling, that IFNβ and TNFα synergize to drive the expression of a panel 
of delayed genes that define a distinct antiviral state. These genes are either not 
responsive to IFNβ or TNFα separately or are only responsive to either one of the 
cytokine when used separately [17, 18]. Here, we uncover that in AEC, 
DUOX2/DUOXA2 belong to this category of delayed genes that are not significantly 
induced by IFNβ and TNFα alone, but are remarkably induced to high levels in 
response to the combination of IFNβ and TNFα. Previous attempts to identify the 
mechanisms underlying the specific regulation of genes dependent on IFNβ and TNFα 
synergism was performed through bioinformatic analysis of the promoters of this panel 
of genes in order to identify enrichment in specific TF binding sites. However, no 
specific TF was identified [17]. Here, through a targeted strategy using siRNA, we 
demonstrate for the first time that the synergistic action of IFNβ and TNFα engages a 
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specific STAT2 and IRF9-dependent, but STAT1-independent, signaling pathway. 
Interestingly, our results revealed that TNFα contributes to IRF9 induction and that 
TNFα synergism with IFNβ induces an extended maximum activation of JAK-
mediated STAT2 phosphorylation. Thus, IRF9 induction and STAT2 phosphorylation 
likely contribute to activation of the non-canonical STAT2/IRF9 pathway during 
costimulation by IFNβ/TNFα. This is consistent with previous reports that identified 
TNFα-mediated activation of JAKs [22, 23]. Whether this STAT2- and IRF9-
dependent pathway is responsible for the regulation of all other genes previously 
identified to be responsive to the combination of IFNβ and TNFα remains to be 
determined. Other studies proposed that TNFα synergizes with IFNβ through an 
autocrine/paracrine loop. Indeed, TNFα can induce the secretion of IFNβ in an IRF1-
dependent manner, thereby controlling the expression of specific delayed genes 
through the classical JAK/STAT pathway [18, 24, 25]. However, this loop is unlikely 
to be involved in the induction of DUOX2 in our system, since TNFα alone is not 
sufficient to activate DUOX2/DUOXA2 expression.  
Previous reports described the capacity of STAT2 and IRF9 to activate gene 
transcription independently of STAT1 [26-30]. However, none of these studies have 
linked activation of the STAT2/IRF9 pathway to the specific synergistic action of 
IFNβ and TNFα. Interestingly, in the absence of STAT1, STAT2/IRF9 display only 
limited DNA-binding affinity for the typical ISRE sequence targeted by the IRF9 
DNA-binding domain as part of the ISGF3 complex [26] and the specific DNA-
binding consensus sequence for this non-canonical complex remains to be determined. 
The possibility that STAT2/IRF9 uses a yet uncharacterized consensus responsive 
element would explain the failure of the previous bioinformatics strategy aimed at 
identifying TFs acting downstream of IFNβ and TNFα, as it was based on databases of 
known DNA-binding consensus sites [17]. It is noteworthy to mention that a 
STAT2/IRF9-dependent induction of RIG-G gene expression in response to all-trans 
retinoic acid (ATRA) was reported [31]. Interestingly, ATRA was shown to be a potent 
inducer of DUOX2 in AEC [32].  
To date, regulation of DUOX2/DUOXA2 expression was mainly investigated in 
thyrocytes, as well as in airway and gut epithelial cells following bacterial infection [6, 
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33-35]. Our observation that DUOX2/DUOXA2 are induced following infection with 
SeV in two different AEC models, A549 and ALI-Calu-3, as well as in NHBE, adds to 
the picture of the previously reported RV-induced DUOX2/DUOXA2 expression in 
primary AEC [6, 36-38]. Importantly, SeV is a member of the Paramyxoviridae family 
of negative sense single-stranded RNA (ssRNA) viruses, whereas RV belongs to the 
Picornaviridae family containing positive sense ssRNA. Furthermore, poly (I:C) used 
to engage Toll-like receptor (TLR) 3 also induces DUOX2 expression in primary AEC 
[6]. Thus, altogether these data strongly support the idea that the DUOX2-dependent 
antiviral pathway might be relevant to a broad number of respiratory viruses. 
Interestingly, infection by RSV barely triggered detectable induction of 
DUOX2/DUOXA2. In contrary, SN-RSV-UV was a potent inducer of 
DUOX2/DUOXA2, thus demonstrating that the presence of intracellular replicating 
RSV interferes with DUOX2/DUOXA2 induction. This is of particular significance, as 
most human pathogenic viruses have evolved strategies to circumvent the key 
mechanisms of the innate antiviral response for their own replication needs [20]. Thus, 
the observation that DUOX2/DUOXA2 expression is the target for viral evasion points 
to the importance of DUOX2 in the capacity of the host to mount an efficient antiviral 
response. In this line, we unveiled for the first time that DUOX2 is critical for the 
outcome of respiratory virus infections through its key function in the establishment of 
the antiviral state specifically induced by the synergistic action of IFNβ and TNFα 
secreted during SeV infection. The capacity of RSV to counteract this novel antiviral 
pathway adds to its previously recognized capacity to interfere with other key antiviral 
events, including RIG-I-dependent signaling or IKKε, TRAF3 or STAT2 stability [39, 
40]. Altogether these evasion mechanisms contribute to the development of RSV-
associated pathologies. Interestingly, DUOX2 expression is decreased in patients with 
Cystic Fibrosis (CF) [41]. Thus, our data sheds light into a potential mechanism for 
increased susceptibility of CF patients to respiratory virus infections [42]. 
Up to date, the demonstration of a role of DUOX2 in the antimicrobial defense 
was restricted to bacterial infections. This function of DUOX2 appears to be 
evolutionary conserved. In Drosophila, absence of the DUOX homologue at epithelial 
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surfaces profoundly alters the outcome of intestinal bacterial infection and fly survival 
[43]. The current model proposes that at airway surfaces, H2O2 in combination with the 
secreted lactoperoxidase (LPO) enzyme and thiocyanite forms the microbicidal 
compound hypothiocyanate. To date, studies based on the use of antioxidant enzymes 
support the necessity of H2O2 in the LPO-dependent antibacterial defense [44]. In this 
line, further studies suggest that DUOX2 is a source of H2O2 production in the airways 
[45, 46]. However, none of these studies clearly demonstrated a functional connection 
of DUOX2-generated H2O2 production in LPO-dependent airway antibacterial 
defenses. Whether the H2O2/LPO system contributes to an antiviral defense still 
remains to be clearly established. In vitro studies have shown that the products of LPO 
activity, hypothiocyanate and hypoiodous acid, possess virucidal properties [47-49]. 
However, no data are available showing this activity in an in vivo context. In our 
setting, the H2O2/LPO system is unlikely to play a role based on the following 
observations. First, LPO is not significantly secreted from in vitro cultured AEC [50] 
and all studies, which previously demonstrated an antimicrobial function via the LPO 
system, required addition of LPO in the experimental setup [44, 45, 49]. However, here 
we observe an antiviral effect of DUOX2 without the ectopic addition of LPO. 
Moreover, we did not observe an antiviral effect of the supernatant in a cell free system 
(Figure S2). In the same line, rather than a role in the synthesis of extracellular 
virucidal components, we identified a significant role of DUOX2 in the regulation of 
secreted levels of IFNβ and IFNλ, but not of TNFα,  nor IFNα, IFNω, IFNγ, IL6, and 
IL1α (data not shown). Interestingly, DUOX2 specifically regulates IFNβ  and IFNλ 
levels at late time points of infection (starting at 24hpi and 32hpi, respectively) but not 
at early times (6hpi). Hence, DUOX2 seems to play a role in sustaining the levels of 
IFNβ and IFNλ during viral infection. Further studies will be required to unveil how 
DUOX2 fosters sustained IFNβ and IFNλ levels in the SN of infected cells. An 
interesting working model would be that, through its capacity to diffuse across 
membranes, DUOX2-derived H2O2 could modulate intracellular signals regulating 
production and/or secretion of IFNβ  and IFNλ. Such a mechanism was previously 
shown to be implicated in the DUOX2-dependent regulation of NF-κB activity, and 
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thereof resulting IL-8 levels and neutrophil recruitment [51]. The closely related 
homolog of DUOX2, DUOX1, which is also expressed in AEC was previously shown 
to regulate EGFR-dependent signaling [52, 53]. Additionally, DUOX1-derived H2O2 
was shown to regulate intracellular protein phosphatase activities [54, 55]. Although 
intracellular signaling modulation is a likely mechanism, regulation of IFNs expression 
in our system was not due to altered transcriptional regulation, since IFNβ and IFNλ 
mRNA levels were not affected by the specific downregulation of DUOX2 by siRNA. 
Thus, it can be excluded that DUOX2 regulates the signaling cascades leading to NF-
κB and IRF-3 TFs, which are key regulator of IFN-encoding genes. It is noteworthy to 
mention that a recent publication has placed DUOX2 as a potential regulator of 
proinflammatory responses via shedding of the soluble TNFR in human AEC 
following TLR3 stimulation by poly (I:C) [56]. Here, we did not observe an effect of 
DUOX2 downregulation on TNFR shedding during SeV infection (data not shown).  
 In conclusion, our study unveils a key function of DUOX2 in the establishment 
of a late antiviral state triggered by the synergistic autocrine/paracrine action of IFNβ 
and TNFα secreted during respiratory virus infection. Importantly, induction of the 
antiviral state by the combination of IFNβ and TNFα is specifically driven by a non-
canonical STAT2/IRF9-dependent, STAT1-independent signaling pathway. Thus, our 
study reveals a novel antiviral signaling cascade that acts in a late fashion compared to 
the classical ISGF3-dependent antiviral pathway. 
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Titles and legends to figures 
 
Figure 1: DUOX2 and DUOXA2 are induced upon SeV infection of AEC.  
In A-C, A549 cells were infected for the indicated times with SeV (40HAU/106 cells). 
In D, A549 cells were infected for the indicated times with SeV or UV-treated SeV 
(40HAU/106 cells). In E-G, polarized Calu-3 cells cultured for 10 days in ALI (ALI-
Calu-3) and presenting an UAR ≥ 800 Ωcm2 were infected with SeV (40HAU/106 
cells) at the apical side for the indicated times. In A, C, D, E and G total RNA were 
extracted and DUOX2, IFIT1 or DUOXA2 mRNA absolute copy numbers were 
quantified by qRT-PCR. In B and F, DUOX2 protein expression was analyzed by 
immunoblot using anti-DUOX1/2-specific antibodies. In D, SeV N protein expression 
was detected using anti-parainfluenza antibodies. Equal loading was verified using 
anti-tubulin or anti-actin antibodies. All data are presented as mean ± SD. Statistical 
analyses were conducted using one-way ANOVA with Tukey post-test, except in D, 
where analysis was performed using a t-test. Statistical significances are presented 
compared to the non-infected control, except in D, where the SeV infected condition is 
compared to SeV-UV infected condition. *p<0.05, ***p<0.001. The dotted line in 
qRT-PCR graphs represents the threshold of detection. IB, immunoblot; NS, non 
specific; hpi, hours post-infection; UAR, Unit Area Resistance. 
 
Figure 2: SeV mediates induction of DUOX2 and DUOXA2 through secreted 
proteins. 
In A, a schematic representation of the timeline used to generate SN from infected cells 
is presented. See Experimental Procedures for details. In B-D, A549 cells were 
stimulated with untreated (SN-SeV) or UV-treated supernatant (SN-SeV-UV) from 
SeV-infected cells for 24h or the indicated time. SeV infection (40HAU/106 cells, 24h) 
was conducted for comparison. In E, cells were stimulated with SN-SeV-UV or SN-
SeV-UV subjected to heat treatment. In F, A549 cells were treated for 24h with SN-
SeV-UV generated from cells exposed to DMSO or 0.1 mM Z-VAD-FMK. In B, D, E 
and F DUOX2 or DUOXA2 mRNA expression were analyzed by qRT-PCR. In B, 
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STAT1-Tyr-701 phosphorylation, STAT1, and SeV protein levels were analyzed by 
immunoblot. In C and E, DUOX2 protein expression was analyzed. In E, IFIT1 
expression was analyzed by immunoblot. In F, PARP cleavage was assessed in SeV-
infected A549 cells treated with DMSO or Z-VAD-FMK, as well as in cells stimulated 
with SN-SeV-UV/DMSO or SN-SeV-UV/Z-VAD-FMK. qRT-PCR data are presented 
as mean ± SD. Statistical analysis was conducted using one-way ANOVA with 
Dunnett post-test, except in E and F, where a t-test was used. *p<0.05, **p<0.01, 
***p<0.001. IB, immunoblot; NS, non specific; ns, non significant; SN, supernatant. 
 
Figure 3: Costimulation by IFNβ and TNFα efficiently induces DUOX2 and 
DUOXA2 expression and DUOX2-dependent H2O2 production. 
In A and B, A549 cells were stimulated with recombinant IFNβ or TNFα or a 
combination of both for 24h. SeV infection (40HAU/106 cells, 24h) was conducted for 
comparison. In C, A549 were infected with SeV (40HAU/106 cells) and IFNβ and 
TNFα levels in the supernatant were measured by Multiplex ELISA. In D, A549 cells 
were transfected with control siRNA (siCTRL) or siRNA targeting the IFN receptor 
chain 1 using a mixture of siIFNΑR1(1) and siIFNΑR1(2) and/or the TNFRSF1A 
receptor using siTNFRSF1A. Forty-eight hours post-transfection cells were stimulated 
with SN-SeV-UV for 24h. In E, A549 cells were stimulated as in A and where 
indicated were transfected with siCTRL or siRNA targeting DUOX2 (siDUOX2(1)) 
48h prior to stimulation. In A, B, and D, DUOX2 or DUOXA2 mRNA absolute copy 
number were analyzed by qRT-PCR. In A, DUOX2 protein expression was analyzed 
by immunoblot. In D, IFNΑR1 expression levels were analyzed by qRT-PCR and 
TNFRI levels were detected by immunoblot. In E, H2O2 production was analyzed 
using the HVA assay. Where indicated, catalase was added at 400 U/mL. All qRT-PCR 
and H2O2 measurement data are presented as mean ± SD. Fold induction were 
calculated over the corresponding non-stimulated condition. The pointed line in graphs 
represents the threshold of detection. Statistical analysis was conducted by one-way 
ANOVA using Tukey multiple comparison analysis. *p<0.05, **p<0.01, ***p<0.001. 
IB, immunoblot; NS, non specific; SN, supernatant. 
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Figure 4: DUOX2 induction is regulated in a STAT2/IRF9-dependent, STAT1-
independent manner.  
In A-C, A549 cells were transfected with siRNA specific for STAT1, STAT2 or IRF9. 
48h post-transfection cells were stimulated with SN-SeV-UV for 24h in A and B or 
IFNg for the indicated time in C. In D, A549 cells were pretreated with AG490 
(100µM) and Bayer-18 (100µM) or DMSO (vehicle) for 1h before stimulation with 
IFNβ and TNFα for 24h. In A, B and D DUOX2 mRNA absolute copy number was 
analyzed by qRT-PCR and DUOX2 levels were expressed as % of the siCTRL 
condition. In A, DUOX2 protein levels were analyzed by immunoblot. In A-E, 
STAT2-P-Tyr690, STAT2, STAT1-Tyr-701, STAT1, IκBα-P-Ser32, IκBα, or IRF9 
protein levels were analyzed by immunoblot. All qRT-PCR data are presented as mean 
± SD. Data were analyzed by one-way ANOVA with Dunnett post-test. **p<0.01, 
***p<0.001. IB, immunoblot; NS, non specific; ns, non significant; SN, supernatant. 
 
Figure 5: DUOX2 is necessary for the establishment of an H2O2-dependent 
antiviral state.  
In A, a schematic outline of the experimental timeline used for experiments in B-D is 
presented. A549 cells were transfected with siCTRL, siDUOX2(1) or siDUOX2(2) 
before being stimulated with SN-SeV-UV from non-infected or SeV-infected A549 
cells or with IFNβ and TNFα for 24h. DUOX2 expression was analyzed by 
immunoblot using DUOX1/2 antibody. Twenty-four hours post-stimulation with SN-
SeV-UV or cytokines, cells were infected with recombinant RecRSV-GFP at a MOI of 
1 for 72h and release of infectious virus particles was quantified by plaque forming 
unit assay. In D, catalase was added 6h prior to RecRSV-GFP infection. All data are 
presented as mean ± SD. In B-D, data were analyzed by one-way ANOVA with 
Dunnett post-test, siCTRL vs. siDUOX2(1) or siDUOX2(2) or in D, IFNβ+TNFα vs. 
IFNβ+TNFα+catalase, . *p<0.05, **p<0.01, ***p<0.001. SN, supernatant; ns, non-
significant. 
 
Figure 6: DUOX2 regulates late type I/III IFN secreted levels.  
	   168 
In A, A549 cells were transfected with siCTRL, siDUOX2(1) or siDUOX2(2) and 48h 
post-transfection, cells were infected with SeV (40HAU/106 cells) for the indicated 
times. DUOX2 expression was analyzed by immunoblot using DUOX1/2 specific 
antibodies. Release of IFNβ, IFNλ and TNFα  was measured by multiplex ELISA. In 
B, A549 cells were transfected with siCTRL or siDUOX2(2) for 48h and infected as in 
A for the indicated times. IFNβ, IFNλ (IL-28A and IL-29) and TNFα mRNA absolute 
copy numbers were analyzed by qRT-PCR. Data were analyzed by two-way ANOVA 
with Bonferroni post-test. *p<0.05, **p<0.01, ***p<0.001. The dotted line in qRT-
PCR graphs represents the threshold of detection. hpi, hours post-infection; ns, non 
significant. 
 
Figure 7: DUOX2 induction controls a late IFNβ/TNFα-dependent antiviral state 
in NHBE cells. 
In A and C NHBE cells were infected with SeV (40HAU/106 cells) for 24h. In B and 
C, NHBE cells were transfected with siCTRL or siDUOX2(1). In B, NHBE cells were 
stimulated with IFNβ and TNFα for 24h before infection with RecRSV-GFP and 
quantification of infectious virion release as described in Figure 5. Data were analyzed 
by one-way ANOVA with Dunnett post-test. In C, release of IFNβ, IFNλ and 
TNFα  was measured by multiplex ELISA. Data were analyzed by two-way ANOVA 
with Bonferroni post-test. In A-C, DUOX2 or DUOXA2 expression levels were 
analyzed by qRT-PCR. *p<0.05, **p<0.01, ***p<0.001. The dotted line in qRT-PCR 
graphs represents the threshold of detection. hpi, hours post-infection; ns, non 
significant. 
 
Figure 8: SN-RSV-UV triggers higher expression of DUOX2 than direct RSV 
infection.  
In A and C, A549 cells were infected with RSV at an MOI of 3 for the indicated time 
points. SeV infection (40HAU/106 cells) was conducted for comparison. In B, A549 
cells were infected with RSV at an MOI of 3 or 10 or with SeV at 40HAU/106 cells for 
24h. In D-F, ALI-Calu-3 cells were infected with RSV as in A. In G, A549 cells were 
infected with RSV at an MOI of 3 for 24h and IFNβ/TNFα levels in the supernatant 
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were measured by Multiplex ELISA. In H and I, A549 cells were stimulated with SN-
RSV or UV-treated supernatant, SN-RSV-UV, for 24h. RSV infection (MOI=3, 24h) 
was conducted for comparison. In J, A549 cells were treated as in Figure 4A and 48h 
post-transfection were stimulated with SN-RSV-UV for 24h. In A, C, D, F, H, and J 
DUOX2 or DUOXA2 mRNA absolute copy numbers were quantified by qRT-PCR. In 
H and J, these values are presented as % DUOX2 induction. In B, E, I and J, DUOX2 
protein expression was analyzed by immunoblot. In H, STAT1-Tyr-701 
phosphorylation, STAT1, and RSV protein levels were analyzed by immunoblot. In J, 
STAT2, STAT1 or IRF9 protein levels were analyzed by immunoblot. All qRT-PCR 
data are presented as mean ± SD. Data were analyzed by one-way ANOVA with 
Tukey post-test except in J, where a Dunnett post-test was used; *p<0.05, **p<0.01, 
***p<0.001. The pointed line in qRT-PCR quantification data represents the threshold 
of detection. hpi, hours post infection; IB, immunoblot; MOI, multiplicity of infection; 
NS, non specific; SN, supernatant; UAR, Unit Area Resistance.   
 
Figure 9:  Model of the innate immune antiviral response triggered by IFNβ and 
TNFα in AEC. SeV infection of AEC triggers the secretion of IFNβ and TNFα. 
Binding of IFNβ to its cognate receptor activates the “classical” antiviral pathway 
mediated by the ISGF3 TF. Additionally, the synergism between IFNβ and TNFα 
induces late DUOX2 expression through a non-canonical antiviral signaling pathway. 
This pathway involves STAT2 and IRF9, but is entirely independent of STAT1. Late 
DUOX2 induction and H2O2 production is essential for the cells to mount an efficient 
antiviral state, at least in part through regulation of IFNβ and IFNλ levels at late time 
points of infection. The importance of this novel airway antiviral defense mechanism is 
underlined by the observation that pathogenic RSV is able to counteract DUOX2 
induction suggesting that this virus has evolved a strategy to evade the DUOX2-
dependent antiviral response. 
Tables 
 
Table 1: siRNA oligonucleotide sequences used for siRNA knockdown 
siRNA Accession number   Antisense oligonucleotide sequence (5’-3’) 
CTRL  UGUGAUCAAGGACGCUAUGUU 
STAT1(1) NM_139266.2, NM_007315.3 GGCGUUAGGACCAAGAAGC 
STAT1(2) NM_139266.2, NM_007315.3 GAACCUGACUUCCAUGCGG 
STAT2 NM_198332.1, NM_005419.3 UAACCAGGCAACUCAGUCCUU 
IRF9 NM_006084.4 UACCUGACCAAGUCUCUGCUU 
IFNΑR1(1) NM_000629.2 ACUAUAGACACCAAUUUUCUU 
IFNΑR1(2) NM_000629.2 UCACUAUUGCCUUAUCUUCUU 
TNFRSF1A NM_001065.3 UAGUAGUUCCUUCAAGCUCUU 
DUOX2(1) NM_014080.4 UAAACAUUAGACGGGACUUAUCCUC 
DUOX2(2) NM_014080.4 UUAGGGUUGAGAUCACUCCUU 
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Table 2: Primer sequences used in qRT-PCR analysis 
Gene Accession 
number 
Sense (S)/ 
Antisense 
(AS) 
Sequence (5’-3’) 
DUOX2 NM_014080.4 S                      
AS 
ACCTAAGCAGCTCACAACT 
CAGAGAGCAATGATGGTGAT 
DUOX2 NM_014080.4 S                      
AS 
GATGGTGACCGCTACTGGT 
CAGAGAGCAATGATGGTGAT 
DUOXA2 NM_207581.3 S                      
AS 
TAACGGCTACAGACAGTGAG 
CTGCTCTCAACGCTCTGG 
IFNΑR1 NM_000629.2 S                      
AS 
TGACCAGAAATGAACTGTGTCA 
TTTAAATAGTTAAGAGCTTGCCCG 
IFNΒ1 NM_002176.2 S                       
AS 
GAACTTTGACATCCCTGAGGAGATTAAGCAGC 
GTTCCTTAGGATTTCCACTCTGACTATGGTCC 
IFIT1 NM_001548.3 S                      
AS 
GCCCAGACTTACCTGGACAA 
GGTTTTCAGGGTCCACTTCA 
IL28A 
 
NM_172138.1 S                      
AS 
CTCAGGTTGCATGACTGGTGG 
GAGGCCTCTGTCACCTTCAAC 
IL29 NM_172140.1 S                      
AS 
CTTCCAAGCCCACCACAACTG 
CTTGAAGCTCGCTAGCTCCTG 
TNFα NM_000594.2 S 
AS 
CAGAGGGCCTGTACCTCATC 
GGAAGACCCCTCCCAGATAG 
S9 NM_001013.3 S                      
AS 
CGTCTCGACCAAGAGCTGA 
GGTCCTTCTCATCAAGCGTC 
β-actin NM_001101.3 S                      
AS 
GACTTCGAGCAAGAGATGG 
AGCACTGTGTTGGCGTACAG 
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NOX2 - master regulator of early proinflammatory responses 
in virus-infected AEC 
Following respiratory virus challenge AEC are the initial orchestrators of 
antiviral and proinflammatory defenses. A key event in triggering these defenses is the 
activation of TFs, such as NF-κB, that regulate the expression of antiviral and 
proinflammatory cytokines, which foster antiviral immune mechanisms. In order to 
properly activate these immune mechanisms, AEC signaling underlies a multitude of 
regulations. The recently recognized processes of redox-regulation are now emerging 
as control mechanisms in the early events following viral infection. In this doctoral 
thesis we present a role for the ROS-producing enzyme NADPH oxidase NOX2 in the 
activation of NF-κB and the regulation of downstream proinflammatory cytokines 
expression in Paramyxoviridae-infected AEC. NOX2 is thus a key molecule in the 
initiation of AEC-triggered inflammatory processes in the setting of respiratory virus 
infections. 
Our studies on the redox-regulation of NF-κB revealed that the NADPH oxidase 
NOX2, but not NOX1, NOX5 nor DUOX2, which are expressed in the A549 AEC 
model, is a regulator of early proinflammatory signaling in Paramyxoviridae-infected 
AEC. On a molecular level, we demonstrated that NOX2 influences the virus-induced 
activation of the proinflammatory TF NF-κB. More specifically, in absence of NOX2, 
achieved by RNAi transfection, we observed a decreased phosphorylation of IκBα at 
Ser32. Further, NOX2 also had an impact on the phosphorylation of the p65 subunit of 
NF-κB at Ser536. We show that this phosphorylation is necessary to attribute full 
transactivation potential of NF-κB in Paramyxoviridae-infected AEC. Consequently, 
NOX2 influences NF-κB target gene expression. Indeed, using multiplex ELISA 
analysis, we demonstrate that knockdown of NOX2 affects levels of TNFα, as well as 
levels of IL-6, IFNβ, IFNλ, IL-6 and IP-10 (Annex - Figure A1). Of note, expression of 
IFNα, IFNω as well as IL-1α were not reproducibly affected. Thus, the NOX2 
NADPH oxidase has a major impact on the AEC-induced proinflammatory response 
following respiratory virus infection via the regulation of NF-κB activity.  
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With regards to the mechanism by which NOX2 elicits its regulation on the NF-
κB-activating events, our working hypothesis was that NOX2 might regulate the 
upstream kinase responsible for p65 Ser536 and IκBα Ser32 phosphorylation. Follow-
up studies from our laboratory shed light on the exact mechanism by which NOX2 
regulates NF-κB activation. Soucy-Faulkner et al. demonstrated that NOX2 was 
essential for the expression of mitochondrial adaptor MAVS, which lies upstream of 
both, p65 and IκBα phosphorylation events. Decreased MAVS expression leads to a 
limited signal transduction to IKKβ, the kinase responsible for p65 phosphorylation at 
Ser536 and IκBα phosphorylation at Ser32 in our context, consequently resulting into 
decreased NF-κB activation and target gene expression (Soucy-Faulkner et al., 2010; 
Yoboua et al., 2010). The study of Soucy-Faulkner et al. demonstrated that the effect 
of NOX2 on MAVS not only limits itself to the NF-κB activation, as NOX2 regulation 
of MAVS expression also influenced the activation of IRF-3 as well as IRF-3 target 
gene expression (Soucy-Faulkner et al., 2010). Thus, NOX2 cumulatively regulates the 
expression of a panoply of antiviral and proinflammatory mediators during the early 
phase of the antiviral response. NOX2 is thus a key element in sustaining early 
antiviral and proinflammatory action in Paramyxoviridae-infected AEC.  
How NOX2 regulates MAVS mRNA expression levels is still unknown. A 
possible explanation would be that NOX2 has an activating effect on TFs regulating 
MAVS expression. Concerning the transcriptional mechanisms that control MAVS 
levels, it is well established that MAVS gene expression is not induced following virus 
infection. However, the field of MAVS transcriptional regulation has not yet been 
explored in much detail making the proposal of potential mechanisms for NOX2 action 
rather difficult. It is also possible that degrading processes and mRNA stability 
mechanisms of MAVS mRNA could be affected by NOX2. In this context it has been 
shown that MAVS mRNA stability changes upon ssRNA and dsRNA stimulation 
(Xing et al., 2012). Interestingly, NADPH oxidase activity has previously been linked 
to regulation of mRNA stability. NOX2 was responsible for decreasing IL-8, but not 
IL-6 and ICAM1 mRNA stability specifically following LPS, but not TNFα 
stimulation in endothelial cells (Al Ghouleh and Magder, 2012). Further, ROS derived 
from an unidentified NADPH oxidase positively regulate mRNA stability of the Kv 4.3 
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channel following Angiotensin II stimulation in cardiomyocytes as well as LPS-
induced TLR4 mRNA half-life in vascular smooth muscle cells (Lin et al., 2006; Zhou 
et al., 2006). Although these data appear rather unrelated to the context of viral 
infection, they potentially suggest the implication of NADPH oxidases in the very 
specific events regulating MAVS mRNA stability. 
 
 
The DUOX2 NADPH oxidase – guardian of the late antiviral 
state  
DUOX2 induction is mediated by IFNβ and TNFα in late stages of viral infection 
Whereas the NOX2 NADPH oxidase affects early antiviral and proinflammatory 
events of Paramyxoviridae-infected AEC, the role of the other NADPH oxidase family 
members expressed in our A549 model of AEC, notably NOX1, NOX5 and DUOX2, 
remained enigmatic. Our main focus of study was on DUOX2 function, as we and 
others had previously obversed an induction of DUOX2 expression in virus-infected 
AEC (Harper et al., 2005). To further characterize the importance of this virus-induced 
upregulation of DUOX2 expression, we conducted a detailed analysis of DUOX2 gene 
expression in SeV-infected AEC. This analysis revealed that DUOX2 expression 
augments gradually in a late-fashioned manner, contrasting the transient induction of a 
typically early ISG, IFIT1. Further, the gene expression of DUOX2 activator 
DUOXA2, necessary for DUOX2-dependent ROS production, increases in a similar 
fashion. This virus-triggered induction of DUOX2 and DUOXA2 expression has been 
confirmed by others in the setting of RV infection of primary airway epithelial cells 
(Chattoraj et al., 2011; Comstock et al., 2011; Harper et al., 2005; Schneider et al., 
2010). Hence, DUOX2 and DUOXA2 are induced by respiratory virus infection with 
viruses from two quite distinct viral families, as RV is a positive-sense RNA virus 
from the Picornaviridae family. Adding to this, a viral dsRNA mimetic, polyI:C has 
also been shown to be a DUOX2 inducer (Harper et al., 2005; Yu et al., 2011). From 
these data we propose that DUOX2 and DUOXA2 induction and their function might 
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come into play during infection with other respiratory viruses and this will be a 
pertinent question to be addressed in future studies. Interestingly, with regards to RSV, 
infection does not lead to significant DUOX2 and DUOXA2 induction and we propose 
that RSV possesses a mechanism that interferes with efficient DUOX2 expression, an 
issue that will be discussed in more detail below. 
The late-fashioned DUOX2 and DUOXA2 induction during SeV infection 
suggests that intermediary factors produced during the course of infection come into 
play to drive the induction of these two genes. Indeed, we found that heat-sensitive 
secreted factors are a major trigger of DUOX2 and DUOXA2 expression in virus 
infection since UV-treated supernatant from virus-infected cells was able to induce 
DUOX2 and DUOXA2 expression. More specifically, we provide evidence that IFNβ 
and TNFα, which are secreted from virus-infected cells, synergize to induce significant 
levels of DUOX2 and DUOXA2. To our knowledge, these are the first data linking the 
combination of IFNβ and TNFα stimulation to DUOX2 and DUOXA2 induction, as 
previously, among several cytokines, only IFNγ was described as a strong inducer of 
DUOX2 and DUOXA2 gene expression in primary bronchial epithelial cells as well as 
primary tracheobronchial epithelial cells in ALI culture (Gattas et al., 2009; Harper et 
al., 2005). Our data on IFNγ stimulation in the A549 AEC model does not support this 
result, which is potentially due to differences in the models used. Differential 
expression levels of the IFNγ receptor (IFNGR) in different AEC models could be one 
reason for these diverting results. TNFα is the only other cytokine associated with 
increases in DUOX2 expression. However, this was demonstrated in intestinal 
epithelial cells and a similar effect was not observed in primary AEC nor in our model 
of study (Harper et al., 2005; Lipinski et al., 2009).  
As one considers the multitude of different cytokines secreted upon infection, it 
becomes evident that these, besides their independent action on their cognate signaling 
pathways, must also exert a complex combinatorial action fostering cross-talk between 
the individual cytokine-engaged signaling pathways. This is also the case for IFNβ and 
TNFα stimulation, whose combinatorial, synergistic action on ISG induction was first 
reported by Mestan et al. (Mestan et al., 1988). Importantly, a synergistic antiviral 
effect following IFNβ and TNFα co-stimulation was also observed in the context of 
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RSV infection (Merolla et al., 1995). As mentioned in the Introduction, IFNβ signals 
via a by IFNΑR mediated JAK-STAT pathway, responsible for the induction of ISG 
expression. TNFα, via the TNFR signaling pathway, engages into NF-κB activation 
and consequent expression of various NF-κB target genes. Combined action of IFNβ 
and TNFα has previously been shown to foster the expression of quite a distinct set of 
delayed antiviral genes defining a novel antiviral state, different from the one induced 
by each cytokine separately (Bartee et al., 2009; Yarilina et al., 2008). The question 
remains on how IFNβ and TNFα signaling pathways intersect and how synergy is 
achieved. One possibility is that TNFα induces JAK-STAT signaling, leading to the 
induction of ISGs. Indeed, several data in the literature document that TNFα has the 
capacity to drive IRF1-dependent IFNβ gene expression, which thereafter leads to the 
activation of the IFN-dependent JAK-STAT pathway (Fujita et al., 1989; Tliba et al., 
2003; Yarilina et al., 2008). However, this mechanism does not explain the synergistic 
action of IFNβ and TNFα on DUOX2 expression in our experimental context, since we 
do not observe TNFα-induced activation of the JAK-STAT pathway measured by 
STAT1 phosphorylation at Tyr701 and STAT2 phosphorylation at Tyr690, nor TNFα-
induced DUOX2 expression. However, we do observe TNFα-induced expression of 
IRF1 and IRF9, suggesting that TNFα activates the expression of ISGs in a STAT 
phosphorylation-independent manner. Interestingly, IRF1 expression is increased 
significantly after costimulation of IFNβ and TNFα compared to individual stimulation 
suggesting that this protein could constitute a marker for cytokine synergy. Other 
studies report that TNFα is able to increase the expression of IFNΑR2, the cognate IFN 
receptor, thereby potentializing the IFN-induced JAK-STAT pathway (Takayama et 
al., 2000). We do not exclude a regulatory mechanism of TNFR signaling on IFNΑR 
expression, since our experiments demonstrated that cytokine-stimulated cells, which 
had decreased TNFRI receptor levels achieved by RNAi treatment also showed 
decreased mRNA expression levels of IFNΑR1. Altogether, the interference of TNFR 
levels with IFNΑR levels as well as the TNFα-induced IRF1 and IRF9 expression 
suggests that TNFα impacts on IFN signaling, which might explain IFNβ and TNFα 
synergy.  
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DUOX2 is regulated by a novel IFNβ- and TNFα-induced, STAT2/IRF9-
dependent signaling cascade 
The following issue we addressed in this work was the implication of specific 
TFs in the regulation of DUOX2 expression. Regarding this, our results show that 
DUOX2 expression is strongly dependent on the presence of STAT2 and IRF9, but 
does not depend on STAT1 in the regulation of its gene expression since treatment 
with STAT2- and IRF9-specific RNAi strongly abolished the expression of DUOX2 
induced by the supernatant of virus infected cells as well as by IFNβ and TNFα 
costimulation (Annex, Figure A2). Previously, the STAT1-dependence of DUOX2 
expression has been addressed in various cell types under different stimuli and it 
demonstrated a cell type-specific dependency pattern: whereas IFNγ-induced DUOX2 
expression in pancreatic cancer cells was dependent on STAT1, it was STAT1-
independent under the same stimulus in airway epithelial cells (Hill et al., 2010; Wu et 
al., 2011). Thus, our data, combined with the data of Hill et al. suggest that DUOX2 
expression in the airway epithelium does not depend on STAT1 (Hill et al., 2010). The 
ISGF3 transcription factor that is activated during the course of IFN signaling consists 
of STAT1, STAT2, and IRF9. Since our data suggest the implication of STAT2 and 
IRF9, but exclude STAT1 implication in DUOX2 regulation we propose the 
importance of a non-canonical transcription factor complex that acts independently of 
STAT1, but is entirely dependent on STAT2 and IRF9. In support of this, the existence 
of such a STAT2/IRF9-dependent, STAT1-independent non-canonical pathway has 
been described previously (Hahm et al., 2005; Kraus et al., 2003; Perry et al., 2011; 
Sarkis et al., 2006).  
The importance of TNFα in the regulation of DUOX2 induction suggested that 
NF-κB, which becomes activated downstream of TNFR activation, might be 
implicated in the regulation of DUOX2 induction. This transcription factor has recently 
been shown to regulate DUOX2 expression in the context of Lipopolysaccharide (LPS) 
stimulation in pancreatic cancer cells (Wu et al., 2013). However, our results do not 
suggest the implication of NF-κB in the regulation of DUOX2 expression upon viral 
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infection as we do not observe changes in DUOX2 levels upon inhibiting NF-κB 
activation in the context of stimulation with supernatant from SeV-infected cells. 
From our study, the question regarding the composition of the TF(s) regulating 
DUOX2 arises. DUOX2 might likely be regulated by a STAT2/IRF9-containing 
complex consisting of a STAT2 homodimer and an IRF9 molecule. However, it is also 
possible that STAT2 heterodimerizes with a different STAT protein in order to regulate 
DUOX2 expression. From the seven mammalian STAT proteins, besides STAT1 and 
STAT2, STAT2 has only been shown to interact with STAT6 following the stimulation 
by IFNα (Gupta et al., 1999; Wan et al., 2008). Interestingly, STAT6 has recently been 
implicated in the regulation of DUOX2 in intestinal epithelial cells following IL-4 and 
IL-13 stimulation. Thus STAT6 could be a potential candidate for STAT2 heterodimer 
action (Raad et al., 2012). Further molecular studies will be needed to discern the exact 
composition of the DUOX2 regulating transcription factor(s) in our experimental 
setting.  
Another unanswered issue from our study is if STAT2/IRF9 regulate DUOX2 
gene expression directly, implying binding of STAT2/IRF9 complexes to the DUOX2 
promoter. It is known that in the context of IFNγ stimulation of pancreatic cells, a 
STAT1-binding IFNγ-activating sequence (GAS) sequence plays an important role in 
DUOX2 regulation (Wu et al., 2011). The same group recently identified a NF-κB 
binding site that comes into play in pancreatic cells upon IFNγ and LPS stimulation 
(Wu et al., 2013). Further, a putative STAT6-binding GAS sequence has been 
identified in the DUOX2 promoter region, but its physiological importance remains to 
be demonstrated (Raad et al., 2012). Thus the DUOX2 promoter indeed contains target 
sequences for STAT binding. The Drosophila DUOX promoter also contains an ATF2-
binding site, which underlies the regulation of a MAP kinase pathway following 
stimulation with bacterial extract. It is very likely that this site is conserved in the 
human DUOX2 promoter, since in intestinal epithelial cells DUOX2 expression is also 
increased following treatment with bacterial extract (Ha et al., 2009b). However, the 
importance of this pathway in the context of virus-induced DUOX2 expression remains 
to be explored. Regarding STAT2/IRF9-regulated DUOX2 expression, the 
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DUOX2/DUOXA2 bidirectional promoter region has not been studied in terms of the 
physiological existence of ISRE or IRF9 consensus sites that could be potential binding 
sites for these TFs. Furthermore, the nature of the consensus sequence of the 
STAT2/IRF9 containing complex is still obscure. Whereas a STAT2/IRF9-containing 
complex was described to bind to an ISRE in the context of ATRA-induced RIG-G 
expression, a different study demonstrated that STAT2/IRF9 containing complexes 
have only limited ISRE binding capacities (Bluyssen and Levy, 1997; Lou et al., 
2009). During our preliminary DUOX2 promoter analyses using the MatInspector 
transcription factor binding site search tool from Genomatix 
(http://www.genomatix.de/matinspector.html), we did not localize any ISRE consensus 
sequence within the bidirectional promoter region of DUOX2, which only spans 
approximately 170 nucleotides (Cartharius et al., 2005; Christophe-Hobertus and 
Christophe, 2010; Xu et al., 2012) MatInspector is a software tool which uses a large 
library (> 600) of nucleotide position weight matrices to locate transcription factor 
binding sites in DNA sequences (Cartharius et al., 2005; Quandt et al., 1995). Further, 
the search engine did not detect any ISRE consensus sequence within -6000bp and 
+7000bp of the TSS of the DUOX2 gene (Annex – Figure A3).  It is thus possible that 
the STAT2/IRF9 complex binds indeed a different sequence for DUOX2 regulation. 
On the other hand, it might be possible that the important regulatory region targeted by 
STAT2/IRF9 lies outside this quite extensive stretch of DUOX2 promoter. Future 
detailed studies of the DUOX2 promoter reactivity towards IFNβ and TNFα in 
combination with ChIP assays should give better insight on the nature of the 
transcription factor and its target sequence implicated in the regulation of DUOX2. 
In this context, we also suggest that IRF1 could play a pertinent role in DUOX2 
regulation. This TF has previously been linked to the STAT2/IRF9-dependent, STAT1-
independent pathway of ATRA-induced RIG-G gene expression, which is reminiscent 
of the pathway regulating DUOX2 expression (Lou et al., 2009). Lou et al. placed 
IRF1 upstream of the STAT2/IRF9 complex, regulating IRF9 expression (Lou et al., 
2009). Furthermore, other data suggest the importance of IRF1 following IFNβ and 
TNFα costimulation, as IRF1 is necessary for TNFα-induced IFNβ production 
(Yarilina et al., 2008). Additionally, as mentioned above, our results show a synergistic 
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induction of IRF1 expression following stimulation with IFNβ and TNFα, which is not 
or only weakly observed in the case of a simple stimulation with each cytokine. 
Altogether, these data suggest that IRF1 could indeed play a role in the regulation of 
DUOX2 by IFNβ and TNFα. 
Our results, demonstrating that IFNβ and TNFα costimulation engages in a 
STAT2/IRF9-dependent, but STAT1-independent signal transduction pathway, suggest 
that IFNβ and TNFα costimulation might specifically engage into a novel non-
canonical STAT2/IRF9-dependent signaling pathway. Importantly, a previous 
microarray study identified that the combination of IFNβ and TNFα is able to induce 
more than 850 novel host cell genes (Bartee et al., 2009). One hypothesis arising from 
our data is that these genes might be specifically regulated in a STAT2/IRF9-
dependent, but STAT1-independent manner. Further studies are necessary to evaluate 
if this hypothesis holds true. Indeed, it would be very exciting to be able to attribute a 
specific gene expression signature to the combinatorial stimulation of IFNβ and TNFα. 
This being said, this also implies that during the costimulation of IFNβ and TNFα a 
certain switch exists that specifically turns on the STAT2/IRF9-dependent, STAT1-
independent IFN-signaling axes. The nature of this exact mechanism remains to be 
characterized.  
 
DUOX2 exerts an antiviral function in a ROS-dependent manner 
The observed induction of DUOX2 during SeV infection as well as following 
IFNβ and TNFα treatment led us to believe that DUOX2 could be part of the IFN-
regulated machinery necessary for antiviral defense. We addressed this question 
experimentally and showed that a decrease of DUOX2 achieved by RNAi treatment led 
to a decrease in the antiviral state as measured by an increase in viral load. This 
correlated with increased intracellular viral protein levels, therefore excluding a 
mechanism by which DUOX2 presumably inhibits viral budding from the cells (Annex 
– Figure A4). Together, these results indicate that DUOX2 is necessary for an efficient 
antiviral response. Using the antioxidant enzyme catalase, which targets H2O2 in the 
extracellular compartment, we demonstrated that the antiviral action of DUOX2 
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depends on the production of H2O2. Although the use of catalase, due to its non-
specific nature regarding DUOX2 action, only hints that DUOX2-produced H2O2 is the 
antiviral mediator, these data, combined with the results obtained by the RNAi 
approach strongly suggest the importance of DUOX2-produced H2O2 in the 
establishment of the antiviral state.  
The implication of DUOX2-produced ROS in the antiviral response has 
previously been addressed in several studies. As mentioned in the introduction, 
DUOX2, via its H2O2-producing activity, feeds an antibacterial H2O2/LPO/OSCN- 
system (Gattas et al., 2009; Moskwa et al., 2007). Based on the data of Mikola et al., 
this system could also have antiviral action, as it has been shown that OSCN- 
specifically targets certain viruses in vitro. A more recent study by Fischer et al. 
addressed the importance of this system in the context or respiratory virus infection, 
notably RSV, and concluded that not OSCN-, but rather hypoiodous acid, whose 
generation was achieved by supplementing the experimental setup with iodide, could 
be the potential antiviral agent generated by a DUOX2-driven system (Fischer et al., 
2011). However, the implication of DUOX2 per se in this system was not proven, as 
catalase was the only agent used to demonstrate the implication of DUOX2-specific 
ROS. Regarding our experiments, we believe that DUOX2-derived H2O2 does not exert 
its antiviral function in an LPO-dependent manner. Firstly, LPO is not known to be 
secreted from in vitro AEC cultures (Conner et al., 2007). Secondly, using supernatants 
from DUOX2-expressing and non-expressing cells, achieved by application of 
DUOX2-specific and control RNAi, we do not see a differential antiviral effect of 
these upon incubation with RSV-GFP, thereby suggesting that the antiviral action in 
our system is not driven by a component in the supernatant fraction. Rather, we believe 
that DUOX2-generated H2O2 is able to cross the membrane and enter the cell to act on 
intracellular signaling pathways to indirectly foster antiviral action.  
Such intracellular action of DUOX2-derived ROS has previously been 
demonstrated in different settings. First, DUOX2-derived ROS were implicated in 
TNFRI shedding from the plasma membrane following poly-I:C stimulation of AEC 
(Yu et al., 2011). However, we experimentally excluded this mechanism. In a similar 
manner, DUOX1-derived H2O2 is able to regulate intracellular signaling via 
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inactivation of protein tyrosine phosphatases. One report demonstrated increased 
STAT6 phosphorylation via inactivation of PTP1B (Hirakawa et al., 2011). A second 
study demonstrated increased T cell receptor (TCR) signaling via increased 
phosphorylation of ZAP-70 due to oxidative inactivation of SHP-2 (Kwon et al., 2010). 
These data demonstrate the possibility that DUOX2-derived extracellular ROS exhibit 
their biological effect intracellularly.  
 
DUOX2 sustains the secretion of late type I IFNs 
Regarding the mechanism by which DUOX2 enforces its antiviral function, our 
data demonstrated that DUOX2 is necessary for maintaining secreted IFNβ and IFNλ 
levels at late time-points from virus-infected AEC. Thus, DUOX2 fosters the antiviral 
state by sustaining the presence of late antiviral cytokines. Data showing that in AEC 
derived from chronic obstructive pulmonary disease (COPD) patients versus healthy 
donors, RV-induced DUOX2 levels correlate with an increase in expression levels of 
antiviral genes, such as IFNβ and IFNλ, support our results (Schneider et al., 2010). 
The diminution of IFNβ and IFNλ levels observed in DUOX2-RNAi treated AEC 
could explain the decreased antiviral state in these cells. To address the question of 
how DUOX2 could regulate extracellular protein levels, we analyzed these cytokines’ 
mRNA expression. We did not observe a significant change in cytokine mRNA levels 
between control-RNAi and DUOX2-RNAi treated, SeV-infected cells. This suggests 
that DUOX2 influences the levels of these cytokines at a post-transcriptional level. 
Continuing this line of thought, further preliminary experiments show that DUOX2-
RNAi treatment decreases intracellular IFNβ protein levels in SeV-infected A549, 
suggesting that DUOX2 might be implicated in the modulation of translational 
mechanisms that regulate the synthesis of these cytokines (Annex - Figure A5). The 
mammalian target of rapamycin (mTOR) pathway is a master regulator of protein 
translation. It is also implicated in the regulation of type I IFN and ISG expression 
(Cao et al., 2008; Colina et al., 2008; Costa-Mattioli and Sonenberg, 2008; Kaur et al., 
2008). Interestingly, NADPH oxidase-derived ROS have been shown to modulate the 
mTOR driven pathways (Li et al., 2010). Hence, such data support the hypothesis that 
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IFNβ translation might indeed be regulated by a redox-sensitive mTOR pathway, 
which could be driven by DUOX2-derived ROS.  
One remaining question from our studies concerns the effect that decreased IFNβ 
and IFNλ secretion might exert on the antiviral state. What are the consequences on 
ISG expression in the absence of DUOX2? Are the expression levels of all ISGs 
altered or does IFNβ and IFNλ diminution at late time points affect the expression of a 
specific subset of ISGs? First of all it needs to be mentioned that DUOX2 expression 
itself might be affected by the decrease in IFNβ and IFNλ levels as it could underlie 
the regulation of a feed-forward loop driven by IFNβ. Regarding the effect on ISG 
expression, taking into account current knowledge on ISG signatures and specificity of 
ISG expression in the context of different viral infections, we hypothesize that only a 
specific subset of ISGs will be affected by the fluctuations in IFNβ and IFNλ levels. In 
other words, specific antiviral mechanisms might be altered that are determinants in 
regulating the outcome of Paramyxoviridae infection.  
The discussed antiviral function of DUOX2 could be supported by the presence 
of its activator DUOXA2, which is necessary for DUOX2-dependent ROS production. 
Our studies demonstrate that DUOX2 and DUOXA2 are both induced by 
autocrine/paracrine action of IFNβ and TNFα in virus infection. Thus, it would be very 
plausible that DUOXA2 knockdown by RNAi treatment results in a similar increase in 
viral replication as observed with DUOX2 RNAi.  
When considering the more global events occurring in virus-infected airways, it 
needs to be mentioned that our experimental model, despite the specific insight it gives 
on AEC antiviral mechanisms, is at the same time limited and cannot be used to 
foresee the outcome of a viral infection in an in vivo setting. It is possible that the 
physiological consequence of DUOX2 action – the decrease in antiviral cytokine levels 
- also affects the hematopoietic cell compartment, targeting cells of the immune system 
that express the type I IFN receptor. Thus, DUOX2 might foster antiviral immunity not 
only within the AEC compartment. Additionally, it might contribute to the activation 
of innate immune players. Studies on animal knockout and chimera models will need 
to be conducted to cofirm this hypothesis. In this context, a recent investigation using 
DUOX2 knockout mice demonstrated that DUOX2 is driving TLR5-mediated 
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inflammation induced by flagellin stimulation. DUOX2 was necessary for recruitment 
of the neutrophil compartment into the lung. The use of such a model would certainly 
be pertinent in the context of a viral infection. However, data generated from it should 
also be analyzed with care as one has to consider that global DUOX2 deficiency in 
mice might lead to defects in the thyroid metabolism and thyroid hormone synthesis 
which could affect immunological responses in an unforeseeable manner.  
 
RSV interferes with DUOX2 induction 
Besides the use of SeV, we also analyzed the expression of DUOX2 and 
DUOXA2 following the infection with RSV, a pathogenic member of the 
Paramyxoviridae family. Our results demonstrate only weak DUOX2 and DUOXA2 
induction in the setting of RSV infection. Interestingly however, when analyzing 
DUOX2 and DUOXA2 induction following treatment with UV-treated supernatant 
from RSV-infected cells, considerable levels were observed. This correlates with the 
fact that secreted IFNβ and TNFα concentrations from RSV-infected cells were in the 
similar range to those measured after SeV infection. We further observe that the 
magnitude of DUOX2 induction is inversely correlated with the quantity of replicating 
RSV, since supernatant from RSV-infected cells that had not been treated with UV and 
therefore still contained infectious replicating viral particles showed less potency in 
DUOX2 induction than supernatant from RSV-infected cells that had been treated with 
UV. These results suggest that the presence of replicating RSV inhibits DUOX2 
expression. Since secreted IFNβ and TNFα levels in SeV infection, which efficiently 
induces DUOX2, and RSV infection are comparable, we speculate that RSV has in put 
place an inhibitory mechanism(s) that does not target the primary antiviral pathways 
leading to the initial secretion of these cytokines. Rather, in our experimental setting, 
RSV may target the STAT2/IRF9-dependent signaling pathway that is specifically 
induced by IFNβ and TNFα synergy. How exactly RSV achieves interference with this 
novel antiviral pathway will be subject to further studies. So far, from the literature it 
seems evident that several RSV viral proteins could be involved in such an inhibitory 
mechanism. NS1 and NS2 of RSV proteins have both been described to target STAT2 
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thereby shutting down IFN-induced antiviral JAK-STAT signaling (Elliott et al., 2007; 
Lo et al., 2005; Ramaswamy et al., 2006; Swedan et al., 2009). Besides NS1 and NS2, 
the RSV attachment protein G can also interfere with the JAK-STAT signaling 
pathway via modulation of SOCS-1 and SOCS-3 expression, which are negative 
regulators of the IFN-induced JAK-STAT pathway (Hashimoto et al., 2009; Moore et 
al., 2008). These members of the SOCS family could equally inhibit the STAT2/IRF9-
dependent pathway described in our studies.  
Several outcomes of RSV-mediated DUOX2 inhibition can be envisioned. The 
first scenario is that the inhibition of efficient DUOX2 induction by RSV might 
interfere with the generation of a complete antiviral state. Consequently, the antiviral 
response against RSV would not prove as effective, resulting in increased viral load 
and virus-related pathology. Interestingly, in CF patients, DUOX2 expression in the 
airways is decreased compared to healthy donors (Wright et al., 2006). The absence of 
DUOX2 could thus contribute to the increased susceptibility to respiratory virus 
infections observed in these patients (Zheng et al., 2003). Further, from several studies 
it is clear that DUOX2 is an effective player in antibacterial defenses, and, although so 
far only described in the gut, a regulator of homeostasis of commensal bacterial 
populations (Gattas et al., 2009; Ha et al., 2009b; Moskwa et al., 2007). Thus, 
inhibition of DUOX2 expression by RSV could not only have an effect on the infecting 
virus itself, but could also lead to an imbalance in airway resident bacteria and 
decreased antibacterial defenses against pathogenic bacteria. In this context, RSV 
infection often presents itself with complicating bacterial co-infections and one reason 
for this could be the interference of RSV with DUOX2 antibacterial defenses 
(Thorburn et al., 2006).  
 
Study improvements 
A major drawback of our study includes the issue of DUOX2-derived ROS and 
their function in the antiviral response. Our study was able to demonstrate an increase 
in H2O2 production following IFNβ and TNFα costimulation as well as SeV infection. 
This increase was shown to be DUOX2 dependent. Using the antioxidant catalase, we 
	   201 
demonstrate that H2O2 is indeed important in conveying an increased antiviral state. 
However, although the application of catalase can be taken as proof that extracellular 
H2O2 is implicated in the antiviral response, it does not however provide clear evidence 
for the implication of DUOX2-derived ROS in the antiviral defense. Indeed, these ROS 
could be generated by a different source. We propose that future studies using 
expression of inactive DUOX2 variants could deliver much clearer results on the 
implication of DUOX2-derived H2O2. In this context, patients suffering from congenic 
hypothyroidism (CH) are known for mutations in the DUOX2 genes. For instance, the 
Gly1518Ser mutation in the DUOX2 genes of such patients results in DUOX2 
enzymatic inactivation (Hoste et al., 2010). Further, three other mutations have been 
described to cause inactivation of the DUOX2 enzyme: S965fsX994 deletion that 
causes a frameshift resulting in a termination signal within exon 22 of the DUOX2 
gene; Tyr1150Cys as well as Ala728Thr mutations equally result in enzyme dead 
variants (De Marco et al., 2011). The application of DUOX2 expression plasmid 
constructs containing these mutations could give straightforward insight on the 
implication of DUOX2-derived ROS in the establishment of the late antiviral state. 
 
NOX2 and DUOX2 – a united couple in the antiviral defense 
As early and late antiviral responses are tightly intertwined, one cannot separate 
the action of NOX2 in the early phase of viral infection from DUOX2, which functions 
at late stages of viral infection. In other words, NOX2 and its influence on early 
antiviral signaling and antiviral proinflammatory genes expression will also determine 
if, during the late antiviral response, DUOX2 can be induced efficiently. This suggests 
a model by which initial NOX2-regulated NF-κB and IRF-3 activation drives an early 
antiviral response, characterized by IFN induction and ISG expression. DUOX2 is 
among these ISGs, and its expression might highly depend on this early action of 
NOX2. Once expressed, it sustains antiviral action via prolonged IFNβ and IFNλ 
stimulation in AECs (Figure 14). We have not evaluated DUOX2 expression in the 
context of decreased NOX2 expression and viral infection. However, based on the 
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effects we observed on IFNβ and TNFα cytokine levels in NOX2-RNAi conditions, it 
is very likely that DUOX2 expression would also be affected in these conditions.  
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Figure 14: NOX2 and DUOX2 in the antiviral airway defense. 
Schematic presentation resuming the findings of this doctoral thesis work. NOX2 
regulates ΝF−κΒ activation and ΝF−κΒ regulated cytokines expression following 
Paramyxoviridae infection of AEC. DUOX2 is induced during the late phase of viral 
infection via synergistic action of secreted IFNβ and ΤΝFα. Induction of DUOX2 
expression relies on a non-canonical, STAT2/IRF9-dependent signaling pathway. 
DUOX2 is necessary for the establishment of an efficient antiviral state as it sustains 
the late expression of antiviral cytokines IFNβ and ΙFΝλ. Pathogenic RSV evades the 
DUOX2-mediated antiviral mechanisms, as it has developed means of interfering with 
the DUOX2-inducing signaling cascade.  
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What is the beginning of it all? 
The presented data raises the following fundamental question, which has not 
been resolved by the studies conducted during this thesis: how, upon AEC infection by 
viruses, are NOX2 and DUOX2 activated to be able to elicit their ROS-dependent 
functions? Is it possible that besides their putative basal ROS producing activity 
serving in housekeeping function, viral infection might trigger a signal that specifically 
turns on or increases NADPH oxidase activity? This scenario is very likely for the 
basally expressed NOX2 but might also be the case for DUOX2, as our observed 
elevated DUOX2 mRNA and protein levels in the context of AEC viral infection might 
additionally require an induction of DUOX2 activity in order to translate into a 
physiological, ROS-dependent change following viral infection.  
In the case of NOX2, classical activation is driven by phosphorylation events of 
the regulatory subunits p47phox, p67phox, and p40phox. This culminates into the 
recruitment of these subunits to the cytochrome b558 membrane complex, thereby 
inducing molecular mechanisms that culminate into the ROS generating electron-
transfer. Many kinases were shown to be involved in the phosphorylation events 
leading up to NOX2 activation in a diverse array of contexts. As mentioned, several 
PKC isoforms (PKCα, PKCδ, PKCβ, PKCγ, and PKCζ), PKA, p21 activated kinase, 
Erk1/2, AKT, PI3K, and possibly others come into play (Lam et al., 2010). 
Interestingly, most of these kinases also become activated during the course of viral 
infection, which could constitute the necessary signal to trigger NOX2 activation 
(Arnold and Konig, 2005; Marchant et al., 2010; Monick et al., 2001; Monick et al., 
2004; Monick et al., 2005).  
Further, it is very likely that close proximity of the NADPH oxidase with the 
viral entry site is necessary to trigger infection-dependent ROS production. This could 
be achieved via the existence of membrane microdomains where on the one hand virus 
entry is likely to occur and on the other hand NADPH oxidases are present. In this 
context it has been shown that IL-1R- and TNFR-mediated activation of NF-κB is 
driven by NOX2, which localized to plasma membrane lipid rafts and was necessary 
for TRAF6 and TRAF2 recruitment following receptor-mediated caveolin-dependent 
	   205 
endocytosis (Li et al., 2006; Li et al., 2009). Viral cell surface receptors, such as the 
RSV receptor nucleolin, have been shown to localize to such membrane microdomains. 
Thus, the RSV entry site could find itself in close proximity to NOX2, thereby laying 
the basis for an efficient signal transduction that links the event of viral entry with 
NADPH oxidase activation.  
Additionally, the site where viral genome detection occurs might need to be in 
close distance to an NADPH oxidase. In this context, it has been known that certain 
PRRs find themselves in close proximity to NADPH oxidases. For instance, a complex 
formation of flagellin-sensing TLR5 and DUOX2 has been demonstrated previously 
(Joo et al., 2012). However, for Paramyxoviridae infection, it still remains to be 
demonstrated if NOX2 is indeed in close proximity to the virus-recognizing PRRs 
RIG-I and MDA-5 in AEC.  
In the case of DUOX2, studies in the Drosophila model propose that DUOX2 
basal enzymatic activity is necessary for the balance of symbiotic existence with 
commensal microorganisms in the gut, a pathway referred to as activity pathway. On 
the contrary, microbial infection leads to potentialisation of ROS production by DUOX 
by means of increasing DUOX expression via the expression pathway (Ha et al., 
2009b). A similar mechanism can be pictured in the lung epithelium, where basal 
DUOX2 expression could keep a balance in airway resident microorganisms. 
Respiratory virus infection might lead to increased ROS production by induction of 
DUOX2 gene expression. Besides increases in DUOX2 expression levels, Ca2+ 
fluctuations might constitute a DUOX2 activating signal during virus infection. In this 
context, the Drosophila model has been helpful in delineating the dependency of 
DUOX activity on Phospholipase C β, which is necessary for generating inositol 
triphosphate (IP3) which in turn will lead to Ca2+ release from the endoplasmatic 
reticulum (Ha et al., 2009a). In this line of thought, it is noteworthy that DUOX2 
activity is highly induced in thyroid cells following phorbol ester PMA stimulation in a 
manner dependent on PKC, which lies downstream of phospholipase C (Rigutto et al., 
2009). It is known that certain viruses or viral proteins increase the cytosolic Ca2+ 
concentration (Brisac et al., 2010; Chami et al., 2006). This phenomenon has not yet 
been evaluated in the case of SeV or RSV infection. However, if changes in Ca2+ levels 
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should occur in Paramyxoviridae infection, these could plausibly constitute a 
triggering signal for DUOX2 activity.  
 
 
4 Conclusion 
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“ […] Much remains to be learned about these enigmatic proteins […] ”. With 
this phrase, Pr. Vignais ended his last review on the phagocyte NADPH oxidase NOX2 
(Vignais, 2002). And indeed, since the publication of these words, our scientific 
knowledge on NADPH oxidases has increased tremendously. Today, while I am 
writing this sentence, 11320 scientific publications can be found after my search for 
“NADPH oxidase”, whereas at the beginning of 2002 there were only about 3000. The 
first non-phagocytotic oxidase, NOX1, was only discovered in 1999, approximately at 
the same time when the DUOXs were discovered in the thyroid (Dupuy et al., 1999; 
Suh et al., 1999). Today, NADPH oxidases are known to control processes such as cell 
transformation, angiogenesis, inflammation, immune activation and many others. This 
is where we stand. This is where this thesis adds yet another piece to the complex 
puzzle of NADPH oxidases. 
We started our scientific journey with a hypothesis, namely that NADPH 
oxidases regulate the antiviral and proinflammatory mechanisms following 
Paramyxoviridae infection of AEC. Now, that we have ended our journey we can say 
that, yes, indeed, NADPH oxidases regulate antiviral and proinflammatory 
mechanisms in SeV- and RSV-infected AEC. We reveal that NOX2 is a major 
contributor to SeV- and RSV-induced inflammatory processes as it contributes to NF-
κB and consequently virus-induced cytokine expression of AEC. Further, we 
demonstrate that AEC upregulate DUOX2 NADPH oxidase during the course of viral 
infection and that this upregulation contributes to a global antiviral resistance state. 
Our results further indicate that human pathogens, such as RSV, possess strategies to 
counteract this antiviral mechanism. To our knowledge, these are the first reports 
demonstrating the implication of NOX2 and DUOX2 in proinflammatory and antiviral 
processes in AEC. 
We believe that these results lay an important foundation, not only for the 
understanding of the principles of AEC antiviral defense, but also for future studies. 
An issue that has not been addressed in this thesis is the exploitation of our results to 
improve lung immunity in respiratory virus infection. Could NOX2 constitute a 
potential target for calming the “cytokine storm” observed in pathogenic virus 
infections? Can airway antiviral immunity be increased by enforcing the DUOX2 
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system? If yes, how could this be achieved? Several sources propose that targeting 
NOX2 might indeed constitute a means to improve disease outcomes associated with 
respiratory virus infections (Vlahos et al., 2012). We argue that targeting NOX2 might 
not be such a straightforward issue. Although NOX2 clearly seems to be a regulator for 
post-infection inflammatory processes and our study adds to a broader understanding 
of the events taking place specifically in AEC, we still have unsufficient knowledge to 
whether NOX2 in AEC or in hematopoietic cells should be the target of intervention. 
In this context it should be stressed that inhibiting NOX2 might unlikely be specific to 
a certain compartment. Further, dampening NOX2 to downregulate the cytokine-
environment might be a double-edged sword, considering that DUOX2 induction 
requires precence of IFNβ and TNFα. Further, other literature demonstrates that NOX2 
supports RIG-I signaling by sustaining MAVS levels (Soucy-Faulkner et al., 2010). 
Thereby, NOX2 inhibition might have the negative side effect of hampering with AEC 
antiviral mechanisms.  
Attempting to increase DUOX2-mediated antiviral responses might indeed be 
beneficial in RSV infection, since our results suggest that this virus interferes with the 
mechanisms that upregulate DUOX2 expression. The identification and targeting of the 
mechanism by which RSV interferes with this pathway should be a priority as it could 
significantly enhance airway antiviral immunity in RSV infection.  
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Annex – Contribution to other scientific work 
 
 
1. Requirement of NOX2 and Reactive Oxygen Species for efficient RIG-I-
Mediated Antiviral Response through Regulation of MAVS Expression 
 
Anton Soucy-Faulkner, Espérance Mukawera, Karin Fink, Alexis Martel, Loubna 
Joan, Yves Nzengue, Daniel Lamarre, Christine Vande Velde, Nathalie Grandvaux. 
 
PLoS Pathogens, 2010, 6(6): e1000930. 
 
This article highlights a crucial role for NOX2 in the airway antiviral defense. It 
shows that NOX2 is essential in maintaining MAVS levels, thereby establishing the 
basis for efficient antiviral signaling. In the absence of NOX2, MAVS levels were 
decreased, which resulted in decreased IRF-3 activation and antiviral cytokines 
expression in the context of SeV infection in AEC. Previous data have indicated 
that IRF-3 activation following AEC infection might indeed be subject to NADPH 
oxidase-dependent redox regulation, however our work was able to identify the 
mechanism, by wich NOX2 sustains airway antiviral function in a redox-sensitive 
manner. 
 
 
2. Innate host defense: NOX and DUOX on phox’s tail 
 
Grandvaux Nathalie, Soucy-Faulkner Anton and Fink Karin. 
 
Biochimie, 2007, 89(9):1113-22.  
 
This review article published in 2007, discussed the at the time of publication still 
quite novel notion that NADPH oxidases not only functioned in phagocyte innate 
immunity, but were subtle regulators of innate immune processes in various 
cellular contexts. 
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3. Inhibition of the beta interferon gene by the human herpesvirus 6 immediate-
early 1 protein 
 
Joanna Jaworska, Annie Gravel, Karin Fink, Nathalie Grandvaux  and Flamand Louis. 
 
Journal of Virology, 2007, 81(11):5737-5748. 
 
The study by Jaworska et al. studied the mechanism of Human Herpesvirus-6 (HHV-6) 
in the inhibition of the antiviral immune response. More specifically, HHV-6 
immediate early protein-1 (IE1) was found to interfere with efficient IRF-3 activation. 
Thus work contributed significantly to the understanding of how HHV-6 evades 
antiviral immunity to establish successful infection. My work in this context consisted 
in the analysis of IRF-3 dimerization in the presence of IE1A and IE1B following 
transfection of TBK-1 to activate the antiviral signaling cascade.  
 
 
 
 
